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„There is plenty of room at the bottom. “ 
 
On the 29th of December 1959, physicist Richard Feynman held his historical talk in front of a scientific 
audience at the California Institute of Technology. [1] It was not until then that people started to think about 
the endless possibilities of something so small. Feynman prospected that scientists in the future will be able 
to manipulate individual molecules and atoms for the construction of more advanced data storages or 
microscopic machines. It took another twenty years until the scanning tunneling microscope was developed, 
which finally allowed scientists to monitor individual atoms for the first time. [2] Norio Taniguchi finally 
coined the term nanotechnology in 1974. [3]  
However, what is nanotechnology? The prefix originates from the Greek word nanós, which translates to 
dwarf and is nowadays used to describe, e.g., the billionth part of a meter (10-9 m). [4] A sheet of paper, for 
example, has a thickness of 100,000 nm, an ant is 5,000,000 nm long, and the human DNA strand has a 
diameter of 2.5 nm. [5] There are several, slightly different definitions by the International Organization for 
Standardization (ISO), [6] the Organization for Economic Co-Operation and Development (OECD), [7, 8] 
the European Commission (EC), [9] and the American Society for Testing and Materials International 
(ASTM) [10], but there is consensus that an object is considered to be in the nanoscale if one or more external 
dimensions (height, length, width) are in the size range between 1 and 100 nm. Thus, nanomaterials can exist 
as three-dimensional particles with three dimensions in the sub 100 nm range, tubes with two-dimensions 
within this range, or platelets with one dimension within this range. [6]  
The term engineered nanomaterial (ENM) is used for intentionally produced nanomaterials. Nanotechnology 
engages with structures, shapes, or particles within the nanoscale, requiring a tight collaboration between 
material scientists, chemists, physicists, and biologists. Nanomaterials can also be naturally born through 
volcanic eruptions, dust from cosmic sources, or fires; for these materials, the term unintentionally 
nanomaterial is used within this thesis. [11] ENMs of the same chemical composition as their bulk 
counterparts have an increased surface to volume ratio, leading to a higher share of the atoms being exposed 
on the material's surface, where the crystalline structures need to have defects and thus more reactive sites. 
This can fundamentally alter the interaction between the particle and the surrounding environment, e.g., gold 
nanoparticles are effective catalysts, whereas bulk gold is one of the least reactive materials. Furthermore, 
the composition, surface functionalization, morphology, and the hydrophilic or hydrophobic nature of the 
particles can be designed to improve functionality. [12-14] 
The interdisciplinary nature of nanotechnology has rapidly advanced into broad applications in the fields of 
chemistry, [15-18] construction, [19, 20] medicine, [12, 21-23] biotechnology, [24-26] electronics, [27, 28] 
automotive, [29, 30] personal care, [31, 32] food and packaging, [33, 34] as well as many more. [35] The 
European Union (EU) acknowledged the importance of nanotechnology as member of a group of six Key 
Enabling Technologies (KETs) additionally comprising micro and nanoelectronics, industrial biotechnology, 
advanced materials, photonics, and advanced manufacturing technologies. The KETs are thought to stimulate 
industrial innovation and address societal challenges and create advanced and sustainable economies in the 
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21st century. [36] These technologies are driving factors for economic growth as well as sustainability, 
eventually making our everyday lives more comfortable. With broad applications, there are nearly endless 
ENM compositions, surface functionalization, shapes, sizes, or structures. [37]  
1.2 NANOSAFETY 
With continually growing fields of applications for ENM and immense technological and economic potential, 
it needs to be kept in mind that nanotechnology also entails potential risks. [38, 39] due to their high surface 
to volume ratio, some nanomaterials are chemically more reactive. [40] Decreasing particle size will lead to 
increased reactivity for some ENM [41] and, furthermore, to the generation of reactive oxygen species (ROS) 
known to be one of the major causes of inflammation. [42-44] ENM’s high reactivity [45] leading to 
beneficial intended uses, might make ENMs harmful for humans and the environment. [46, 47] All ENMs 
entering the market should be tested for their safety for human and the environment. Therefore, it is of 
greatest interest to considerately take the hazard potential into account while exploiting nanotechnologies' 
full potential. [48, 49] Exposure to dusts from handling powders of ENMs is mostly limited to manufacturers 
and production workers as well as scientists working with nanotechnology. [50, 51]  Whereas consumers and 
the general population can be exposed to ENMs released into the environment or used in consumer products 
(e.g. other ENMs as sunscreens in cosmetics).[52]  
 
 
Figure 1: Production Volume of Nanomaterials in tons/year in France in 2019 [53]. Dark blue is marking the lower limit and 
light blue the upper limit of the production volume. 
The European Union Observatory of Nanomaterials (EUON) currently lists 331 unique nanomaterial entries 
on their webpage. [54] Over 4400 consumer products are registered in the Danish database containing a 
„nano claim“. [55] Figure 1 shows the production volume of some essential ENMs in the year 2019 in 
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France. [53]. SiO2, TiO2, CaCO3, Carbon Black are the most relevant materials, of which between 10,000 
and 1,000,000 tons are produced as ENM. Various pigments and metal oxides with production quantities 
between 100 and 10,000 tons are the next most relevant substance class of ENMs. 
The growth ENMs production volume and applications can lead to a higher exposure and diversified exposure 
pathways. When assessing the safety of ENMs, it is essential to understand their lifecycle and fate. Pioneering 
in the field of ultrafine particles, Oberdörster et al. and Seaton & Donaldson introduced in 2005 the term 
“nanotoxicology” while simultaneously pointing out the two elements to assess the potential risk of 
nanomaterials: the toxicity of ENMs and the expected exposure. [45, 56, 57] Several nanomaterials are 
embedded in a matrix, leading to a decreased probability of exposure. However, in other cases, nanomaterials 
might get taken up by humans through inhalation [58], ingestion [59] or skin contact [60, 61]or will end up 
in the environment. [62] ENMs, which lead to unexpected illnesses upon exposure, might be developed. [48] 
asbestos fibers are not a nanomaterial, but set precedence of a fatally long lag time between exposure and 
illness: Asbestos fibers have previously been used as inexpensive fillers in construction materials to function 
as anti-flaming agents but are nowadays known for their carcinogenic potential inducing the very specific 
mesothelioma cancer. [63] High aspect ratio nanomaterials (HARN) that are also similarly long and rigid as 
asbestos have similar toxic potential, leading equally to mesothelioma. [64-67] Among ENMs, only the 
“Mitsui NT7” type of Carbon Nanotubes (CNTs) fulfills these criteria and has been formally recognized as 
carcinogen. [68] 
Most ENMs do not share these criteria, but nonetheless their hazards needs to be thoroughly assessed to 
facilitate risk management and prevent humans and the environment from being exposed to ENMs in 
quantities that cause adverse effects. [69] However, previously established guidelines to determine the hazard 
potential of bulk materials need adaptations to be applicable to ENM. Especially for inhalation studies the 
physicochemical properties (PCPs) of ENM must be assessed. The dispersibility, shape, particle size, 
dissolution, reactivity, and several more intrinsic and extrinsic PCPs are directly influencing the deposition 
within the lung, translocation to systemic sites, and inflammatory potential. [45]   
 
The 3R principle calls for in vivo studies to be conducted with as little burden for the animals as possible 
(refinement), as little animals as possible (reduction) and wherever possible for a replacement by non-animal 
methods. [70-72] Hence there is a challenge to predict potential adverse effects of ENM based on their 
material properties (comparable to QSAR predictions for molecules) [73]. In a tiered approach, the intrinsic 
physicochemical properties (PCPs) of ENMs are addressed first, followed by the extrinsic properties (also 
termed “functionality” or interactions at the bio-nano interface), and in vitro toxicity testing to predict 
potential toxic effects in humans. In vivo testing in animals is the last resort to assessing the adverse effects. 
[70] 
There is a tremendous amount of ENMs ranging in size, morphology, surface functionalization, and 
compositions. [69, 74] It is nearly impossible to test all PCPs that may eventually trigger biological responses. 
Therefore, the ISO published several essential characterization techniques relevant to the risk assessment in 
a tiered approach. The tiered testing methods should aim at the physicochemical characterization of the 
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ENMs with the surface area as calculated through the Brunauer-Emmett-Teller (BET) equation, [75] the bulk 
chemical composition, surface chemistry, particle size, particle size distribution (PSD), morphology/shape, 
surface charge, agglomeration/aggregation state, crystal structure, and solubility. [76-78]  
There are several physiological ways how humans can take up both naturally occurring NMs as well as ENM 
either through inhalation, ingestion, or dermal uptake and injections for medical applications.   
 
1.2.1 Inhalation Uptake 
The most critical pathway for uptake of ENMs into the human body is by inhalation. [45] Ultrafine, airborne 
particles such as unintentionally produced soot from combustion engines or inorganic dust from volcanoes 
eruptions or dusts from handling ENM powders can remain suspended in the air for hours and can be 
transported over long distances. The inhalable fraction (below 10 µm agglomerate size) can enter the human 
airways, and the respirable fraction (below 2.5 µm) can reach the lower airways and alveoli. Despite several 
allegations, [79] only a negligible fraction of ENM can cross biological barriers, resulting in systemic 
availability and internalization of cells other than by endocytosis.[80] Instead, ENMs mostly remain in the 
primary target organ, the lung, and are cleared by different processes, depending on where they are deposited: 
For the deposition in the upper airways a clearance through the mucociliary transport is rate-determining. 
Here particles deposit on the mucus blanket which covers the airways. The mucus blanket is then moved 
towards the pharynx by cilia.[81] Particles that reached the alveolar region are taken up by alveolar 
macrophages and are either digested or transported to the mucociliary escalator, the interstitium or the lung-
associated lymph nodes. The alveolar clearance is slower than the mucociliary clearance. [58, 81]  
ENMs taken-up by macrophages may partially or fully transform and or dissolve during these processes, and 
both the released ions and the remaining (transformed) particles may induce adverse effects. [82, 83] In 
standard inhalation models (i.e. OECD 413 and STI), groups of rats are exposed to defined (usually three) 
concentration of ENMs within an aerosol for a defined period (e.g., six hours per day, five days per week for 
13 weeks in an OECD TG 413). [84, 85] After the exposure, the rats are examined for adverse effects induced 
by ENM inhalation; furthermore, lung and other organ burdens can be analyzed. However, these tests use 
animals and are time-consuming and expensive, making it impossible to test all ENMs by inhalation toxicity 
studies. This is calling for alternative approaches for nanotoxicological assessment for human exposure. 
Immediately after deposition, ENMs interact with the lung lining fluid upon reaching the alveolar tract 
(Figure 2). PCPs of the ENMs such as surface functionalization, zeta-potential, and surface charge may alter 
their biological systems' behavior, eventually leading to different adverse effects. Uptake in cells and ensuing 
biokinetics confront the ENM with different physiological compartments, e.g., lysosomal fluids. Within 
STIS, a relationship between inflammation and surface-area dependent dose was found for carbon black. [86] 
Inhalation of ZnO ENM induced olfactory epithelium necrosis after 14- or 21- days in rats. Other ENMs are 
known to elicit concentration-dependent pulmonary inflammation. [87] Interspecies differences of e.g., the 
ventilation volume and the immune system need to be considered in extrapolating from animal (mostly rat 
and mice) inhalation studies to human effects. But very clearly, cohort studies on occupational exposure 
confirm that certain fine and ultrafine particles can be toxic even at low exposure concentrations. E.g., 
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occupational exposure to crystalline SiO2 resulted in an overall elevated standardized mortality ratio for renal 
disease, silicosis, lung cancer, and non-malignant respiratory disease. [68, 88, 89] And yet, puzzles remain. 
E.g., the substance of BaSO4 was widely considered as inert and insoluble material. Surprisingly though, 
inhalation studies with nano-BaSO4 in rats have shown rapid clearance from the lung with less than 10 days 
halftime. More than 30% of the Ba was found in the bones.[90] The abiotic and in vitro screening methods 
failed to predict such behavior.  
 
Figure 2: Schematic uptake of ENM through inhalation. After inhalation, particles are exposed to the lung lining fluid first, 
followed by the lysosomal fluid within the alveolar tract. 
1.2.2 Oral 
Oral uptake is another relevant pathway for the uptake of nanomaterials. ENMs can be taken up either via 
the ingestion of food (e.g., additives and formulated nutritional supplements), [91] or unintentional hand to 
mouth transfer, or swallowing particles cleared from the lung by the mucociliary escalator (Figure 3). [92] 
The toxicity of ENMs depends on their extrinsic properties upon exposure to the different relevant 
compartments, saliva, gastric juice, intestinal juice. [91] Even though the compartments within the 
gastrointestinal (GIT) tract contain enzymes, most inorganic ENMs will not be digested. However, some may 
partially or even fully dissolve. [93, 94] Persisting particles are excreted with the feces or absorbed – usually 
just a small fraction. Ingested ENM can also affect the commensal gut microbiota. [95] Bioavailability and 
toxicity are governed by particle size and aggregation and the surface reactivity and the release of toxic ions. 
[96] Studies have shown that ZnO nanoparticles, which are intentionally used for their antimicrobial property 
in packaging and could, therefore, accidentally leach into the food, could penetrate microbial cells where 
they induced cytotoxicity through reactive oxygen species (ROS) generation. [97] Zn uptake increased with 
decreasing particle size in rodents, leading to hepatic injury, kidney toxicity, and lung damage, [98] but the 
study did not conclusively demonstrate uptake as particles or as ions. The food-grade TiO2,E171, with only 
>36% of the particles being below the size of 100 nm (hence not an ENM by legal definitions) was found in 
some parts of the body.[99] Furthermore, only a little clearance within the tissues of mammals was found in 
a study with 16 rats[100] Sub chronic studies in rats with intragastrically administered TiO2 at concentrations 
of up to 5000 mg/kg body-weight/day accumulated in liver, spleen, kidney, and lung tissue, adverse effects 
nephrotoxicity, hepatic injury, and myocardial damage were observed. [101] With an approximate uptake of 
lnhalative uptake of ENM 





1.1 - 2.2 mg/kg body-weight/day by humans, TiO2 is one of the most relevant food additives. [99]  For SiO2, 
the European Food Safety Authority (EFSA) estimates an even higher daily intake of between 20 - 50 mg for 
a 60 kg person. [102] In a ten-week feeding study in mice with 30 nm SiO2 ENM and 30 µm SiO2 particles, 
Si content accumulated in similar concentrations in the liver whereas only the nano-sized particles caused 
adverse effects as usually observed in fatty livers. [103] EFSA requires producers to assess the safety of all 
purposely produced ENMs with a size between 1-100 nm, of materials larger than 100 nm with characteristic 
properties of the nanoscale, and materials not purposely engineered as an ENM but with fractions of particles 
with less than 50% in particle number in the range of 1-100 nm. [104]  For the risk assessment the following 
extrinsic properties need to be determined: stability, solubility, degradation, dispersibility and reactivity. 
[104]  
 
Figure 3: Schematic uptake of ENM through oral ingestion. After ingestion, particles are exposed to saliva first, followed by 
gastric juice within the stomach and intestinal juice within the intestine. 
 
1.3 REGULATIONS AND REQUIREMENTS 
Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) is the most important 
regulation of the European Union that is adopted to protect human health and the environment from the risks 
that can be posed by chemicals. [105] The REACH regulations also apply to all ENM produced or imported 
into the EU. [106] Therefore, hazard identification, hazard assessment, exposure assessment, and risk 
assessment must be conducted for chemicals manufactured or imported in the EU. [107] As of January 2020, 
manufacturers of nanomaterials have to provide information on ENMs, including the chemical safety 
assessment (ANNEX I), characterization of nanoforms, or set of nanoforms (ANNEX VI) and registration 
information requirements (Annexes III and VII-XI) including data on toxic effects. [106] Fulfilling the 
information requirements on nanoforms recently introduced by the new European Chemicals Agency 
(ECHA) guideline may entail extensive testing of each nanoform. [108] Testing requirements for each 
nanoform are derived from the yearly production volume of the substance. For production volumes above 
1 ton/year, acute toxicity testing must be assessed through the oral route. Production volumes between 10-
100 tons/year require, in addition to the acute toxicity studies, short-term repeated dose toxicity studies over 
28 days if exposure of humans via inhalation is likely. Furthermore, the recovery period and lung clearance 
Oral uptake of ENM 
Saliva Gastric Juice Intestinal Juice 
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shall be considered to assess nanoforms' toxicokinetics without high dissolution rate. And the degradation as 
well as transformation for non-soluble nanoforms. Additionally for nanoforms with a production volume 
above 100 tons/year, sub-chronic 90-days toxicity studies need to be conducted. [108] The ECHA guidelines 
require animal testing for each nanoform, unless if it can be shown by grouping and read-across that animal 
tests were previously examined on a similar nanoform. The perspective of an enormously increasing 
consumption of test animals intensified the development of alternative testing and non-testing (grouping) 
methods, such as those elaborated in this thesis. Physicochemical descriptors, as given in Table 1, are 
required to define a nanoform. Nanoforms with similar hazard profiles can be grouped in a “set of similar 
nanoforms” and only one nanoform needs to be tested in order to apply the test results to all nanoforms of a 
set. The similar compositions of nanoforms are not enough to justification the grouping of different 
nanoforms, because additional particle properties influence the hazard profile of a nanoform. Thus, defining 
sets of similar nanoforms has great potential to reduce animal testing. Identifying intrinsic and extrinsic 




1.4 NANOMATERIAL GROUPING AND RESEARCH NEEDS FOR SIMILAR 
NANOFORMS 
ENM can be produced in several nanoforms with different sizes, crystalline forms, shapes, and surface 
characteristics. The ECHA Guidance on nanoforms [108] defines nanoforms and sets of similar nanoforms. 
It notes that, in principle, toxicological data from a nanoform may be used for the safety assessment of another 
nanoform if it can be shown that they are similar enough.  For other chemicals (molecules, not ENM), this 
approach is well-established and is termed grouping (identify sets of sufficiently similar chemicals) and read 
across (use the known toxicological properties of one chemical for the safety assessment of another chemical 
of this group). This approach helps to avoid case‐by‐case animal testing of all nanoforms of a given substance, 
but it does require testing by physical-chemical and alternative toxicological methods to substantiate the 
grouping. The ECHA provided guidance on read-across of chemicals as well as sets of similar nanoforms. 
[109, 110] While methods and read-across for chemicals have been developed during the last decade [111], 
specific methods and decision criteria to define groups of sets of similar nanoforms are not yet commonly 
accepted. The European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC) proposed a 
decision-making framework for the grouping and testing nanomaterials (D4FnanoGrouping). [112] This 
framework highlighted the importance of assessing extrinsic properties to assign nanomaterials into four 
different main groups with additional sub-groups. The system-dependent properties – biopersistence, bio-
physical interactions, uptake, and biodistribution  – were been chosen as relevant parameters for grouping 
purposes next to intrinsic properties and in vitro cellular next to apical toxical effects. [113] In the 
nanoGRAVUR project, a framework for the testing of ENM was established based on three Tiers. Starting 
with Tier 1, answering the question of “What they are” in terms of the ENMs' physical structure and chemical 
composition. Within Tier 2, the questions on “where they go” in terms of release and exposure and “where 
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they go” in relevant media are answered by assessing extrinsic properties. Furthermore, the “what they do” 
was assessed through reactivity studies abiotic and in vivo. Tier 3 then examined human toxicity and 
ecotoxicity (Figure 4). [114] 
 
Figure 4: nanoGRAVUR grouping framework proposing a Tiered assessment of the risk. Figure reproduced from Wohlleben 
et al. 2019. [114] 
There are several more grouping frameworks, e.g. Kuempel et al. proposed the assessment of basic 
parameters such as particle size, shape, density, surface area, reactivity, solubility, multiple exposures or dose 
groups, the biological significance of response, and target lung region surface area and volume In animal 
tests. [115] Obviously, in-vitro testing and extrinsic (system-dependent) PCPs are very important for 
grouping frameworks, but so far, no OECD guidelines for their assessment exist. Furthermore, solely the 
determination of the system-dependent reactivity by electron spin resonance is described through an ISO 
norm; all other existing methods are not standardized. [116] On top of that, plenty of approaches assessing 
the in vitro toxicity are existing, but none of them are standardized, and none systematically considers in-
vitro dosimetry.
Tier 1 
"What they are : 







"What they are : 



















"what is the NEP": 
NEP-dependent 
processes , uses , 
testing needs , 
specific NEP: 
dispersion 
state of ENM 
Tier2 
"Where they go": Release / Exposure 
Dustiness upon NEP 
application 
[ ] 







"Where they go": In relevant media 
Ion-releasing 
Dlssolu tlon In 
relevant media 
"What they do " 
RNctMly 
(ablollc) ,] [ RNctMly (In vllro) ] 
Concentrat ion & exposit ion at 
workplace , e.g. breathing zone for 
humans 
Spec ifi c testing 
of fate , moblllty , transport 
& trans forma ti on 
Specific testi ng 
of uptake and clearance 






NEP = nano-enabled product * = also a descriptor of nanofonns or sets of similar nanoforms 
# = also a descriptor of discrete forms 
r - ful:e ; o; rt;-- -I 















2 MOTIVATION AND OBJECTIVES 
 
MOTIVATION AND OBJECTIVES 
12 
2.1 DISSOLUTION AND TRANSFORMATION 
What happens to the nanomaterials after being taken up by humans? How can one explain, and properly 
predict for example the unexpectedly fast clearance of BaSO4 from the lung, despite its insolubility in water? 
To determine the fate and the hazard potential of a nanomaterial within the human organism or the 
environment, it is mandatory to understand how an ENM interacts with physiological media. Essential for 
the understanding of the behavior is the determination of dissolution and the transformation of NM in relevant 
media. From mineral fibers, it is known that the Continuous Flow System (CFS) can be used to predict their 
persistence in the lung. For the testing of oral ingestion, several ways are presented in the literature.  
The biopersistence of ENM is affecting their biological fate and hence their toxicity. The dissolution of ENM 
in biological media may be used to predict their biopersistence and can be useful to substantiate the similarity 
of nanoforms. Adopting and optimizing the CFS could provide a suitable method to understand their 
biological fate and substantiate sets of similar nanoforms. As many ENM are poorly soluble, such a method 
would require measuring trace amounts close to the detection (LoD) of the ENM’s constituents released into 
the media. Apart from dissolution, ENM can undergo other transformations in biological media resulting in 
altered particles. Inductively coupled plasma mass spectrometry (ICP-MS) and transmission electron 
microscopy (TEM) were used to explore how these methods can be used to deliver the dissolution rate and 
structural information after exposure to physiological media. Most importantly, within this thesis, 
physicochemical parameters that are influencing particle dissolution were assessed. The results gained from 
these abiotic, dynamic dissolution tests were then compared to the particles actual biopersistence obtained 
from in vivo inhalation studies. According to the uptake through oral ingestion, a cascaded static dissolution 
setup needed to be developed to simulate the different compartments along the GI-tract with several pH 
changes. Both the particle dissolution as well as the transformation were to be investigated. 
These processes are directly linked to both, the organ burden of (native and transformed) ENMs and the 
release of potentially toxic ions from ENMs in the human body. The aim of the work described here is, to 
develop and standardize methods to study the dissolution of ENMs in order to predict their fate in the human 
body. The data obtained from applying these methods can assist identifying sets of nanoforms with similar 
hazard profiles. 
 
The following publications are related with this topic: 
 
• Koltermann-Jülly J*, Keller JG*, Vennemann A, Werle K, Müller P, Ma-Hock L, Landsiedel R, Wiemann 
M, Wohlleben W. Abiotic dissolution rates of 24(nano)forms of 6 substances compared to macrophage-
assisted dissolution and in vivo pulmonary clearance: Grouping by dissolution and transformation. 
NanoImpact 2018 Okt, Volume 12, pp. 29-41. DOI: 10.1016/j.impact.2018.08.005.  
 
• Koltermann-Jülly J*, Keller JG*, Vennemann A, Werle K, Müller P, Ma-Hock L, Landsiedel R, Wiemann 
M, Wohlleben W. Addendum to “Abiotic dissolution rates of 24(nano)forms of 6 substances compared to 
macrophage-assisted dissolution and in vivo pulmonary clearance: Grouping by dissolution and 
transformation”. NanoImpact Feb 2019, Volume 14, pp. 100154. DOI: 10.1016/j.impact.2019.100154.  
 
• Keller JG, Graham UM, Koltermann-Jülly J, Gelein R, Ma-Hock L, Landsiedel R, Wiemann M, Oberdörster 
G, Elder A, Wohlleben W. Predicting dissolution and transformation of inhaled nanoparticles in the lung 
using abiotic flow cells: The case of barium sulfate. Scientific Reports 2020, 10. Jg., Nr. 1, S. 1-15. DOI: 
10.1038/s41598-019-56872-3. 
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• Keller JG, Peijnenburg, W., Werle, K., Landsiedel, R., & Wohlleben, W. Understanding Dissolution Rates 
via Continuous Flow Systems with Physiologically Relevant Metal Ion Saturation in Lysosome. 
Nanomaterials 2020, 10(2), 311. DOI: 10.3390/nano10020311. 
 
• Wohlleben W, Hellack B, Nickel C, Herrchen M, Hund-Rinke K, Kettler K, Riebeling C, Haase A, Funk B, 
Kühnel D, Göhler D, Stintz M, Schumacher C, Wiemann M, Keller JG, Landsiedel R, Broßell D, Pitzko S, 
Kuhlbusch TAJ. The nanoGRAVUR framework to group (nano) materials for their occupational, consumer, 
environmental risks based on a harmonized set of material properties, applied to 34 case studies. 
Nanoscale 2019, 11(38), 17637-17654. Doi: 10.1039/C9NR03306H. 
 
• Keller JG, Persson M, Müller P, Werle K, Ma-Hock L, Landsiedel R, Wohlleben W. Subtle differences 
between nanoforms of the same substance induce (dis)similarities of their dissolution and transformation 
behavior that suggest specific groupings for read-across of inhalation hazard assessment. NanoImpact, 
submitted November 2020. 
 
• Keller JG*, Di Cristo L*, Ag Seleci D, Landsiedel R, Werle K, Sabella S, Wohlleben W. Biodissolution in 
cascaded simulants of the gastro-intestinal tract: towards robust screening methods and nanomaterial 
grouping. To be submitted 2020. 
 
• Keller JG, Wiemann M, Gröters S, Werle, K, Vennemann, A, Landsiedel R, Wohlleben W. Which Aerogels 
are safe to use? A categorization approach of 17 organic and two inorganic aerogels based on biosolubility, 
oxidative potential, in vitro reactivity, and in vivo data. To be submitted 2020. 
 
• Yokel R, Wohlleben W, Keller, JG, Hancock ML, Unrine JM, Butterfield A, Grulke EA. Nanoceria 
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2.2 DOSIMETRY 
What and how much does the cell see? 
When comparing results of ENM tested in in vivo toxicity studies with results from in vitro studies, a 
significant discrepancy is often observed [117]. These differences could result from varying effective doses 
present. For ENMs, the determination of the effective dose is challenging since most of ENMs do not ideally 
disperse as affected by particle-particle interactions, and the effective dose is determined by sedimentation 
and diffusion processes. State of the art in vitro testing methods with adherent cells or cells suspensions 
include, e.g., macrophages [118], endothelial cells [119], and pancreatic cancer cells [120]. To determine 
cellular effects of NMs in vitro, it is crucial to quantify the effective dose of NM to select doses relevant to 
the in vivo exposure scenario. Existing in silico techniques to model the dose are the In Vitro Sedimentation, 
Diffusion, and Dosimetry (ISDD) model [121], the Volumetric Centrifugation Method (VCM) [122], and the 
Distorted Grid (DG) model [123, 124]. These models face several challenges since the deposited dose is 
influenced by physicochemical parameters like particle size distribution (PSD), primary particle size, 
effective density, and user-chosen parameters.  
Here the robustness of the DG model towards freeze-thawing protocols and a variation on user-chosen 
parameters such as particle affinity and estimations on polydispersity and their effect on dosimetry was tested. 
By measuring DLS, VCM, and AUC on a broad set of ENM, each differing in particle chemistry, size, shape, 
and surface coating, to identify ENMs and scenarios for which the actual deposited dose can be predicted. 
Information on the effective dose is essential to establish dose-response relations and the toxic potency of 
ENMs. Moreover, avoiding excessively high test concentrations in vitro compared to the in vivo organ 
burdens, avoids irrelevant findings in vitro. The aim of the work described here is, to define limits and 
uncertainties of models for determining effective in vitro doses.  
 
The following publications are related with this topic: 
 
• Keller JG*, Quevedo DF*, Faccani L, Costa AL, Landsiedel R, Werle K, Wohlleben W. Dosimetry in vitro – 
exploring the sensitivity of deposited dose predictions vs. affinity, polydispersity, freeze-thawing, and 
analytical methods. Nanotoxicology 2020. DOI: 10.1080/17435390.2020.1836281 
 
• Wiemann M, Sauer UG, Vennemann A, Bäcker S, Keller JG, Ma-Hock L, Wohlleben W, Landsiedel R. In Vitro 
and In Vivo Short-Term Pulmonary Toxicity of Differently Sized Colloidal Amorphous SiO₂. Nanomaterials 
(Basel) 2018 Mar, Volume 8(3), pp.160. Doi: 10.3390/nano8030160.  
 
• Ma-Hock L, Sauer UG, Ruggiero E, Keller JG, Wohlleben W, Landsiedel R. Using Nanomaterial In Vivo Burden 
Data for In Vitro Dose Setting (OBIV). Small, submitted September 2020. 
 
  
MOTIVATION AND OBJECTIVES 
15 
2.3 CHOICE OF MATERIALS 
The materials were chosen based on industrial relevance and available toxicity data, which will be exploited 
in the conclusion section of this thesis (obtained from in vivo toxicity studies; the references for the toxicity 
data are given in the list below). [125] Pharmaceutical preparations such as micelles and phospholipid 
vesicles were out of scope. This work aims to identify the relevance of physicochemical properties by 
systematic variation and testing of a broad set of materials. The chosen set varies in chemical composition, 
size, shape, crystallinity, and surface treatment. The test set of ENM covers a variety of metal oxide, metal, 
and organic nanomaterials (Table 1) and ranges in sizes between 7 and 500 nm. Identical materials were 
used both for dissolution and transformation, as well as for dosimetry studies. Most of the materials were 
sourced from the Joint Research Center (JRC) Nanomaterials Repository of the Organization for Economic 
Co-operation and Development (OECD) sponsorship program. [126]  
These materials are sourced from large individual batches with significant industrial relevance. As provided 
by the ENM producer, the single batches are subsampled by JRC and procured as thoroughly characterized 
NMs for benchmarking, testing in research and development, and regulatory studies. The harmonization of 
test material within different labs furthermore allows the comparison and the reproduction of results. The 
most relevant  ENM supplied by JRC are Ag NM300, BaSO4 NM220, [127] Bentonite NM 600, CeO2 
NM211, CeO2 NM212, [127-129] SiO2 NM200, SiO2 NM203, TiO2 NM102, two UV active nanomaterials 
TiO2 NM104 coated with Al2O3, and TiO2 NM105, [43] ZnO NM110 and triethoxycapryl silane coated 
ZnO NM111. [43] Ag Sigma was purchased from Sigma-Aldrich. The non-nano sized reference material 
BaSO4 IRMM381 was provided by the Institute for Reference Materials and Measurements (IRMM). [130, 
131] Four additional silica ENMs with different sizes of untreated, colloidal silica: Levasil 50, Levasil 100, 
Levasil 200, and Levasil 300 were all commercially acquired from Akzo Nobel N. V.. [132] Two more 
nanoforms with surface coatings, which are based on Levasil 200, were tested: SiO2_aminated and 
SiO2_phosphonated. [133] Nouryon Pulp and Performance Chemicals AB provided Si_Std, Si_anis_Std, 
Si_Al, Si_anis_Al, and Si Silane. SiO2 Amorphous IUF was provided by the Leibniz Research Institute for 
Environmental Medicine (IUF). The Institute for Occupational Medicine (IOM) procured SiO2 DQ12 for the 
PATROLS project. The Korea Research Institute of Standards and Science (KRISS) produced and provided 
the food-grade TiO2 E171. Additionally, a broad set of relevant pigments was investigated, including three 
different kinds of iron oxides, two CuPhthalocyanines, and three Diketopyrrolopyrrool. 
Cu_Phthalocyanine_nano Cu_Phthalocyanine_halogen, DPP_nano, DPP_non_nano, DPP_premixed, 
Fe2O3_nano_A, and the Fe2O3_nano_B were produced and provided by BASF SE. [134] The borderline-
nano Fe2O3_larger was provided by Rockwood Holdings Inc. [135] Powdered CuO was supplied by 
PlasmaChem GmbH. [136]  
With this selection, the most important material categories shown in Figure 1 are covered. The methods 
developed within this thesis can, therefore, be applied to REACH registration of ENMs.  
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Table 1 Overview of physicochemical parameters of materials used within this thesis. 












Surface Treatment  and Crystallinity  
    [nm] Descriptive [m2/g]  




Polymer Treatment; amorphous 
Ag Sigma 7440-22-4 28 Spheroidal 6.4 PVP; crystalline 
Amorphous SiO2 IUF 7613-86-9 9 Spheroidal 192 Si; amorphous 
BaSO4 NM220 7727-43-7 32 Spheroidal 41 Ba; orthorombic 
BaSO4 IRMM381 7727-43-7 234 Spheroidal 2.5 Ba; orthorombic 
Bentonite NM600 1302-78-9 1362 Platelets 52  
CeO2 NM211 1306-38-3 15 Spheroidal  66 Ce; cubic, ceriantite 




27 Ba; orthorombic 
CuO 1317-38-0 24 Spheroidal 34 Cu 
Cu_Phthalo_halogen 1328-53-5 14 Platelet 69 Cu; 72% crystalline 
Cu_Phthalo_nano 147-14-8 17 Spheroidal 53 Cu; 82% crystalline 
DPP_nano 84632-65-5 36 Spheroidal 94 DPP; 65 % crystalline 
DPP_non-nano 84632-65-5 233 Spheroidal 16 DPP; 75 % crystalline 
DPP_premixed 84632-65-5 400 Spheroidal 17 Acrylic acid; monoclinic 
Fe2O3_nano_A 1309-37-1 15-130 x 4-21 Rods 107 Fe; 95 % crystalline 
Fe2O3_nano_B 52357-70-7 37 Spheroidal 30 Fe; 95 crystalline 
Fe2O3_larger 1309-37-1 48  12 Fe 
Levasil 50 7613-86-9  Spheroidal 50 Si; amorphous 
Levasil 100 7613-86-9  Spheroidal 100 Si; amorphous 
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Levasil 200 7613-86-9 15 Spheroidal 200 Si; amorphous 
Levasil 300 7613-86-9  Spheroidal 300 Si; amorphous 
SiO2_amino 7613-86-9 15 Spheroidal 200 Amino; amorphous 
SiO2 NM200 7613-86-9 13 Spheroidal 190-220 Si; amorphous 
SiO2 NM203 7613-86-9 26 Spheroidal 213 Si; amorphous 
Silica_Al 7631-86-9 13 Spheroidal 175 Al; amorphous 
Silica_anis_Al 7631-86-9 5 Spheroidal 427 Al; amorphous 
Silica_silane 7631-86-9 11 Spheroidal 216 Si; amorphous 
Silica_Std 7631-86-9 11 Spheroidal 209 Si; amorphous 
Silica_anis_Std 7631-86-9 11 Spheroidal 214 Si; amorphous 
SiO2 DQ12 14808-60-7 112 Spheroidal 11 Si; 87% crystalline 
SiO2_phosphonate 7613-86-9 15 Spheroidal 200 Phosphonate, amorphous 
TiO2 E171 13463-67-7 169 Spheroidal 11 Ti, Anatase 
TiO2 NM102 1317-70-7 35 Spheroidal 80 Ti 
TiO2 NM104 13463-67-7 30 Spheroidal 60 Ti 
TiO2 NM105 1317-80-2 21 Spheroidal 51 Ti; anatase + rutile 




12 Zn; zincite 
ZnO NM111 1314-13-2 80 Spheroidal 14 Triethoxycaprylsilane; zincite 
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Author contribution: In this work, the author was responsible for the data generation for several physchem 
parameters such as dissolution, transformation, and dosimetry for all case study materials as well as the 
interpretation of the results and illustration of data tables. 
 
Abstract: 
The project nanoGRAVUR (BMBF, 2015–2018) developed a framework for grouping of nanomaterials. 
Different groups may result for each of the three distinct perspectives of occupational, consumer and 
environmental safety. The properties, methods and descriptors are harmonized between the three perspectives 
and are based on: Tier 1 intrinsic physico-chemical properties (what they are) or GHS classification of the 
non-nano-form (human tox, ecotox, physical hazards); Tier 2 extrinsic physico-chemical properties, release 
from nano-enabled products, in vitro assays with cells (where they go; what they do); Tier 3 case-specific 
tests, potentially in vivo studies to substantiate the similarity within groups or application-specific exposure 
testing. Amongst all properties, dissolution and transformation are least modulated by different nanoforms 
within one substance, whereas dustiness, dispersion stability, abiotic and especially in vitro surface reactivity 
vary more often between different nanoforms. The methods developed or selected by nanoGRAVUR fill 
several gaps highlighted in the ProSafe reviews and are useful to implement (i) the concept of nanoforms of 
the European Chemicals Agency (ECHA) and (ii) the concept of discrete forms of the United States 
Environmental Protection Agency (EPA). One cannot assess the significance of a dissimilarity, if the 
dynamic range of that property is unknown. Benchmark materials span dynamic ranges that enable us to 
establish bands, often with order-of-magnitude ranges. In 34 case studies we observed high biological 
similarity within each substance when we compared different (nano)forms of SiO2, BaSO4, kaolin, CeO2, 
ZnO, organic pigments, especially when we compared forms that are all untreated on the surface. In contrast, 
different Fe2O3 or TiO2 (nano)forms differ more significantly. The same nanoforms were also integrated in 
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The project nanoGRAVUR (BMBF, 2015 - 2018) deve lop ed a framework for grouping of nanomaterials. 
Different groups may result for each of the three distinct perspectives of occupational, consumer and 
environmental safety. The properties , methods and descriptors are harmonised between the three per-
spectives and are based on: Tier 1 intrinsic physico - chemical properties (what they are) or GHS classifi -
cation of the non - nano-form (human tox , ecotox, physical hazards) ; Tier 2 extrinsic physico-chemical 
properties, release from nano-enabled products, in vitro assays with cells (where they go; what t hey do); 
Tier 3 case- specific tests, potentially in vivo studies to substantiate the simi larity within groups or appli -
cation-specific exposure testing . Amongst all properties, dissolution and transformation are least modu-
lated by different nanoforms w ith in one substance, whereas dustiness, dispersion stability, abiotic and 
especially in vitro surface reactivity vary more often between different nanoforms. The methods devel -
oped or selec ted by nanoGRAVUR fill several gaps highlighted in the ProSafe reviews, and are useful to 
implement (i) the concept of nanoforms of the European Chemicals Agency (ECHA) and (ii) the concept 
of discrete forms of the United States Environmental Protection Agency (EPA). One cannot assess the sig-
nificance of a dissimilarity, if the dynamic range of that property is unknown. Benchmark materials span 
dynamic ranges that enable us to establish bands, often with order-of-magnitude ranges. In 34 case 
studies we observed high biological similarity within each substance when we compared different (nano) 
forms of SiO2, BaSO4, kaolin, CeO 2, ZnO, organic pigments, especially when we compared forms that are 
all untreated on the surface. In contrast, different Fe2O3 or TiO 2 (nano)forms differ more significan t ly. The 
same nanoforms were also integrated in nano-enabled products (NEPs) for automotive coatings, clinker -
reduced cements, cosmetic sunscreen, and lightweight polymers. 
Particles, i.e., minute pieces of matter with defined physical 
boundaries, 2 are commercially available in a myriad of grades 
that are optimised in composition, size, shape and coatin g for 
specific applicat ions .3 '4 If the number metric median diameter 
of the constituent particles is below 100 nm, that grade is 
identified as nanomaterial for regulatory purposes by the 
definition that was recommended by the European 
Commission. 5 The identifi cat ion as nanomaterial is explicitly 
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intended to be without regard to hazard or risk,5 but triggers 
additional or more specific testing requirements from 2020 on 
the revised REACH Annexes.6 Several frameworks have been pro-
posed that structure the risk assessment of nanomaterials in 
tiered testing strategies, 7 often supported by elements 
of grouping and read-across strategies,8•9 often targeting a 
reduction of animal testing by alternative methods. 10 - 12 The 
tiered testing strategies serve two main purposes: 
a. Industry has an interest to ensure the safe use of novel 
nanomaterials early during development, using a minimum 
amount (milligrams) of available material and without animal 
testing. If the safety testing feeds back to optimize the balance 
of performance, safety, costs and sustainability ( or to stop the 
development), then the term "safer-by-design" is often used to 
describe this good industrial practice. The comparison of a 
novel nanomaterial to benchmark materials with a well-known 
(eco)toxicological profile can support the confidence in the 
assessment, but it is unknown which material properties 
shou ld be used to make that comparison. 
b. European regulators have established the concept of nano-
forms (NF, nanomaterial form of a chemical which is character-
ised by ranges of morphology, particle size distribution, surface 
chemistry, specific surface area) to register forms of a substance 
that are identified as nanomaterial in the substance dossier. 13 
The data requirements in the revised REACH Annexes VI to X 
have been amended accordingly. 5 Concepts of similarity and 
grouping are relevant since "sets of similar nanoforms" can be 
registered, with a justification. 5 Registrants can use concept of 
grouping for such justification and can use read-across to 
fill data gaps of one NF (or one set) by existing data of the 
non-nano-form or of another NF ( or another set) of the same 
substance, if there is a specific hypothesis why "source" and 
"target" form should be similar. 14 Although the guidance pro-
poses specific properties to substantiate the similarity, it does 
not mark them as mandatory and lists no methods, nor descrip-
tors, nor benchmark materials. 14 
There are numerous deficiencies of the existing regulatory 
guidances and of the published frameworks: 
Most of the grouping frameworks, including the 
seminal NIOSH proposal 15 and its implementation, 16 the 
DF4nanogrouping framework 17 and its implementations, 18 - 20 
limit their scope to human safety, more specifically to inhalation 
hazards. Regarding the prediction of the environmental hazard 
of nanomaterials two approaches are pursued. Besides model-
ling and the development of structure-activity-relationships, 21 
only a single framework assesses the environmental hazard 
from a grouping perspective with proposed trigger values for the 
identified physico-chemical properties to be relevant for ecotoxi-
city of metals and metal oxides.22 "23 Several frameworks recog-
nize that the integration of nanomaterials into nano-enabled 
products (NEPs) determines the material properties of the frag-
ments that may be released throughout the life cycle24 and 
screening e-tools such as the LICARA nanoscan, 25 GuideNano, 26 
SUN,27 •28 select some relevant NEP properties, but no grouping 
framework integrates the safety of consumer use of NEPs or the 
safety of professional handling of NEPs. 7 
Nanoscale 
View Article Online 
Nanoscale 
The DF4nanogrouping 17 •18 selects specific methods of ana-
lysis, quantitative cut-offs and benchmark materials. 7 In con-
trast, the ECHA nanomaterial grouping guidance refers to the 
generic physico-chemical guidance 29 that lists numerous 
optional methods, and refers also to the DF4nanogrouping 
method selection Tables S2 and S4. t14 Often the frameworks 
used the same terminology and some select the same material 
properties to compare (nano)-forms, 7 but many properties may 
be determined by different analytical methods, and for some 
the reliability and standardisation is insufficient. 30 Additionally, 
there are numerous options of data reduction from the multidi-
mensional raw data (images, spectra, distributions) to simple 
scalar descriptors (one numerical value) that can quantify the 
similarity between (nano)forms or the homogeneity of groups. 
The project nanoGRAVUR (2015-2018) was funded by the 
German Federal Ministry of Research, and by industry and 
comprised partners from academia, regulatory agencies, insur-
ance companies and industry. This paper presents the 
nanoGRAVUR grouping framework for nanomaterials and its 
implementation by selected methods of analysis and quantita-
tive benchmark material values. Different groups may result 
for each of the three distinct perspectives of Occupational, 
Consumer and Environmental safety (OGE}, but rely on a harmo-
nised set of material properties with specific methods of ana-
lysis, descriptors and ranges. The proof of concept is provided 
via quantitative data on 34 case studies. 
Framework and selection of properties 
The nanoGRAVUR grouping framework (Fig. 1) consists of three 
tiers. Tier 1 determines intrinsic physicochemical properties 
("what they are") and/or the GHS classification of the non-nano 
form (human tox, ecotox, physical hazards). Tier 1 allows the 
user to describe concerns and accordingly a grouping hypo-
thesis. Depending on the purpose of grouping (Table 1), Tier 2 
Tier 1 
"WMllhllyar e: 
+Mi.ll -"WMtthllyan : 
liiii■ --Tier 1 NEP "VN11$ ttw NEP- : 
- NE.P-dependenl = ----·-· ' lllStlngr.eds, .,,, ... 
I Tier2 
[ ._...,,.-,1- 1 • .:..-::: I OusllnffS upOf!NfP ........... 
[ ][ ,, ... , ..... 1 UpOf!Hposure 
I 
Fig. 1 nanoGRAVUR grouping framework. ENM: engineered nano-
material; NEP: nano-enabled product; GHS: globally harmonised 
system; CLP: classification and Labelling of Products; * denotes pro-
perties used by ECHA to differentiate nanoforms; 13 # denotes properties 
used by EPA to differentiate discrete forms. 1 Dashed boxes denote pro-
perties with no sufficiently developed method. 
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-I Table 1 nanoGRAVUR selection of material properties . The set is harmonised across the three purposes of grouping for (0) occupational , (C) consumer and (E) environmental risks. includes the z :;r OJ ,,,. 
risks in the value chain of nano-enabled products (NEP). and can be compared to regulatory guidance and previous frameworks that addressed selected purposes. 1•13•14 •17•22 Proposed: property is ~ z, 0 




.;;· to select appropriate conditions in further testing . The symbols for maturity of the methods are indicative of technology readiness level (TRL) 4 or lower( - ), 5 to 7 (0) , 8 or higher(+) in 
@ 
-I nano GRAVUR (0 ) ffi 
;o nanoGRAVUR occup ation ( C) ECHA nanofor m Environ me ntal 
0 data in case con sum er (E) nanoG RAVUR EPA discrete registration , bes t ECHA groupin g DF4n anogroupin g haza rd groupin g 9l. 
8 
Prop erti es studi es environm ent method TRL form s (2017 ) prac tice (201 7) guid ance (201 7) framework (201 5) fram ework (201 8) 
iii" What th ey are Prim ary particl e shape ✓ Criterion O,C,E + Criterion Cri te rion Propo sed Criter ion 0 Crit erion E 
'<: Prim ary particl e di me nsion ✓ Criterion O,C,E + Criterion Cri te rion Propo sed Crit erion E Q. 
n Com positi on + GHS (incl. ✓ Crit erion O,C,E + Cri terion Cri terion Proposed Crite rion 0 Crit erion E 
ffi impuriti es) 
3 Specific surfa ce area (BET/ ✓ + Criterion Propo sed Suppl. 0 .;;· 
~ VSSA) ,..., Sur face chem istry ✓ 0 Criterion Cri te rion Proposed Suppl. 0 
0 
to ( descrip tive) 
Sur face charge (zeta - ✓ + Criterion Pro posed Suppl. 0 
po tential ) 
Hydrophobi city ✓ Propo sed Suppl. 0 
Rigidity ( for fibers) Proposed 0 
NEP classes & in tended use (✓) Crite rion (NEP) O,C 
sce narios 
Specific NEP: g g- 1 con tent ✓ Crite rion (NEP) 0 + 
ofENM 
Specific NEP: dispersion (✓) Crit erion (NEP) O,C 0 
state of ENM 
Where th ey go: Dustin ess ✓ Crit erion 0 + Pro posed Qualifier 0 
release /exposure Criti cal shapes upon (✓) Crite rion (NEP) O,C 0 
exposure 
Agglo. of ENM upon NEP (✓) Crit erion (NEP) O,C 0 
appli catio n 
Resilience of NEP Matr ix ✓ Crite rion (NEP) O,C + 
Wh ere th ey go: in Dispersability (dispersion ✓ Crit erion O,C,E +0 Propo sed Criterion 0 
relevant media stabili ty) 
Solubili ty in water (screenin g ✓ Crit erion O,C,E + Proposed Crite rion 0 
tes t) 
Disso luti on ra te in relevant ✓ Criterion O,C,E 0 Pro posed Criterion 0 
media 
Ion releas ing (✓) Criterion E +o Crit erion E 
Transform ation "change of ✓ Crit erion E (Tier 3) 0-
what th ey are" 
Mobili ty (in soil s) ✓ Criterion E (Tier 3) + 
Mobili ty (systemi c) by altem . Criterion C 
Method 
Affinity Proposed E 0 
(heteroagg lomeration ) 
Wh at th ey do Reactivity ( abiotic) ✓ Criterio n O,C,E +0 Pro posed Crite rion 0 Cri terion E 
Reactivity (in vitro) ✓ Crit erion O,C +0 Criterion 0 
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determines extrinsic physicochemical properties, the release 
from nano-enabled products (NEPs, if in scope) and /or in vitro 
assays ("what is the NEP"; "where they go"; "what they do"). If 
the assessment remains inconclusive, Tier 3 deals with case-
specific testing, potentially in vivo studies to substantiate 
the similarity within groups or application-specific exposure 
testing. 
The nanoGRAVUR grouping framework serves three pur-
poses of testing and grouping, that each require a different 
perspective: occupational safety, environmental safety, consu-
mer safety . Aspects of both hazard and exposure are con -
sidered, and the intended use in NEPs is systematically inte-
grated in the testing strategy . Depending on the purpose of 
grouping, only a sub-selection of the material properties is 
required . The assessment is guided by 
i. the purpose of grouping (Table 1) 
ii. tiers with increasing specificity of testing (Fig. 1 ). 
Compared to the properties that are proposed (but not 
mandatory) by the ECHA guidance, 1 4 a core set of pro-
perties overlaps, some properties were added, and some 
were tested but not selected . Despite this difference, we 
view the nanoGRAVUR framework as an implementation of 
the ECHA guida nce: if the purpose of grouping is to assess 
the risk of occupational handling of powders ("O" in 
Table 1), our choice of properties is a selection of the pro-
perties proposed by ECHA, without additions . The reason 
for selecting is that we do no t group by intrinsic properties 
that are only a proxy of biological interactions. This con -
cerns especially properties that describe sur face chemistry 
including hydrophobicity and charge. Instead, we group 
by extrinsic properties ( dispersibility, biological reactivity, 
dissolution in biological and environmental media), that 
assess the interactions more directly, and correlate to 
human and ecological ha zard and fate results. 31 - 33 The 
additional properties decrease the uncertainty of risk esti -
mation at limited additional efforts, as they are descriptive 
(e.g. NEP categories/intended uses), rely on simple methods 
of ana lysis (see next section), and widen the scope to 
NEPs as relevant for the value chains related to pro-
fessionals, consumers and the environment . While the NEP 
does not need to be included in the assessment, at 
least the intended use of the engineered nanomaterial 
(ENM) needs to be known to select a "relevant medium" 
in Tier 2. This reasoning was already implemented in the 
DF4nanogrouping, 1 7 but is expanded here to environmental 
media. 
In the stepwise methodology of the ECHA grouping gui -
dance, the nanoGRAVUR Tier 1 data requirements of 
"Primary particle shape", "Composition (incl. impurities) " 
with the corresponding "GHS/CLP human toxicity (bulk)", 
"GHS/CLP ecotoxicity (bulk)" and "GHS/CLP physical 
hazards (bulk)" constitutes ECHA Step 1. We derive our 
hypothesis of most important hazards via the data 
reduction to quantitative property ranges as a simple 
implementation of ECHA steps 2 to 4. The only grouping 
decision that can be taken after Tier 1 is the grouping of a 
Nanoscale 
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highly soluble NF with their non-nano-form of the same 
substance, based on water solubility with a specific method 
of analysis and cut -off value (Table 2). All other cases will 
require testing by Tier 2 methods to substantiate the simi-
larity of different NFs in a group . The testing in Tier 2 con-
stitutes ECHA Steps 5 to 6, and the focus on extrinsic pro-
perties is supported explicitly by the ECHA guidance, 
reading "It should be noted that differences in the physical 
parameters seen when characterising the nanoforms does not 
per se exclude the possibility to apply read-across. Indeed, 
similarities in the parameters related to the behaviour (e.g. 
solubility) or those relating to their reactivity may be more 
important to consider when building a read-across justifica-
tion" .1 4 The Tier l _NEP data requirement of "NEP classes & 
intended use scenarios" adds a grouping hypothesis by rele-
vant release and exposure pathways, and is essential to 
select relevant media in Tier 2 . Of note, the same approach 
is taken by the US-Canada Regulatory Cooperation Council, 
where the prioritization of either of the human exposure 
pathways trigger dissolution testing in each different media, 
complemented by composition ionic toxicity, shape, and 
surface reactivity .34 
The nanoGRAVUR scheme for ecologica l hazard grouping 
requires only Tier 2 results, and is consistent with the pre-
vious grouping developed on the basis of tests with algae, 
daphnia and fish embryo, that focused on ion release, reac-
tivity, and shape 2 2 and its further development. 2 3 The 
additional property "surface affinity" was added, and further 
adaptations are not excluded . Groupin g regarding environ-
mental fate was based on a preliminary description of pro-
cesses. Depending on the complexity of the studies, these are 
Tier 2 (e.g. dissolution in environmental media) or Tier 3 
tests (e.g. mobility in soil and biological transformation). For 
the latter, no triggers were identified but these tests need to 
be performed to enable fate grouping.2 3 The proposed 
methods of analysis and some quantitative cut-off values are 
listed in Tab le 2. 
Analogously, if the validi ty of the hypothesis for gro upin g 
by occupational safety remains inconclusive after Tier 2, 
specific testing in Tier 3 is possible. This may involve exposure 
testing at specific workplaces and may involve in vivo animal 
studies . 
In Tier 2, the assessment of exposure is approximated by 
dustiness and NEP properties that are most relevant for 
release or emission . This ena bles risk -based groupings, but 
still supports hazard-based groupings as prioritised in 
REACH. Thus, a grouping hypothesis might be that different 
NEPs that have similar matrices with different embedded 
ENMs are similar in the rate and form of released fragments, 
and thus also similar in the hazard by such fragments, as 
motivated by results on human hazard 35 - 40 and ecologica l 
hazard 24 ' 4 1 of such fragments . Specific methods support the 
assessment of emission, fate and transport behaviour, as 
detailed in the following chapter, and thus expand from the 
groupings perspective of environmental hazard 22 and human 
hazard. 17 
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~ Table 2 Properties, harmonised methods of analysis, descriptors , and benchmark materials as proposed by the nanoGRAVUR grouping-framework for nanomaterials. Additional information on z ::y 




Optional: data reduction to indexed "' ;;;;· in 
@ Properties Method s Descriptors, [metric] Benchmark-materials property band s 
~ 
ffi Primary particle shape NanoDefine methodology Minimum external dimen sion NanoDefine IRMM-repos itory Sphere 1, rod 2, platelet 3, fibre 4 
;o Primary particle ( consistent with ECHA nanoform s) [nm]+ aspect ratio [unitle ss] NanoDefine IRMM-repository Spherical and 0 < 10 nm 1; other 2 
~ 
8!. dimen sion 
R' Rigidity (for fibres) No valid method established yet Modulus of elasticity [MPa] NM400 (10 nm, non-rigid) //NM401 Not established 
i'I\' ( for MWCNT: diameter [nm]) (67 nm, rigid) 
'<: GHS CLP (bulk) Identify composition by XRF (or ICPMS, Consider impurities >1 % Not required 
Q. human toxicity, XRD), compare to CLP of Bulk if n 
ffi ecotoxicity existe nt. 
3 Solubility in water OECD TG draft: in 5 mM NaHC0 3 , pH7 Document mg L- 1 of metal ion; TG specifies CuO (<50 nm , SA: 29 m2 O not significant/1 low ( <1 mg L - 1)/ 
1 at 10 mgL -1, 24 h the TG assesses % dissolved g-1, non-coated). On CuO 2 mid (<10 mgL - 1)/3 high (<50 mgL - 1) 
N (PlasmaC hem): 0.32 mg L -l disso lved 
D Physico-chemical BulkGHS CLP H-phra ses Not required to 
hazards (bulk) 
Product classes and None (descriptive) Sunscreen //plastics (solid Consumption by consumer //contained 
application scenario s polymer s)//cement in consumer products //indu strial or 
professional use 
Specific application Assignment to three fixed categories, Not required Disperse system : 1 composites //2 
NEP: state of dispersion which determine the dispe rse system as suspen sions//3 powder 
ofENM well as the type of embedding and Embedding into a matrix: 1 complete 
agglomeration embedding //2 partly embedding //3 
attachment // 4 isolated 
Agglomeration in matrix: 1 highly 
agglomerated //2 slightly agglomerated // 
3 individualised 
Specific application in Mass-% ENM in NEP Not required O low/1 mid /2 high with low <5 wt%; 
NEP: content (g g- 1) mid: 5 to 50 wt%; high >50 wt% 
ofENMinNEP 
Dustiness EN 15051 method s (RD, CDD) and Dustiness coefficient dependent Fibre benchmark s in FLU method: (o low/1 mid /2 high) 
alternative methods with similar on mass and number [mg kg-1, # NM400 (low du sting tendency: Particle ranges in DEM method: 
strain intensity (e.g. SRD, SHA, DEM) or kg- 1] factor of emission in 150 mg- 1 h- 1), NM401 (high dusting inhalable: low <4000 mg kg-1, 
FLU (esp. for fibres) number metric tendency: 8000 mg- 1 h- 1) moderate 4000- 15 000 mg kg- 1, 
high >15 000 mg kg- 1 
Thoracic: low <1847 mg kg-1, moderate 
1847-5000 mg kg-1, high >5000 mg 
kg-1 
Alveolar: low <70 mg kg-1, 
moderate 70 mg kf 1 - 300 mg kg-1, 
high >300 mg kg-
Agglomeration of ENM For fibre s: du stin ess Fibres: volumetric share of Fibre benchmark s: ARIGM001 Fibre ranges <0.04 (low), 
upon application of For sprays: intended application. constituent fibres in agglomerates (Xv= 0.003), NTX-3 (Xv= 0.913) 0.04-0.4 (medium), >0.4 (high) 
NEP Each with morphologic al analysis of the in relation to amount of single 
du st fibres within the dust(%) 
Resilience of NEP For mechanical stress: tensile Tensile strength [MP a] or Tensile stre ngth (inverse to sanding 
matrix elongation (ISO method) elongation at break [%] release rates): 
• Low resilience ( <10 N mm - 2 ): cement ~ 
• Mid resilience (10- 100 N mm- 2): ~ ~ 
epoxy, PA, acrylic ► 
~ 
~ 
, High resilience (>100 N mm - 2): a: 
:) 
stee l, aluminium alloy 
~ 






Published on 20 September 20 19. Dow nloaded by Universitaet Duisburg Essen on 9/20/20 19 2:55:04 PM. 
?i Table 2 (Contd.) ,:, OJ 
§ "O 
:;i Optional: data reduction to indexed 
~ 
in Properties Methods Descriptors, [metric ] Benchmark-materials prop erty band s 
Critical dimen sions Dustine ss + SEM analysis of aerosol Amount of WHO-fiber-like objects NM400: 0.4% Not established 
upon exposure sa mple : form from total number (%) NM401: 20.4% 
Ion-relea sing OECD TG draft: screening method Dissolved ions [ mg 1- 1] Ion releasing if >0.1 mg L -l metal ions. 0: no/1: yes 
10 mg L- 1 ENM in relevant medium CuO in env. medium >0.8 mg L - 1 cu 2• 
Dissolution in relevant Flow-through disso lution: ICPMS Rate k [ng cm- 2 h- 1] 
media quantification of ions 
Transformation Flow-through disso lution : Comparison of shape and size For lysoso mal disso lution : For lysoso mal disso lution : 
"change s of what TEM, (SAD, XPS) detection ( optionally also crystallinity) • Non-persistent, high disso l. 1: non persistent high disso lution 
they are " on remaining solids before /after disso lution testing (ZnO NM110) k > 100 ng cm- 2 h- 1 
• Non-per sistent, significant 2: non persistent significant 
transformation (BaSO4 NM220) transformation k = 1- 100 ng cm- 2 h- 1 
• Low dissolution, significa nt 3: low disso lution significant 
transformation (SiO2 NM203) transformation k < 1 ng cm- 2 h- 1 
• Low disso l., low transform. (CeO2 4: low disso lution, low transformation 
NM212) k < 1 ngcm - 2 h- 1 
For environmental transformation: For environmental transformation: 0: 
BaSO4 NM220 (particles dissolve but non persistent , high transformation 1: 
become more crystalline) no/low transformation 
Homo-agglomeration TG318 in relevant medium (instead of 3 TiO2 NM105 10- 90%, Ag NM300 <10% un sta ble (OJ/intermediate 
x 3 Ca x NOM media) >90% (from TG318) (1)/>90% stable (2) (from TG318) 
Affinity (hetero- tbd. possibly Geitner et al. ES&T 2016 or Attachment efficiency (a) or tbd. No 0/yes 1 
agglomeration) microscopic qualitative analysis relative fraction of attached particle s 
to benchmark 
Mobility Soil columns based on OECD TG 312 Transport dista nce [% of total tbd 1: high or breakthrough (100%), 2: 
length ] mobile in soil column, 3: no mobility 
Reactivity (abiotic) ESR ( ecotoxicity), ESR + FRAS ESR: relative to LoD if ESR: BaSO4 (neg) vs. CuSO4 (pos) Additive scoring of ESR/FRAS: 
(human toxicity) 1.3 x negative control: mBOD significant above LoD ( +1/3 point), 
(CPH) and mBOD(DMPO) above 10% of positive control (+1 
point) 
FRAS: relative to LoD and positive FRAS positive benchmark: Mn2O3 1: low, 2: mid-low, 3: mid-high, 4: high 
benchmark: sBOD and mBOD (sBOD = 2866 nmolTEU m- 2 ENM). 
Reactivity (in vitro) NR8383 dose response • LDH (LOAEC) [µg mL - 1] No benchmark required Score = number of vectors with 
• GLU (LOAEC) [µg mL -l] significant effects at surface dose of 
• TNF (LOAEC) [µg mL - 1] 0.006 m2 mL- 1 
-I ::r • H2O2 (LOEAC) [µg mL- 1] 
"" 0 NR.K-52E protein carbonylation Carbonyl inten sity rel. to positive CuO (positive control) Not established 
i control. 
()\' 
Additional properties that were tested in case studies but not selected for the nanoGRAVUR framework @ 
-I Surface chemistry Descriptive Not required Not required 1 untreated ; 2 hydrophilic 
::r functionali zation; 3 hydrophobic (D 
{ funcationalization ; 4 core-shell coating Hydrophobicity Water sess ile drop Contact angle (0 ) Not required H' il = hydrophilic, o to 90°; 
~ H'ob = hydrophobic, >90° 
ili' Surface charge Electrophoretic mobility Zeta potential at pH7, mV Not established Not established 
q Reactivity (photo-) Rhodamine-B-degradation Photon efficiency ( uni tless, % ) Not esta blished Not established 
Q_ ~ 
n ~ 
iif z )> 3 OJ ;:i. 
sZi- :, a: 
'< 0 
~ 




Framework concept in comparison to 
other approaches 
There are fundamentally different grouping approaches. E.g., 
one may group not by measurement of material properties but 
by hazard testing. NIOSH grouped by in vivo potency.16 This is 
equivalent to skipping Tiers 1 and 2, and performing only Tier 
3 in vivo. However, the resulting groups have no logical 
relationship, as is provided by the intrinsic and extrinsic pro-
perties, and thus also deviates from the seminal NIOSH propo-
sal of four groups delimited by shape, solubility, and bulk 
toxicity42 that was the basis of the AGS BekGS52743 and 
of the DF4nanogrouping, 17 and is still recognisable in the 
nanoGRAVUR scheme. Another grouping by toxicity was per-
formed via cytokine profiling, 44 but the experimental effort to 
generate such data may prevent a robust and pragmatic regu-
latory use, and may be more appropriate for mechanistic 
studies. However, it is interesting to note that both the group-
ing by in vivo potency and the grouping by cytokine profiling 
result in groups given primarily by the substance composition, 
e.g. grouping TiO2 NFs, ZnO NFs and non-nano-forms, SiO2 
NFs.16•44 Yet another complementary categorisation was 
proposed by the FutureNanoNeeds project, combining by 
"information multiplexing" the physico-chemical properties, 
descriptors of the adsorbed corona (in an unspecified 
medium), and a mapping of the biologically accessible epi-
topes ,45 and the chemical basis of nano-bio interactions was 
thought to enable structure - activity-relationships. 46 With the 
sparse data on corona and epitopes, these concepts may be 
true but remain speculative. If validated, the FutureNanoNeeds 
concept might be an approach to group especially pharma-
ceutical nano-formulations by their systemic transport, but the 
specificity would fall short of the Tier 3 requirements of 
specific uptake and clearance tests, and the experimental 
workload might not be justified against an in vivo study as 
valid option. We do not consider pharmaceutical purposes 
here. 
Recommended methods to determine 
material properties 
The selection of specific methods of analysis or combinations 
of methods is an integral element of the nanoGRAVUR group-
ing-framework. Table 2 specifies the selected methods of 
analysis, the data reduction to descriptors as well as rec-
ommended metrics, and representative benchmark materials 
(OECD NMs). Additional details on the SOPs are provided in 
the ESI.t 
We harmonised the selection of methods across all 
different purposes of grouping, aiming to simplify the practi-
cal implementation, to reduce costs, and to maximise the mul-
tiple use of data. The ProSafe review on the reliability of 
methods for the regulatory assessment of nanomaterials 
indicated for each property several "preferred methods", but 
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also discussed their limitations and knowledge gaps. 30 The 
overlap between that ProSafe preference and the nanoGRAVUR 
selection is substantial, and supports the robustness of the 
nanoGRAVUR grouping framework. The nanoGRAVUR method 
selection deviates rarely from the ProSafe preference, and fills 
some essential knowledge gaps, as discussed in the following. 
Tier 1 Methods for "what they are" properties 
The methods and descriptors for "what they are" properties 
concerning particle size distribution, shape, and specific 
surface area are implemented according to the recommen-
dation of the project NanoDefine for methods (TEM and BET 
for powders, analytical centrifuges for suspensions), and 
descriptors (number metrics median). 47•48 The sample prepa-
ration is an essential element and was included in the 
NanoDefine validation. 49 For the chemical composition we 
agreed with ProSafe that ICPMS is suitable, but recommend 
XRF as digestion-free proxy for composition and all inorganic 
impurities. Properties that were not selected for the 
nanoGRAVUR framework were nonetheless determined for the 
case studies by methods recommended by ProSafe, i.e. crystal-
line phase by XRD, surface hydrophobicity by contact angle 
measurement, surface chemistry by XPS, surface charge via 
zeta potential by electrophoretic analyses. 
Tier t _NEP Methods for "what is the NEP" properties 
Description of "what is the NEP" was beyond the scope of the 
ProSafe review but does not require methods other than the 
highly established elemental composition analysis (e.g. full 
digestion, then ICP-OES) and the morphological charac-
terisation of a TEM cross-section to assess the dispersion state 
(examples in Fig. SI_3,t criteria in Table 2). Producers of NEPs 
would not need to measure the composition if it is known 
from the production process. 
Tier 2 Methods for "where they go" properties 
For the biodurability as central element of the "where they go" 
assessment we follow the advice of ProSafe to use the OECD 
draft TG on "solubility in aqueous media ", but restricted here 
to the "screening method", which we use in Tier 1 to assess 
the solubility in water ( documented as mg L - 1 value, assessed 
in the OECD draft TG as "% dissolved") and in Tier 2 to assess 
the release of ions in a relevant medium (in mg L - i metric, 
since essential for ecotoxicity grouping). Once the intended 
use of the NEP is known, the release and the affected environ-
mental compartment can be identified and in case of aquatic 
ecotoxicity the dissolution in the medium for the test organ-
ism can be determined .22 We agreed with ProSafe that the 
"dissolution rate in physiological fluids [needs] to be further 
developed", and showed on 24 (nano)forms of 7 substances 
that the flow-cell method as described by ISO(fR19057:2017 
correctly predicts materials with low human in vivo and in vitro 
biodurability, and differentiates between nano forms. 50·51 The 
detection of dissolved ions provides the ng cm- 2 h- 1 metric 
recommended by Oberdorster et al.,52 is grouped by order of 





include the assessment of transformation via the TEM analysis 
of remaining solids. 51 The "extended" test of the draft TG was 
not deemed useful in comparison. 
Regarding the transport as another aspect of "where they 
go" properties, nanoGRAVUR does not endorse the full scope 
of OECD TG 318:2017, which requires to perform 54 measure-
ments for 1 property per each NF, but instead we restricted the 
test to the specifically relevant medium to capture the dis-
persion stability by homoagglomeration. It is anyway not 
obvious how the multidimensional stability diagram over pH, 
NOM and Ca2• variation would be reduced to a simple descrip-
tor to quantify the similarity of different NFs.33 Reviews have 
considered methods to rank NEP matrix materials by their 
release rates during professional handling or consumer use. 
Our choice of tensile strength is highly standardised, but only 
relevant for mechanical stresses. For other release concerns we 
recommend to adhere to the stepwise decision-m aking process 
by the ISO draft TR of PG29, which would e.g. recommend the 
interlaboratory-tested NanoRelease protocol to assess and 
compare the form and rate of release by environmental 
weathering. 53 
There are numerous methods for the determination of dus-
tiness data. 54 - 56 The most common methods (with convention-
al mg kg- 1 metric), which are standardised and also proposed 
by ECHA, are the rotating drum method (RD, EN 15051-
2:2013) and the continuous drop-down method (CDD, EN 
15051-3:2013). Since dustiness levels depend strongly on the 
used method ,57 •58 different methods were tested concerning 
suitability, including the CDD method of EN 15051-3:2013, the 
small rotating drum method (ref. 54, CEN(fC 137; in It kg- 1 
metric), the fluidizer method especially designed for fibres 55 •56 
(in It cm - 3 , It kg- 1 or It kg- 1 s- 1 metric), and a dustiness equi-
valent method (DEM, in mg kg- 1 metric) that is designed to 
mimic the CDD method by evaluating intrinsically measured 
size distributions (see ESI chapter 2.4.1 t). Due to different 
assets and drawbacks of the methods and strongly limited 
comparability, no single method could be excluded or pre-
ferred, and it is recommended that for grouping purpose only 
data of one dustiness method should be used. For the case 
studies, results based on the DEM method were chosen, since 
DEM was able to provide dustiness data for most of the test 
substances in the metric proposed by ECHA (i.e., in mg kg- 1 
metric) . For fibres, the average concentration was determined, 
in accordance with the metric of most exposure limit values. 
Tier 2 Methods for "what they do" properties 
To assess "what they do" via surface reactivity, we combine the 
two abiotic assays of electron spin resonance (ESR, also known 
as electron paramagnetic resonance, with the DMPO and CPH 
spin traps as described by ISO/TS-18827:2017) and the very 
sensitive Ferric Reduction Ability of Serum (FRAS) assay59 with 
the cell-based NR8383 macrophage assay. The NR8383 assay 
uses four standardised read-outs (LDH, ROS, GLU, TNF) and 
was pre-validated against in vivo inhalation studies. 60 We also 
found strong correlation between the abiotic assays and cell-
based protein carbonylation, but did not see a necessity to 
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complicate the scheme by yet another redundant assay. 
(Bahl et al. in preparation) We slightly disagree with ProSafe 
on the strategy and terminology to assess surface reactivity. 
Redox potential and band gap are not synonyms as it seems to 
be suggested by Steinhauser et al. 30 Instead, the LUMO band 
energy may be a more relevant parameter,1 9 but even that 
remains a proxy for the actual biological oxidative damage. 
Hence, we do not define methods for any of the proxies, but 
group by the directly determined biological oxidative damage 
(sBOD). 
For specific purposes, or when the evidence from Tier 2 
remains inconclusive, the user is advised to overrule Tier 2 by 
a more specific testing in Tier 3. It is intended as backup with 
methods that are specific to a certain purpose of grouping, 
and that may be performed under conditions that are specific 
to a certain intended use with a scenario of emission or 
exposure. Human toxicity testing in Tier 3 may include in vivo 
studies, preferentially by OECD test guidelines, to support the 
similarity of different NFs and would overrule dissimilarity of 
screening methods in Tier 2. If exposure is relevant for the 
purpose of grouping, then Tier 3 may compare the similarity 
of personal exposure at specific workplaces. If environmental 
fate is central for the hypothesis of grouping, then Tier 
3 might rely on environmental fate and transformation, for 
which OECD guidelines (e.g. TG312) exist but are not yet vali-
dated and standardised for nanomaterials. The Tier 3 is not 
fully detailed here, as the escalation to Tier 3 is anticipated to 
be the exception rather than the rule. 
Two major method gaps remain: we believe that hetero-
agglomeration can be a predictive parameter for toxicity to 
environmental species such as algae. Therefore a screening 
method was developed that indic ates the attachment efficiency 
to algae. 23 However, laboratory comparison tests and standard-
isation are still missing . It is also believed that the rigidity of 
fibres is predictive of adverse pulmonary effects, 61 but 
all methods are exploratory. An ongoing BAuA research 
project tests an approach based on curvature analysis and 
oscillatory measurement and may be one of the possible 
implementations . 
Although the nanoGRAVUR framework can serve multiple 
purposes, it remains consistent with literature for the purpose 
of grouping by occupational hazard of handling nanomaterial 
powders: here the nanoGRAVUR framework and method selec-
tion coincide with the DF4nanogrouping, except that the Tier 
2 dissolution is now assessed by an improved methodology 
of dissolution rates in a different metric (ng cm - 2 h- 1 instead 
of mg L- 1). 1 7 •1 8 Thus, via the recommendation of the 
DF4nanogrouping method selection in the ECHA guidance,1 4 
also the nanoGRAVUR method selection should be a defend-
able implementation of the ECHA grouping guideline. In com-
parison, the general ECHA physico-chemical guidance R7.1, 
that is also recommended by the ECHA grouping guidance, 1 4 
allows many alternative methods. We concluded that similarity 
or dissimilarity can only be substantiated by identical 
methods, as supported also by the EPA guidance on the differ-
entiation of "discret e forms" .1 




We note that the determination of extrinsic properties by 
"functional assays" is as such not an innovation. Oomen et al. 
remarked that for molecular chemicals the partition coefficient 
log kow is an example of a functional assay with very high regu-
latory acceptance, combining high predictivity and practical 
value .7 We believe that for (nano)particles the assays for 
surface affinity, surface reactivity and dissolution rate will 
become just as important. Benchmark nanomaterials and 
benchmark nano-enabled products are essential to achieve 
reproducible groupings across different labs with slightly 
differing equipment (e.g. for dustiness, sanding, dispersion 
stability, reactivity). 
Proof of concept ( case studies, banding and calibration) 
We applied the framework to 34 (nano)forms of 17 substances . 
Table 3 shows the numerical values of the material properties 
(Tier 1, Tier l _NEP and Tier 2 from Fig. 1), supplemented by 
representative SEM or TEM scans in Fig. SI_l.t The case 
studies cover particles, platelets and fibrous shapes , with 
sizes from 10 nm to >1 µm, BET surface areas from 1 to 
>500 m2 g- 1 , surface chemistry: carbon from 4 to 99%, surface 
charge from - 55 to +36 mV, and hydrophobicity determined 
as water contact angles from <10° to 163°. This lends us to 
believe that the case studies explore a relevant portion of the 
NF design space. 
Boundaries for the numerical ranges that define groups 
depend on the purpose (perspective) of grouping and may be 
universal or substance-specific. The nanoGRAVUR framework 
does not yet support a quantitative measure of similarity, nor 
criteria for sufficient similarity to substantiate read-across. But 
our diverse case studies allow an analysis how criteria of simi-
larity impact the groups that result: one could consider the 
similarity between different NFs of the same substance as 
"ideal" if the different NFs are assigned to the same bands for 
all Tier 2 properties that are selected for the grouping purpose 
by Table 1. In a more pragmatic weight-of-evidence approach, 
one would jointly assess several properties that are relevant for 
the grouping purpose; such approach would implement the 
stepwise ECHA process of hypothesis formulation, data gather-
ing and hypothesis substantiation for regulatory grouping.1 4 
In any case, Tier 3 can be used to overrule Tier 2, as exempli-
fied in case studies . 
In the following, we assess the similarity within sub-
stance families with the properties and descriptors given in 
Table 1 and Fig. 1 for the occupational and environmental 
grouping perspectives. We compare against in vivo and 
OECD guideline studies (Table 5) of human and environ-
mental hazards, by well-established inhalation and relevant 
aquatic and soil organisms. We then perform via the 
rules given in Table 2 the data reduction to simple descrip-
tors and order-of-magnitude ( decadic) bands, resulting in 
Table 4, and again assess the similarity - this procedure cali-
brates the banding and grouping against regulatory testing . 
Below, we discuss which properties are very sensitive to 
different NFs, and how this might impact the conclusions 
on grouping of such NFs. 
This p uma\ is© The Royal Society of Chemistry 2019 
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BaS0 4 • The NF and the non-nano-form of BaSO4 share the 
same dissolution rate, and are similarly low reactive, both 
under abiotic and in vitro conditions. The NR8383 assay 
ranked the non-nano-form as being more reactive, but still not 
as "active" . The Tier 2 human perspective approach (Fig. 1) 
would thus recommend a common group for both forms. The 
in vivo STIS of NM220 BaSO4 confirms low hazards at aerosol 
concentrations as high as 50 mg m -s (Table 5). The ECHA 
guideline, which requires a read-across process and, moreover , 
does not recommend a common group for nano- and non-
nano-forms, appears to be overly conservative in this case 
study. 
Organic pigments. The three DPP pigments form are 
another substance family with low abiotic reactivity. However, 
the non-nano-form showed two positive results in the macro-
phage assay (WAECs below the surface area-based threshold 
of <6000 mm 2 mL- 1), and was considered to be "active" .60 The 
non-nano-form was, therefore, a candidate material for Tier 3 
in vivo testing. However, at that stage of analysis a short-term 
inhalation study (STIS) had already shown that both forms of 
DPP elicit no adverse effects up to 30 mg m - 3 , 62 (Table 5). Due 
to this similarity a joint assessment (grouping or read-across) 
of nano and non-nano DPP pigments appears justified.1 8 
Ti0 2 . Among the intrinsic properties of the four tested Ti0 2 
compounds we observed differences not only in particle size 
(21-204 nm) and surface area (15- 80 m 2 g- 1 ) but also in 
surface coating. Here the UV-active Ti0 2 NM102 and NM105 
showed a slightly higher reactivity in the abiotic test (band 1) 
than the NM104_coated and the non-nano-form. The in vitro 
assay dose - response is actually not very different between the 
three NFs (Table 3), but the scoring via specific surface area 
assigns band 3 (NM105, NM104) and band O (NM102), respect-
ively, and is thus suggestive of dissimilarity in contrast to the 
similar abiotic reactivity in surface metric (FRAS sBOD, 
Table 3). The non-nano-form, which has an alumina coating, 
was similar to the NM104 coated NF in the absolute values of 
reactivity, and had no significant in vitro reactivity. The other 
extrinsic properties of TiO2 materials were highly similar, with 
a dispersion stability <10% after 24 h, and, furthermore, 
neither dissolution and nor transformation. As shown else-
where, 23 the attachment efficiency varies significantly between 
different TiO2 NFs. Moreover, in the NR8383 macrophage 
assay TiO2 nanomaterials elicited divergent effects. In 
summary, neither the occupational nor the environmental per-
spective indicated enough similarity of the different TiO2 NFs. 
This finding was attributed to the different crystallinities and 
coatings and does not rule out that more homogeneous selec-
tions of TiO2 NFs may be sufficiently similar to justify 
groupings . 
Si0 2 . In the Tier 2 environmental perspective, the different 
SiO2 NFs are similar to each other in the relevant property 
bands of mobility in soils, dispersion stability, abiotic reactiv-
ity, and attachment to algae (Table 3). Because the dispersion 
stability ranges just around to 90% group cut-off suggested by 
TG318, the SiO2-amino with 94% stability is not in the same 
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Table 3 Numer ical results of the case studies and OECD benchmark material s for both the ECHA recommended properties and the additional nanoGRAVUR harmonised properties . For each 
property , results were obtained for all materials by the same method {Table 2). For the properties that were selected for the nanoGRAVU R grouping framework {Table 1). the numerical values are 
assigned to bands in Table 4. Further measurements {e.g. transformation by TEM scans) provide images that are evaluated directly towards bands as shown in Table 4. "n.s." indicates that the 
result was not significant against the limit of detection . White cells are data gaps; the goal was to test grouping hypotheses . and not to fill all data gaps . Grey cells indicate that the method is not 
applicable. For each property and descriptor, the results are color -coded between the negative and positive benchmark materials {if defined in Table 2). and otherwi se between the minimum and 
maximum values. For surface reactivity (in vitro). light color without numerical value documents that the property was determined , but that this descriptor was not significant up to a dose of 
180 µg ml - 1 
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Table 4 Data reduction of the case studies and OECD benchmark materials : each NF is assigned to a band , represente d by a score Oto 4. The scoring system is specified in Table 2. The similarity 
between different NFs of the same substance is assessed by the scores of those properties that are relevant for the grouping hypothesis, and as selected by Table 1 for the different purposes of 
grouping 
Primary particle shape 
median diameter, nm 
Composition 
Surface Chemistry (descriptive) 
water contact ane:le 
llfecycle release tested 
Spedflc NEP: dlspcrs k,n state of ENM 
"s table after 6 hours In ADaM 
Mobllity (In soils) 
OlssoluUon & Transformation (human 
persp ective) 
ESR CPH: mBOD x-fold of D20 control 
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Table 5 In vivo human toxicity and/or ecotoxicity testing on the case study ENM and benchmark materials. The existence of the data in this table 
was initially the reason for selecti ng the case studies and provided the basis to evaluate and discuss the validity of the framework. Inhalation hazards 
tested by short -term inhalation screening on rats (STIS, 5 d exposure at aerosol concentration indicated , 21 d recovery); results indicated the NOAEC 
or its lower limit by the highest dose tested without adverse effects. 18•62 - 68 Environmental hazards tested by Algae (OECD 201; Raphidocelis sub-
capitata), Daphnia magna (OECD 202), Zebrafish embryo (FET, OECD 236) and soil microflora (ISO 15655), with results given as EC50 or highest dose 
tested ."· 23 n.d. = not determined 
NOAEC (rat, STIS) 
mgm - 3 
ECS0 (algae) 
mgL - 1 
DPP _nano >30 n.d. 
DPP _non-nano >30 n.d. 
CuPhthalo _nano >30 >100 
CuPhthalo _halogen >100 
Fe 2O3_nano _A 30 3.6 
Fe 2O,_nano_B 2.4 
Fe 2O,_ larger 30 111 
SiO,_ untreated 2.5 14 
SiO2_amino >SO 29 
SiO2- phosphonate >SO 46 
NM203 _SiO2-hydrophil 1.0 n.d. 
NM211 _CeO2 <0 .5 8.5 
NM212 _CeO2 <0.5 5.6 
CuO (PlasmaChem) 0.6 1.4 
NM110 _ZnO n.d. 0.1 
NM111 _ZnO coate d 0.5 0.1 
NM10 5_T iO2_nano <2 4.7 
NM104 n.d. 63 
NM400 _CNT <0.5 n.d. 
NM220 _BaSO4 so n .d 
Quartz DQ12 0.1 n .d 
respectively . This does not need to prevent a grouping but 
would necessitate both aquatic and sediment testing in Tier 3 
ecotoxicity . Hund-Rinke et al.22 previously published the 
ecotox-scheme for the grouping of NMs, which was based on 
the properties "Eco toxicity of bulk material ", "Ion release", 
"Reactivity" and "Morphology /Size". The ECS0 results of 
aquatic species confirmed the similarity of SiO2_untreated and 
SiO2_amino, where algae as most sensitive species had ECS0 
of 14.1 and 29.2 mg L- 1 respectively. 22 In the Tier 2 human 
(occupational) perspective, the different SiO2 NFs all share a 
slow (<1 ng cm- 2 h- 1) dissolution and significant transform-
ation by gel formation. 51 All are assigned to the same dis-
solution /transformation band (Table 4). However, their reactiv-
ity differs: the SiO2-untreated has two LOAEC in the NR8383 
assay below the surface area -based threshold of <6000 mm 2 
mL - 1 . It is thus assigned two scores for reactivity (in vitro) and 
would be considered as "active" in the DF4nanogrouping, 
similarly to NM203. Other colloidal NFs have fewer LOAEC 
below that threshold, and are considered as "passive" in the 
DF4nanogrouping .60 The abiotic reactivity is quite hetero-
geneous between the FRAS and EPR parameters in the numeri-
cal values (Table 3) but averages out to a combined band 2 for 
all tested silica NFs (Table 4). Overall, the differences in 
in vitro reactivity would prevent grouping in Tier 2 and would 
necessitate Tier 3 testing. In vivo studies (by STIS) confitmed 
that the NFs are different (Table s) and would indicate 
SiO2_untreated would be a suitable source for the SiO2_amino 
and SiO2_phosphonate as target NFs.69 •70 
Aluminosilicates. Comparing the SiO2 (nano)forms with 
the aluminosilicates (kaolin, bentonite), we found simi-
Nanoscale 
ECS0 ( daphnid s) 
mgL - 1 ECS0 (FET) mg L - 1 
ECS0 (so il micro 
flora) mg L- 1 
n.d. n .d. n.d. 
n.d. n.d. n.d. 
>100 >100 >1000 
>100 >100 >1000 
>100 >100 >1000 
>100 >100 >1000 
>100 >100 >1000 
>100 >100 >1000 
>100 >100 >1000 
>100 >100 >1000 
n.d. n.d. n.d. 
>100 >100 >1000 
>100 >100 >1000 
0.3 ::;30% effect at 100 mg L- 1 ~10 00 
3.4 >100 118 
8.3 >100 173 
n.d. n.d. n.d. 
n.d. n.d. n.d. 
n.d. n .d. n.d. 
n.d n.d n.d 
n.d n .d n.d 
larities in dissolution and transformation from both the 
environmental and human perspective, but differences in 
abiotic or in vitro reactivity (Table 3). Thus, platelet shaped 
aluminosilicate particles were more reactive in the in vitro 
reactivity (bands 2-4, Table 4) than their round shaped SiO2 
counterparts (bands 0-2), and even showed a higher cyto-
toxicity than our positive control Mn2 O3 • In contrast, the 
abiotic reactivity was lower for the aluminosilicates than for 
the SiO2 • Comparing the two Kaolin NFs, IRMM385_Kaolin 
(with BET of 16 m 2 g- 1 ) has lower abiotic and in vitro reactiv-
ity per BET than the other Kaolin (with BET of 24 m 2 g- 1), 
but is still similar. Both Kaolins are significantly less reactive 
than the Bentonite in the NR8383 dose response (Table 3). 
Nevertheless, the in vitro scoring system (compare ESit) 
results in a band 4 for both Kaolin and Bentonite (Table 4). 
At present the high in vitro reactivity especially of bentonite 
is an unresolved issue. First in vivo studies show a high 
inflammatory potential of bentonite inside the rat lung 
(manuscript in preparation), thus confirming the NR8383 
testing results . Possibly the layered structure of bentonite, 
rather than the platelet structure, interferes with the micro-
milieu inside the phagolysosomal compartments, e.g. due to 
swelling, ion binding and /or osmotic challenges . However, 
the damage inferred by bentonite to the lung was transient, 
suggesting that the layered structure of bentonite transforms 
into a far less bioactive particulate. Understanding of the 
transformation processes in vivo may help. Studies on gra-
phenes before /after reduction (thus comparing changes to 
composition at same shape) confirm that the chemical 
speciation is important to describe "where they go" .71 Clearly, 
This Journal ,.; © The Royal Society of Chem istry 2019 
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nanoforms that share the shape of thin platelets can be very environmental fate descriptors, which fall into the same bands 
dissimilar. 
Cu-Compounds. We also compared three copper containing 
materials with similar particle size but different CAS numbers 
(Tier 1, Fig. 1). CuO and two CuPhthalocyanines differed 
already with respect to their Tier 1 properties, e.g. by different 
elemental compositions (5- 10% Cu for the pigments and 46% 
for CuO) and by the GHS classification of bulk CuO as com-
pared to no GHS classification of CuPhthalocyanines. 
Furthermore, CuO is hydrophilic whereas the other two 
materials are hydrophobic with contact angles up to 163°. 
The sizes of the primary particles of the three materials did 
not vary much with 17 and 39 nm for the CuPhthalocyanines 
and 24 nm for CuO. Within CuPhthalocyanine the Cu is 
strongly bound to the comple x, making it almost insoluble 
with dissolution rates around 0.5 ng cm- 2 h- 1 for both 
CuPhthalocyanines and 282 ng cm- 2 h- 1 for CuO.s1 
Accordingly, CuPhthalocyanines showed only limited reactivity 
within the FRAS, ESR and NR83 83 assay with bands of 1 in the 
abiotic assay and between 0- 2 in the in vitro assay. Wher eas 
CuO quickly dissolved, setting free Cu-ions . CuO was the 
material with the highest reactivity in the abiotic test and a 
band of 3 in the in vitro test. It furthermore dissolved the 
quickest, even quicker than the ZnO materials at lysosomal 
pH. The drastic differences are confirmed by STIS, showing 
complete dissolution of CuO with NOAEC at 0.6 mg m -3 
(ref. 67) vs. no adverse effects for CuPhthalo _nano up to the 
highest dose tested of 30 mg m- 3 (ref. 18) (Table 5). The 
CuPhthalo _nano gave most likely false positive result in the 
NR8383 assay, since STIS showed a low hazard potential. 18 
Also, specific tests of ecotoxicity confirm the dramatic differ-
ence between Cu with an EC50 below 0.1 mg L- 1 for algae and 
daphnids, vs. a non-detectable EC50 above 100 mg L- 1 for the 
CuPhthalocyanines (Table 5).22•23 
Fe2 0 3 . For the three tested Fe2O3 compounds, different 
values for the intrinsic properties were measured, such as a 
range in BET from 12 to 107 m 2 g- 1, and furthermore th e Zeta 
potential ranging from - 18 to - 55 mV for Fe2Os_nano _b and 
Fe2Os_larger respectively (Table 3). Despite the significant 
differences in intrinsic properties, almost all extrinsic pro-
perties were found in the same bands in Table 4. E.g., all 
Fe2O3 (nano)forms were similar in low dispersion stability 
<10% after 24 h . They also shared a very low dissolution below 
0.1 ng cm- 2 h- 1 in lysosomal conditions, without transform-
ation. s1 However their reactivity differed: the abiotic reactivity 
band ranged from mid-low (2) to mid-high (3), but remained 
below 10% the positive control for all forms, hence they were 
"passive" in the DF4nanogrouping terminology. 17 In the 
NR8383 assay, Fe2Os_nano _B was the only form with signifi-
cant in vitro reactivity, whereas the other two materials were 
not reactive. Due to this disparity , Tier 3 comparison was 
applied and STIS indicated a similar outcome for the NF and 
non-nano-form of Fe2O3 with respect to treatment-related 
microscopic findings after days 5 and 26 (Table 5). 62 Thus, 
grouping appears justified in the occupational perspective. 
The similarity of Fe2O3 materials was even higher for the 
This journal is© The Royal Soc~ty of Chemistry 2019 
for low dissolution, intermediate mobility in soils, inter-
mediate dispersion stability, lacking transformation and ion 
release. Thus, the environmental fate of Fe2 O3 materials 
appears very similar. Spatial proximity (e.g. by attachment) is 
required for reactivity-induced ecotoxicity. 31 The environ-
mental hazard was estimated to be similar for the two NFs, 
but the attachment to algae is more pronounced for the non-
nano-form. 23 The EC50 results of aquatic species confirmed 
the similarity of Fe2Os_nano _A and Fe2Os_nano _B, where 
algae, as most sensitive species, had EC50 of 23.4 and 
17.7 mg L- 1 (Desmodesmus subspicatus)22 '2 3 and of 3.6 and 
2.4 mg L - i (Raphidocelis subcapitata)23 respectively. In contrast, 
the EC50 for Fe2Os_larger is extrapolated to be 111 mg L- 1 
(Raphidocelis subcapitata) 2 3 (Table 5). Grouping the Fe2O3 NFs 
for the purpose of demonstrating environmental safety is thus 
justified, but a discrepancy remains between the NFs and the 
non-nano-form. 
Ce0 2 • The assessment of the properties of CeO2_NM211 and 
CeO2--NM212 showed that they had hardly any intrinsic pro-
perties in common, such that particle sizes (15 and 40 nm), 
BET (66 and 27 m 2 g- 1), contact angle (10° and 60°), and 
surface charge (- 24 and 15 mV) were all different. 
Nevertheless, CeO2--NM211 and CeO2_NM212 behaved similar 
in many of the Tier 2 properties: both NF had a rather low dis-
persion stability with <10% stable particles after 24 h, no 
transformation (band 1), low dissolution (band 1). It was fur-
thermore found that both materials share band 2 in the 
in vitro reactivity assay, and band 1 for the combined abiotic 
assays . The NF of smaller size, NM211, had higher reactivity 
FRAS sBOD per surface. This small disparity in Tier 2 is an 
interesting case for the calibration of "sufficient similarity", as 
their similarity from the occupational perspective was con-
firmed by STIS in Tier 3 (Table 5), which furthermore revealed 
similar neutrophil influ x at aerosol concentrations of 5 mg 
m- 2.6 s Results of the two Ceria materials were even closer 
related if the surface area of the particles was used as a dose 
metrics for inflammatory responses. 6s However, their environ-
mental transport in soils was significantly different and pre-
vents grouping for all environment al endpoints. The strongly 
reduced mobility in soils of NM212 may be attributed to the 
hydrophobicity and positive charge of this material. On the 
other hand, properties relevant for environmental hazard 
(release of ions, reactivity /attachment, shape) were similar, 
indicated by EC50 values to algae whi ch amounted to 8.5 and 
5.6 mg L- 1 respectively (Table 5).22'23 Thus, grouping the two 
(or more) NFs of CeO2 might not be justified, but read-across 
for specific endpoints, as envisioned by ECHA,14 is justifiable. 
ZnO. The metal oxide particles ZnO_NM110 and 
ZnO_NM111 were largely different from CuO with respect to 
chemical composition and intrinsic properties (primary par-
ticle size 42- 80 nm for both ZnO and 24 nm for CuO and BET 
12-14 m 2 g-1 and 34 m2 g- 1 respectively). Nevertheless, all 
three materials shared bands with <10% dispersion stability, 
and the highest solubility, and were non-persistent/high trans-





NM11166 and CuO67 confirmed the high solubility in vivo and 
indicated a fast clearance from the lung. Furthermore, ZnO 
und CuO exhibited a high abiotic (band 4) and in vitro reac-
tivity (band 3). Although grouping across substances is not per-
mitted by ECHA for regulatory purposes, 14 an industrial risk 
estimation based on these results would consider ZnO und 
CuO similar and would suggest the same measures for worker 
protection at production sites .66·67 They are also the only 
materials with significant photon efficiency in the Rhodamine-
based assay on photo-reactivity, which is proposed by the 
ECHA grouping but not incorporated in the nanoGRAVUR 
grouping scheme.1 4 A large similarity of ZnO NM110 und ZnO 
NM111 was also suggested by the EC50 values for algae 
(0.1 mg L- 1) and daphnids (3.4 to 8.3 mg L- 1) (Table 5).22'23 
Within a substance, read-across from a soluble Zn salt to the 
ZnO NFs seems justified due to the biological similarity and 
high (>100 ng cm- 2 h- 1) dissolution rates. 
NEPs . The nanoGRAVUR scheme also offers a comparative 
risk estimatio n of NFs which were integrated in nano-e nab led 
products (NEPs) for automotive coatings, clinker-reduced 
cements, cosmetic sunscreen and lightweight polymers. 
Representative photographs and cross -section SEM or TEM 
analyses of the NEPs are shown in Fig. SI_2 and SI_3.t The 
values of "matrix resilience" are not reported in Table 3 
because they were not re-measured for each NEP, and because 
some NM were integrated in several different matrices, 
for release testing. As expected, incorporation into solid 
matrices dramatically changed the release probability for NM 
(Fig. SI_4t) . Although the different NFs differed significantly 
by their powder dustiness, the Tier l _NEP properties which 
predict their release potential from NEPs (Fig. 1) were the 
same for each NEP matrix and independent of the embedded 
NF, as confirmed experimentally by three independent labora-
tories (Fig. SI_4t). As an exception CuO added to wood as a 
biocidal preservative differed from all other NEP case studies 
because CuO was attributed as "attached" only. We earlier 
showed that Cu ions have to be released for biocidal perform-
ance . 72 Fragments released from NEPs consisting of the same 
solid matrix but different embedded NFs have been shown to be 
similarly toxic for animals or humans, 35-38'73 We verified this 
grouping hypothesis on the case study of automotive coatings 
containing CuPhthalocyanine. 4° Fragments from NEPs consist-
ing of the same solid matrix but different embedded NFs 
( characterised in Tier l _NEP) are also similar in their ecotoxi-
city. 24 Thus it appears that if the state of dispersion and 
content of a particular NF in the NEP, and also its intended 
use is the same, then the lifecycle-induced fragmentation is-
similar in form, rate, toxicity and ecotoxicity . In our case 
studies, all Tier l _NEP properties that could predict the rate 
and form of the release of fragments were the same for 
different nanoforms in the same solid matrix (see Fig. SI_4t), 
supporting a grouping according to lifecycle issues primarily 
by the matrix material and the intended use of the NEP. Other 
accompanying studies confirmed this grouping hypothesis 
specifically for the automotive coatings with different 
embedded nano- and non-nano-pigments, and for the light-
Nanoscaie 
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weight materials with different embedded CNT, graphene, CB 
or Kaolin fillers. 74-76 Such a grouping is considered to be rele-
vant by US-EPA and industrial downstream users but is not 
foreseen to be used in the context of European regulation e.g. 
REACH. ISO TC229 PG29 is currently working on the standard-
isation of this grouping in form of a decision tree. We found 
that the grouping by matrix and intended use only fails where 
the lifecycle process elicits catalytic activity, such as metal-
based NFs during NEP incineration, 77 or where the NEP for-
mation itself is a reactive process such as cement hydration, 
where the "matrix" crystallinity and porosity is controlled by 
the NFs, and whose formation consumes the NFs, which is the 
very purpose of the slag (GGBS) to replace CO2-intensive 
clinker 78 or of nano SiO2 in a "pozzolanic reaction". 
Several of the case studies have been evaluated by other 
grouping frameworks before and focussed especially on OECD 
NM and on some of the pigments. Comparing e.g. the group-
ing by occupational (inhalation) safety of ZnO NM111, both 
the nanoGRAVUR framework and the DF4nanogrouping frame-
work categorize NM111 in Tier 2 as "biosoluble" in the rele-
vant medium and read across to the non-nano form. In con-
trast, pigment blue 15: 1 (Cu- phthalocyanine) was a false posi-
tive in the binary decision logic of the DF4nanogrouping 
framework, being "active" in Tier 2, but "in vivo passive" in a 
Tier 3 calibration . In the risk matrix of nanoGRAVUR7 9 several 
criteria are combined and result in a "green" risk group, con-
sistent with the "in vivo passive" Tier 3 calibration . Of note, 
the risk matrices that build on the current framework are only 
intended for non-regulatory use. In the current framework, 
fibres are still recognised as a specific group already in Tier 1, 
triggering adapted tests such as descriptors of the form that is 
released during the intended use. In future, benchmark 
materials (e.g. Mitsui NT7) and methods for rigidity are fore-
seen to enhance the robustness of the HARN category. In this 
context it has to be mentioned that the trigger values for fibres 
regarding human toxicity and ecotoxicity presumably differ 
and still need to be defined for ecotoxicity. 23 
We did not test polymer particles among our case studies, 
but the tested pigments (DPP NFs and CuPhthalocyanine NFs) 
represent hydrophobic organic particles with low human tox-
icity62 and low ecotoxicity .23 No unique ecotoxicity 80·81 or 
human toxicity82 of polymer NFs was discovered, and hence 
properties beyond those of our framework should not be 
required to assess the similarity between polymer particles. 
There may be limits if the polymer NF is significantly soluble 
or swelling, such as hydrogels, for which not enough data 
exists to draw conclusion . 
As noted by Gao & Lowry, extrinsic properties result from a 
more or less complex interplay of the surrounding medium 
and one or more intrinsic properties, 83 but some extrinsic pro-
perties are less sensitive than others towards variations of size, 
shape etc. of different NFs of the same substance. The assess-
ment of dissolution and transformation by either the environ-
mental or the human perspective typically assigns different 
NFs of the same substance to the same band, with rare excep-
tions. This property is determined more by the substance than 




by size or shape or crystallinity or organic surface treatment 
(we did not test true core- shell systems, which would certai nly 
modulate the dissolution behavior). 
We observed that, when different NFs of the same sub-
stance are evaluated by harmonized methods, they are often 
assigned to different bands of dustiness, sometimes to different 
bands in the dispersion stability and mobility in soils, some-
times to different bands in abiotic reactivity, but very often to 
different bands of the by descriptor of in vitro (NR8383) reactiv-
ity, which is constructed from several read-outs. The sensitivity 
of dustiness to different NFs is supported by literature, 
which furthermore supports the order-of-magnitude (decadic) 
bands_ss,s6,s4 
Not only for reactivity, our construction of descriptors and 
bands may in fact exaggerate dissimilarity: e.g. for CeO2 reac-
tivity, TiO2 reactivity, GGBS reactivity or SiO2 dispersion 
stability, the numerical values are similar (Table 3), but fall 
on different bands of the universally fixed order-of-magni-
tude (decadic) cutoffs . Instead of the risk-screening purpose, 
for which fixed bands are appropriate, the grouping purpose 
may be better served by floating band center values with a 
fixed order-of-magnitude (decadic) span. The floating bands 
would focus on similarity within a given candidate group of 
NFs but would still keep the evaluation transparent with 
independent assessment of each property. We may also have 
to reconsider the normalization of the NR8383 NOAEC by 
specific surface areas, 60 and the indexing by it, because -
apart from partico-kinetics, cell contact and particle uptake 
into cells - there is no simple and apparent reason why the 
non-nano-form of BaSO4 should be more reactive than the 
NF, or why the non-nano-form of DPP should be significantly 
more reactive than the NF. Possibly the NR8383 evaluation 
can be adapted to the same concept of order-of-magnitude 
(decadic) bands as used for most other descriptors. However, 
this demands careful and quantitative studies on particle 
uptake, especially for well dispersed (i.e. diffusing, not sedi-
menting) particles. 
Any property descriptors that are constructed from several 
red und ant assays need data reduction strategies . On the 
example of "biological reactivity", we combined abiotic reactiv-
ity (two assays, four read-outs) and one in vitro assay (another 
four read-outs), but our addition of "points " (Table 2) is not 
optimal and triggers numerous cases of "false positive dissimi-
larity ". False positives in Tier 2 require the user who wishes to 
use grouping to escalate to Tier 3 testing, only to find there 
that the NFs are similar, such that animal testing should have 
been prevented by a more efficient Tier 2. 
In summary of the case study calibration by the in vivo 
studies and ecotox OECD studies, "ideal" similarity (i.e. 
different NFs are assigned to the same bands for all Tier 2 pro-
perties that are relevant for the grouping purpose by Table 1) 
resulted in false positives (apparent dissimilarity ) in too many 
cases and would have triggered extensive animal testing. The 
more pragmatic weight-of-evidence approach (i.e. , joint assess-
ment of properties that are relevant for the grouping purpose 
by Table 1) is more appropriate to implement the stepwise 
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ECHA process of hypothesis formulation, data gathering and 
hypothesis substantiation for regulatory groupin g.14 
In this perspective, the outstanding importance of bench-
mark materials becomes evident: we cannot assess the signifi-
cance of any dissimilarity, if we do not know the dynamic 
range of that particular property. Benchmark materials span 
the dynamic range. We observe that for many properties the 
dynamic range spans about three to four orders of magnitude 
between the positive and negative controls (i.e. benchmark 
materials). This applies to size, aspect ratio, solubility, reac-
tivity, dissolution rate, dustiness, ENM content, resilience of 
matrix, but not to homo-agglomeration or in vitro-reactivity. 
Thus, order-of-magnitude (decadic) band ranges are appropri-
ate for NFs based on experimental evidence, and this is fully 
in line with the GHS, where such a factor of 10 is often applied 
in the assessment of non-nano chemical substances . As dis-
cussed above, floating band center values would be the next 
step from risk-screening perspective towards a grouping by 
similarity (instead of categorization and banding). But, alterna-
tively to bands, one may develop algorithms that compare the 
pairwise distance of materials in a multidimensional space 
spanned by the relevant properties (Table 1, Fig. 1), and 
compare it to the distance of benchmark materials (Tables 2 
and s). Such concepts are explored in follow-up projects such 
as GRACIOUS (H2020) and InnoMat.Life (BMBF). 
Conclusions 
The methods developed or selected by nanoGRAVUR fill 
several gaps highlighted in the Steinhauser & Sayre (2017)28 
reviews and are useful to implement both the ECHA concept 
of groupin g of nanoforms or sets thereof, as well as the EPA 
concept of discrete forms. Previous frameworks had a 
narrower focus on occupational or ecological hazard. The 
nanoGRAVUR framework serves three purposes of grouping 
for occupational, environmental and consumer safety. 
Depending on the purpose, different properties become rele-
vant to assess the similarity. Grouping decisions can be made 
in the Tier 2 mostly based on extrinsic properties with quanti-
tative bands that are order-of-magnitude (decadic) for many 
properties . Benchmark materials span the dynamic range , 
which in general crosses about three to four orders of 
magnitude. 
Case studies include families of Fe2 O3 , SiO2 , 
Aluminosilicates, BaSO4, CeO2 , organic pigment, ZnO, TiO2 
(nano)forms. We find that for some substances the biological 
similarities were high when (nano)forms only differed in mor-
pholo gy and particle size, specifically for NFs and non-nano-
forms of SiO2 , BaSO4, Kaolin, CeO2 , ZnO, organic pigments. In 
contrast, different Fe2 O3 or TiO2 (nano)forms differ more sig-
nificantly. Surface treatments in the sense of the ECHA gui-
dance13 were tested on ZnO, TiO2 , SiO2 , and were found to 
modulate to a significant extent the dispersion stability and 
the reactivity, but only had transient influence on dissolution 





We further observed that, when different NFs of the same 
substance are evaluated by harmonised methods, they are 
often assigned to different bands of dustiness, sometimes to 
different bands in the dispersion stability and mobility in 
soi ls, sometimes to different bands in abiotic reactivity, and 
very often to different bands by the descriptors of in vitro and 
abiotic reactivity . In contrast, the dissolution and transform -
ation behaviour, measured by several approaches, was primar-
ily determined by the substance . 
The NFs were also integrated in nano-enabled products 
(NEPs) for automotive coatings, clinker -reduced cements, cos-
metic sunscreen, lightweight polymers. Once incorporated 
into a certain NEP with solid matrix, all relevant properties 
that could predict and assess the rate and form of release were 
withi n an order -of-magni tude (decadic) band for different NFs 
in the same solid matrix; together with the state-of-the -art on 
(eco)toxicity of NEP fragments, our findings support a group -
ing of lifecycle issues primarily by intended use and NEP 
matrix . 
The evaluation of the developed framework with a diverse 
set of case studies clearly showed its usability for grouping for 
different purposes - but also the limits: we sti ll need to 
develop rules for read-across, to explore measures that quantify 
similarity across multiple descriptors. The nanoGRAVUR case 
studies, thoroughly tested by ISO standards and OECD guide-
lines, will be essential to validate any future frameworks. 
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Numerous recent reviews have highlighted the urgent need for methods to determine the biodissolution of 
nanomaterials in relevant lung fluids, and to validate the results against the bioprocessing in vivo. Moreover, 
it is largely unknown to what extent (nano)forms of a substance that differ in size, shape, or coating also 
differ in biodissolution. Here we apply a previously optimized abiotic flow-through method to 24 
(nano)forms of 6 substances and compare the results with alveolar macrophage-assisted biodissolution of a 
subset of these nanomaterials in vitro and short-term inhalation results in vivo. As a main result we found 
that the results obtained with the flow-through method for the lung were consistent to the results of in vivo 
studies and were not improved by measuring alveolar macrophage-assisted biodissolution for up to 48 h. 
Based on selected benchmark materials we propose four groups of materials according to quantitative 
biodissolution rates (1 ng/cm²/h to 100 ng/cm²/h cutoffs) and qualitative transformation parameters, as 
detected by TEM analysis. These groups were also reflected by different lung clearance rates, as previously 
determined in short term inhalation studies. Biodissolution was similar within substance (nano)forms of 
Fe2O3, SiO2, CeO2, ZnO, though slightly varied upon surface area/coating. But the difference of 
biodissolution between the substances was in some cases more than 1000-fold. In contrast, Cu-containing 
nanoforms behaved heterogeneously and require case-by-case testing of dissolution and transformation. 
Different production routes and/or surface coatings significantly modulated biodissolution, whereas effects 
of shape or size were limited. In summary, we refined a protocol for the abiotic determination of 
biodissolution along with an integrated assessment of nanomaterial transformation. The protocol is suggested 
as tier 2 methodology for grouping and read-across purposes. 
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Numerous recent reviews have highlighted the urgent need for methods to determine the biodissolution of 
nanomaterials in relevant lung fluids, and to validate the results against the bioprocessing in vivo. Moreover, it is 
largely unknown to what extent (nano)forms of a substance that differ in size, shape, or coating also differ in 
biodissolution. Here we apply a previously optimized abiotic flow-through method to 24 (nano)forms of 6 
substances and compare the results with alveolar macrophage-assisted biodissolution of a subset of these na-
nomaterials in vitro and short-term inhalation results in vivo. As a main result we found that the results obtained 
with the flow-through method for the lung were consistent to the results of in vivo studies and were not impro ved 
by measuring alveolar macrophage-assisted biodissolution for up to 48 h. Based on selected benchmark materials 
we propose four groups of materials according to quantitative biodissolution rates (1 ng/cm 2/h to 100 ng/cm 2/h 
cutoffs) and qualitative transformation parameters, as detected by TEM analysis. These groups were also re-
flected by different lung clearance rates, as previously determined in short term inhalation studies. 
Biodissolution was similar within substance (nano)forms of Fe20 3 , Si 02, Ce0 2, ZnO, though slightly varied upon 
surface area/coating. But the difference of biodissolution between the substances was in some cases > 1000-
fold. Among the Cu-containing materials, the behavior of the two CuPhthalocyanin nanoforms was similar with 
each other, but completely different than the dissolution and transformation of Cu sa lts. Different production 
routes and/or surface coatings significantly modulated biodissolution, whereas effects of shape or size were 
limited. In summary, we refined a protocol for the abiotic determination of biodissolution along with an in-
tegrated assessment of nanomaterial transformation. The protocol is suggested as tier 2 methodology for 
grouping and read-across purposes. 
Engineered nanomat e rials (ENM) are produced in numerous grades, 
which are each optimized for specific applications and differ in prop-
erties such as composition, size, shape, surface treatments. Especially 
fillers and pigments represent established materials that are produced 
in megaton quantities in many different (nano)forms (Woh lleben et al. , 
2017a ; Ministere de !'Environnement , 2015 ). For a given material 
composition, the properties size, shape, and surface chemistry describe 
the "nanoform" for regulatory purposes (ECHA, 2017a ), but none of 
these properties is sufficient to predict the extent to which human or 
environmental hazards differ from the non -nanoform of the same 
composition (Godwin et al. , 2015 ; Landsiedel et al. , 2017 ; Dona ldson 
and Poland , 2013 ). Assessing similarity to known benchmark materials 
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can be a powerful approach to reduce the uncertainty related to the 
risks of innovative (nano)materia ls, and to revisit the safety of estab-
lished materials. Especially the rate of dissolution under simu lated 
physiological conditions (biodissolution) is an important criterion to 
assess similarity between (nano)forms of the same substance in severa l 
frameworks of grouping and read-across (Collier et al. , 2015 ; Nel et al. , 
2013 ; Kuempel et al. , 2012 ; Braakhuis et al., 2014 ; Oomen et al., 2017 ; 
Arts et al. , 2015 , 2016 ). However, Steinhauser and Sayre have stressed 
that most frameworks do not propose a specific method, often confound 
solubili ty with the dissolution rate or transformation , and rare ly pro-
pose quantitative group limits (Steinhauser and Sayre , 2017 ). One has 
to differentiate: 
• "solubility" is measured in equilibrium saturated suspensions , with 
appropriate descriptors of mg/ L ion, identical with the conventional 
solubil ity limit. Implicitly , it often means solubility in water at 
neutral pH and was proposed as Tier 1 screening for solub le ENM, 
(Arts et al. , 2015 ) to be refined to the solubility in relevant mediwn 
as Tier 2 method (Arts et al., 2015 ; Avramescu et al., 2016 ). Pla-
khova et al. demonstrated that "% disso lved " is not an equiva lent 
metric , and probably not appropriate (Plakhova et al., 2016 ). 
• "dissolution rate " is measured out of equil ibrium conditions and 
below the saturation in the relevant medium , with appropriate de-
scriptors in units of ion mass per solid mass per time ( = %/h) or ion 
mass per solid particle surface per time ( = ng/ cm2 /h). It is con-
sidered an extrinsic property. 
• "transformation " describes the propensity of the non-dissolved re-
maining solids to "change what they are " in the relevant medium , 
regarding their physical shape , or size, or chemical identity , and has 
no clearly defined descriptors . It is also considered as extrinsic 
property and has implications for hazard assessment , e.g. if the as-
pect ratio or crystalline phase changes. 
Accordingly, a recent review by Oberdiirster and Kuhlbusch found 
that "because the in vivo dissolution rates of ENM can differ widely , it is 
too simplistic to group ENM just into solubl e and poorly soluble ma-
terials. " (Oberdiirster and Kuhlbusch , 2018 ), and the appropriate dif-
ferentiation of (nano)materials by static solubility values has been 
questioned (Klaessig , 2018 ). To measure instead dissolution rates, flow 
cells (Nti, 2017 ) mimic the non-equilibrium physiological conditions , 
where ions can be transported away from the lungs. Variants of flow 
cells have been used recently for environmenta l disso luti on (Kent and 
Vikesland , 2016 ) and for oral dissolution ofnanomaterials (Bove et al. , 
2017a ). For mineral fibers, flow-through cell dissolution rates corre late 
strongly with in vivo pulmonary clearance (Guldberg et al., 1995 ; !ARC, 
2002 ). Simulant media need to be sufficiently complex to offer oxida-
tive, reductive and pH-driven dissolution pathways (Wang et al., 2016 ). 
Specifically for pulmonary biodissolution , phagolysosomal simulant 
media with a low pH value (4.5) are appropriate because alveolar 
macrophages (AMs) collect and engulf the vast majority of inhaled ENM 
from the alveolar surface , and rapidly transfer them into acidic pha-
golysosomes (Stefaniak et al., 2005 ; Marques et al. , 2011 ). 
Here we apply the abiotic flow-through method with a phagolyso-
somal simulant to a wide range of (nano)material s with different sub-
stance , size, shape , coating . Following the dissolution rate quantifica-
tion we prepare the remaining solids on transmission electron 
microscopy (TEM) grids and assess the transformation of nanoparticles 
by electron microscopy. 
However , abiotic dissolution at phagolysosomal conditions remains 
a simplistic approximation and may underestimate the more complex 
macrophage-as sisted physical (mobility) and chemical (dissolution) 
clearance (Kass, 1964 ; Geiser, 2010 ). Oberdiirster and Kuhlbusch con-
cluded that "Results from [Alveolar Macrophage] in vitro assays with 
microparticles show good agreem ent with in vivo kinetics ; yet further 
studies using MNs/ ENM of different solubiliti es are required to va lidate 
this in vitro AM assay for nanomaterials. " (Oberdiirster and Kuhlbusch, 
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2018 ) Here we hypothesize that AMs might accelerate dissolution , 
especia lly of pH sensitive nanomaterials , and explore to which extent 
the dissolution rates are compatible between abiotic and macrophage-
assisted dissolution , using BaSO4, ZnO and SrCO3 as test cases. ZnO was 
proposed earlier as benchmark material, because it is poorly soluble in 
water , but becomes soluble under phagolysosomal condition s (Arts 
et al. , 2015 ; Avramescu et al. , 2016 ). Further , it is known that SrCO3 is 
poorly soluble in water but readily soluble under acidic conditions. In 
contrast to an earlier approach based on human and dog AMs (Kreyling 
et al. , 1979 ) whose isolation demands human volunteers or animal 
experiments , we used an AM cell line (NR8383) from rat lung lavage 
cells (Helmke et al. , 1987 , 1989 ). It was shown , that NR8383 cells 
maintain their typical AM-like size, appearance , and phagocytic prop-
erties over many passages. In addition , they maintain their im-
munologica l properties, thus reacting to test material exposure by th e 
formation and release of different pro-inflammatory and fibrogenic 
cytokines and chemokines, including TNF-a, IL-1, TGF-/3 and PDFG 
(Helmke et al., 1987 , 1989 ; Koslowski et al. , 2003 ; Albrecht et al., 
2007 ; Scherbart et al., 2011 ; Bhattacharjee et al., 2012 ). Furthermore , 
the cells are capab le of producing H202 e.g . via the NADPH oxidase 
reaction process (also known as "respiratory burst ") which is an in-
herent part of the macrophages' armament and may contribute to the 
processing or dissolution of ENM. 
NR8383 cells have been used for the in vitro testing of a variety of 
ENM including functionalized amorphous silicates , indium tin oxide , 
alwnina , ultrafine titania , (multi -walled) carbon nanotubes (mwCNTs), 
various copolymers and also heparin nanoparticles (Scherbart et al., 
2011 ; Bhattachar jee et al. , 2012 ; Uson et al., 2008 , 2009 ; Pu lskamp 
et al. , 2007 ; Wagner et al. , 2007 ; Eidi et al. , 2010 , 2012 ; Bhattacharjee 
et al. , 2013 ). Most specifically , the in vitro potency screening by 
NR8383 cells correlates excellently with in vivo inflammatory short-
term inhalation study (STIS) resu lts for the purpose s of Tier 2 grouping 
of ENM in the DF4nanoGrouping framework (Arts et al. , 2015 ; 
Wiemann et al., 2016 ), such that cell -assisted biodissolution with 
NR8383 macrophages would seamlessly integrate in a grouping fra-
mework, if necessary. 
2. Materials and methods 
2. 1. Materials 
To obtain results which are representative for the broad field of 
ENM applications, six substances with 24 different (nano)forms were 
selected with prioritization by avai lability of in vivo studies (cited for 
each material in the following) and indu strial relevance (Ministere de 
!'Environnement , 2015 ). The (nano)form s vary in size, crystall init y/ 
shape and coating. Both, CeO2 NM-211 and CeO2 NM-212 were pro-
vided by the JRC repository of the Organization for Economic Co-op-
eration and Development (OECD) sponsorship program , they differ in 
size and form (Keller et al., 2014 ; Molina et al. , 2014 ). The test set also 
includes two kinds of BaSO4 whereas the nanosized BaSO4 NM-220 was 
provided by the OECD sponsorship program (via Fraunhofer Institute) 
and the non-nano-sized BaSO4 IRMM381 is a reference material , pro-
vided by the Institute for Reference Materials and Measurement (IRMM, 
Geel, with kind permission by Solvay) (Babick et al., 2016 ; Woh lleben 
et al., 2017b ). Seven different silica materials were investigated. Four 
different sizes of untreated , colloida l silica: Levasil 50, Levasil 100, 
Levasil 200 and Levasil 300 were a ll commercially acquired from Akzo 
Nobel N. V. (Wiemann et al. , 2018 ). Based on Levasil 200 , we synthe -
sized two nanoforms with surface coatings: SiO2..aminated and 
SiO2_phosphonated (Landsiedel et al. , 2014 ). The powdered silica NM-
203 was provided by the JRC repository of the OECD sponsorship 
program . In addition, the test set includes three different kinds of Iron 
Oxides (Pigment Red 101), the rod shaped Fe2 O3_nano _A and the 
spherica l Fe2Os...nano _B were both provided by BASF SE and the cubic 
Fe2O3_larger (borderline non-nano) was provided by Rockwood 
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Holdings Inc. (Hofmann et al., 2016 ). Two UV-active TiO2 materials 
were compared: TiO2 NM-104 with an Al2O3 coating and TiO2 NM-105, 
both supplied by the JRC repository of the OECD sponsorship program 
and extensively tested by inhalation (Landsiedel et al., 2010 ). Both ZnO 
materials NM-110 and NM-111 are supplied by the JRC repository of 
the OECD sponsorship program and differ in their coating. ZnO NM-111 
has a hydrophobic silicone coating, and is a benchmark "biosoluble " 
material in the DF4nanogrouping framework (Arts et al., 2016 ; 
Landsiedel et al., 2010 ). Furth er more, the test set consists of four 
copper-containing materials: The powdered nanoform CuO, provided 
by PlasmaChem GmbH (Gosens et al., 2016 ), and the suspension-mi-
cronized nanoform Cu2 (OH),CO 3, were previously studied for en-
vironmental transformations (Pantano et al., 2018 ), and we added two 
nanoforms of metal-organic pigments Cu_Phthalocyanine_nano (Pig-
ment Blue 15) and Cu_Phthalocyanine_halogen (Pigment Green 7) , 
which were provided by BASF SE (Arts et al., 2016 ). Hydrophilic SrCO3 
was donated by Solvay and was characterized previously in the course 
of the NanoCare project (Kroll et al., 2011 ). 
2.2. Abiotic ft.ow-through testing of dissolution and Lransfonnalion 
The setup (Fig. 1) implements a "continuous flow system" described 
in ISO 19057:2017 (Nti, 2017 ). It is essentially a replication of the es-
tablished flow-through testing of the dissolution kinetics of mineral 
fibers (Guldberg et al., 1995 ; !ARC, 2002 ), was described for this pur -
pose (Wohlleben et al., 2017c ), and was used here with minor adap-
tations to match the specifics of ENM: The ENM mass of 1 mg was 
weighed onto a membrane (cellulose triacetate , Sartorius Stedim Bio-
tech Gmbl-1, Goettingen, Germany): 47 mm diameter , 5 kDa pore size, 
topped by another membrane, and enclosed in flow-through cells . 
Standard conditions are 1 mg initial solid mass in the flow-through cell, 
and 2 mL/h flow. The phagolysosomal simulant fluid (PSF), an acidic 
buffer simulating the phagolysosomal compartment of macrophages 
(Stefaniak et al., 2005 ; Wohlleben et al., 2017c ), which was previously 
validated for the purpose of inhaled beryllium dissolution by NIST la-
boratories (Stefaniak et al., 2005 ), was employed at 37 ± 0.5 °C. The 
PSF composition is reproduced in the supplementary information (SI). 
In contrast to the larger volume flow cells used by Bove et al. for oral 
dissolution testing (Bove et al., 2017a ), in our setup the ENM are in 
direct contact with the ultrafiltration membrane. In contrast to the flow 
cells used by Kent et al., our cells hold industrially produced ENM, not 
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2016 ). The core idea of separating ions from remaining solids is shared 
by all three setups. 
The programmable sampler drew 4-10 mL of the eluate once per 
day for seven days. For shorter sampling times at the beginning of the 
dissolution, the samples were drawn for only 2-3 h instead of 5 h. The 
rest of the eluate was collected in a container. The ion concentrations of 
the eluates from different time points were determined by inducti vely 
coupled plasma-optical emission spectrometry (ICP-OES Agilent 5100 
and Varian 725 ES) with a limit of detection of 0.1 mg/ L, alternatively 
by inductively coupled plasma-mass spectrometry (JCP-MS Perkin 
Elmer Nexion 2000b) with a limit of detection of 0.1 ppb. Prior to 
taking the measurement , the instrument was optimized in accordance 
with the manufacturer's specification. Duplicate measurements are 
taken and averaged. We measured with 10 s integration time, and the 
dilution factors were between 1 and 10. External calibration used 
concentrations of 0/ 1/5 mg/L with matrix-matched standards. The 
nebulizer (Meinhard 1 mL) had a flow of 0.7 L/min at a pump rate of 
15 rpm. For ICP-MS duplicate measurements were taken and averaged. 
The eluate was diluted with a factor between 100 to 1000 and the ex-
ternal calibration used concentrations of 0.1 / 1/ 10 ppb. The nebulizer 
had a flow of 0. 92 L/ min at a pump rate of 35 rpm. 
After the experiment, the remaining solids were rinsed off the 
membrane as shown in the photo -protocol in Fig. SI_S3 docum enting 
specifically deve loped accessories. The resulting suspension was then 
pelleted onto a TEM grid held at the bottom of a centrifuge vial within 
30 min, then dried , so that the remaining solids morphology can be 
inspected without interference from drying artifacts of PSF salts, which 
are removed by this preparation. The remaining solids were analyzed 
by TEM with a Tecnai G2-F20ST or Tecnai Osiris Microscope (FE! 
Company, Hillsboro, USA) at an acceleration voltage of 200 keV under 
bright-field conditions. For the automated image analysis the pre-vali-
dated NanoDefine SEM/TEM software packages were used (Ullmann 
and Mi.iller, 2017 ; Mielke et al., 2016 ; Muller et al., 2015 ). 
We multiplied the measur ed ion concentration of each eluate with 
the eluted volume to obtain a mass of dissolved ions, and corrected for 
the molar mass m of the pristine ENM and of the detectable met al ion, 
to obtain the mass of ENM solids Mwswlved(t) that were dissolved during 
the sampling interval M,. Interim calculations are detailed in the SI. 
Cumulated from all samplings with concentration c,, flow V, and sam-
pling interval M 0 the dissolved mass at the final time T is 
+ 
flow 
el nanopart icle 
-S:::::::S::::: 3-5 kDa membrane 
Fig. 1. Dissolution setup. The reservoir 
for the physiological fluid is controlled at 
37 °C, as well as the flow-through cells. 
The peristaltic pump regulates the flow-
rate of up to 8 cells in parallel, with a 
programmable autosampler for fluid 
collection. The flow-through cell is 
equipped with 5 kDa membranes to hold 
back particles and only allow the flow of 
ions. The meniscus of the reservoir is 
elevated approx. 0.5 m above the cells 
such that the hydrostatic pressure bal-
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m(ENM) T . 
Mdi=tved(T)= . *~C ;(Wn) *Vi*M ;. 
m(rnetal _wn) i=O (1) 
The dissolution rate k is then obtained via 
M,olid,(T) = Mo ~ Mdissolved(T) with the relation: 
k = ln {Mo/Msouw(T)}/ (SSA(T)*T) (2) 
This calculation is consistent with the first order modeling of ISO 
19057:2017 (Nti, 2017 ), but gives k in units of ng/ cm2/h as re-
commended by Oberdiirster and Kuhlbusch (2018) . SSA(T) is the spe-
cific surface area at time T, equa l to BET at time zero; k can be con-
verted to a halftime t11 2 by Eq_SI_l. The alternative metric "% 
dissolved" is given by Mdissolved (T)/ Mo. 
2.3. Preparation of nanoparticle suspensions for in vitro testing 
BaSO4 NM-220, SrCO3, ZnO NM-ll0 , or ZnO NM-lll ENM were 
suspended in double distilled H2 O at a concentration of 1 mg/ml. 
Suspensions were ultrasonicated on ice for 10 x 10 s using a 3 mm 
probe adjusted to SOW (Vibra Cell™, Sonics & Materials, USA). To re-
move larger aggregates (typical for the spray dried BaSO4 ENM) which 
cannot be engulfed by macrophages, the BaSO4 and SrCO3 suspensions 
were filtered through a depth-type filter with 2. 7 µm pore size 
(Whatman™ GD/X 25 syringe filter with 2.7 µm GF/ D Glass Microfiber 
Membrane). The filtrate was dried and the particle content was mea-
sured gravimetrically , resulting in a concentratio n of 500 µg/mL. 
Aqueous suspensions of SrCO3 and BaSO4 were then adjusted to 90 pg/ 
ml. Suspensions of ZnO NM-ll0 and ZnO NM-lll were diluted to 
11. 25 µg/ mL. All aqueous suspensions were then mixed with an equa l 
volume of double-concentrated (2 x) F-12K cell culture medium pre-
pared from powder medium (Sigma-Aldrich GmbH, Munich , Getmany) , 
supplemented with glutamine ( 4 mM) and penicillin (200 U), strepto-
mycin (200mg/ml) , and 10% (v/ v) fetal bovine serum (FBS) (PAN 
Biotech GmbH, Aidenbach, Germany) , or with double-concentrated 
phagolysosoma l simulant fluid (PSF) adjusted to pH 4.5 with 1 M 
NaOH. The final suspension, as used for dissolution experiments , 
therefore conta ined all F-12K components and supplements , 5% FBS 
and 45 µg/ mL (SrCO3, BaSO4 ) or 5.6 µg/ mL (ZnO) of the ENM, re-
spectively . Equal concentrations of ENM were prepared in PSF. All ENM 
suspensions were prepared short ly before use and vortexed im-
mediately before in vitro application. Based on previous cytotoxicity 
data for BaSO4 and ZnO (Wiemann et al. , 2016 ) the concentrations 
were maximized up to values where cytotoxic effects were absent or 
minimal. For SrCO3 , a no adverse effect level larger than 90 µg/mL was 
found under the same conditions. This strategy was chosen to increase 
the yield of dissolved ions and also to avoid early cell death. 
2. 4. Preparation of the NR8383 rest sys rem 
The rat AM cell line NR8383 (Helmke et al. , 1987 , 1989 ) was 
purchased from ATCC (Manassas , VA, USA) and used for in vitro ex-
periments. Cells were grown in F-12K medium (Sigma-Aldrich GmbH, 
Munich, Germany) supplemented with 15% FBS, glutamin , and peni-
cillin (100 U), streptomycin (100 pg/ml) under standard cell culture 
conditions (37 °C, 5% CO2) as described (Wiemann et al., 2016 ). For 
dissolution tests , the macrophages were detached from the substrate by 
mechanical agitation , fully d ispersed by pipetting , seeded into 96-well 
flat-bottom plates (Primaria™, Coming , NY, USA) at a density of 
3 x 105 live cells per well , and pre -incubated in F-12K supplemented 
with 5% FBS for 24 h. Then the medium was completely replaced by 
ENM suspensions (see above). Cell-free experiments were conducted 
side-by -side , i.e. on the same plates, using F-12K medium with 5% FBS 
and PSF as dispersants. For each single experiment 8 identical wells 
were run in para llel. To accelerate sedimentation of particles and unify 
the onset of exposure of cells to ENM, plates were centrifuged at 100 x g 
(37 °C) for 10 min and incubated under cell culture conditions for 3 h, 
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6h, 12h , 24h , and 48h with SrCO3 or BaSO4 , or 24h to ZnO NM-ll0 
or NM-111, respectively. Phase contrast micrographs were taken to 
monitor gravitationa l settling, uptake of larger particles or cell lysis 
using a Zeiss Axiovert C40 microscope equipped with an Axiocam C3 
camera. 
Following incubation with ENM, cells were completely lysed by 
adding 20 pl of a concentrated mixture of Triton X-100 and proteinase K 
(fina l concentration: 0.1 % and 0.1 mg/mL , respectively) for 45 min , as 
controlled by phase contrast microscopy. Non-lysed ENM were sepa -
rated by ultrafiltration. Therefore lysates were pooled , loaded onto 
100 kDa filter devices (Amicon 100k ultra-0.5 , Merck KGaA, Darmstadt, 
Germany) and centrifuged at 14,000 xg for 15 min. Filtrates were then 
forced through a 3 kDa filter (Amicon 3k ultra-0.5 , Merck KGaA, 
Darmstadt , Germany) by centrifugation (14 ,000 xg , 20min) and used 
for chemical analysis. 
The ionic Ba, Sr, or Zn concentration was assessed by ICP-MS (ICP-
MS 8800, Agilent Technologies, Santa Clara , CA, US) and corrected for 
the molar mass of the pristine ENM and the detectable metal ion, to 
obtain the mass of dissolved ENM solids. Results are shown as 
mean ± standard deviation (SD). To test for statistical significance, 
test values were compared to control values using Welch's unequal 
variances t-test. Test results with p ;; 0.05 were assessed as significant 
(*). All experiments were performed in triplicates. 
2.5. Determination of cytotoxicit;y 
Cytotoxic effects of ENM were monitored by measuring the lactate 
dehydrogenase (LDH) activity in the cell cultur e supernatant as an in-
dicator for membrane damage and / or cell necrosis. Measurements were 
carried out as described (Wiemann et al. , 2016 ) using the Roche Cy-
totoxicity Kit (Roche, Germany). In brief , cell culture supernatants were 
centrifuged (10 min , 200g) to remove larger particles and cell debris. A 
volume of 50 pL was incubated with LDH reaction mix (Roche Cyto-
toxicity Kit; Roche, Germany) and evaluated as described by the man-
ufacturer. Optical density (OD) was measured at 490 and 620 nm in a 
plate photometer (Tecan 200Pro, Tecan , Germany). Measurements 
were routi nely corrected for cell free-adsorption (to erase effects of 
particl es on the optical signal) and normalized to the positive control 
value (set to 100 %) obtained from NR8383 cells lysed with 0.1 % Triton 
X-100 (Sigma, Aldrich , Germany). Particles investigated in this study 
had no influence on the LDH signa ls. 
3. Results 
3.1. Abiotic dissolution and transformation 
The dissolution kinetics of 24 ENM was investigated in pH 4.5 PSF 
(Fig. 2A-E). For some materials, e.g. both nanoforms of CeO2 , the ion 
concentration in the eluate remains below the limit of detection (LoD) 
at any samp ling time. In this case a virtual value was calculated from 
the number of consecutive measurements multiplied by LoD, however 
no plot was generated for this data. With ICP-OES as analysis technique , 
dissolution remained below LoD for a ll nanoforms of CeO2 and Fe2 O3. 
With ICP-MS as analysis technique that is sufficiently sensitive on the 
ppb ion level that is to be expected , (Plakhova et al. , 2016 ) quantitative 
values could be generated also by the flow cells, but would not change 
the assignment to the group of materials with low dissolution rate. The 
dissolution of the barely soluble material BaSO4 NM-220 (Fig. 28) has 
been identified elsewhere as a combination of dissolution and Ostwa ld 
ripening , highlighted by an unexpected growth of particle size (re-
produced in Fig. SI_S6) (Keller et al., 2018 ). Here we compare the non-
nanoform by the same supplier BaSO4_IRMM381, and find that by 
matching the initial surface area of the two forms (testing BaSO4 NM-
220 at Mo = 0.17mg), both the nanoform and the non-nanoform have 
nearly identical k•PP and M,0 n/T (Table 1). In this manner , the max-
imum ion concentration is different but remains for both below the 
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Fig. 2. Dissolution kinetics . A: Cu (red CuO, blue CuPhtalo_nano, yellow CuPhtalo_ha logen, green Cu2 (OH)zCO3 ); B: BaSO4 (red NM-220 1.05 mg, blue NM-220 
0.1 7 mg, yellow IRMM381) , C: SiO2 (red NM-203, blue SiO2_amino), D: ZnO (red NM-110, blue NM-111), with inset enlarging the initia l effects. E: SrCO3 • The error 
bars displayed here equal the duplicate uncertainty of the ICP-OES measurements. 
pH 4.5 solubility limit , such that reprecipitation and Ostwald ripening 
are suppressed. The matching of dissolution rates from nano- and non-
nanoform confirms the validity of the surface-based k metric. 
For all six forms of SiO2 (Table 1 and Fig. 2C) the dissolution is 
rather limited in the acidic PSF medium , as expected. However, we do 
observe a higher dissolution for SiO2 NM-203, which is produced by a 
different process (precipita tion, then drying) than the colloida l nano-
forms of SiO2 (SiO2..untreated _50 to SiO2..untreated_300). Knowing that 
soluble forms of SiOx tend to polymer ize, we stored the elu tion samples 
from NM-203 alternatingly with or without addition of 10% of 1 M HCl, 
but the resulting kinetics superimposed comp letely , confirming suffi-
cient stability of disso lved Si-species before detection. Additionally, we 
measured another SiO2 powder (NM-200) and found similar dissolution 
rates. While there is a trend to release more ions from smaller particles 
(in the SiO2..untreated _50 to SiO2..untreated _300 family (Wiemann 
et al. , 2018 )) , the surface increase is larger so that the nominal dis-
solution rate k is lower for the smaller forms. Considering that espe-
cially in acidic medium SiO2 tends to undergo po lymerization and gel 
formation, a lower initia l concentration of solids might help to de-
monstrate a stronger relationship with size, but wou ld underscore the 
detection limit of our ICP-MS. Interestingly , surface functionalization 
(SiO2_amino _200, SiO2_phosphonate _200) can increase dissolution 
threefold compared to the core particle (SiO2_untreated _200). 
The four Cu-containing nanoforms show a very diverse dissolution 
as seen in Fig. 2A. CuO dissolves comp lete ly after 7 days under standard 
conditions , whereas CuiOHhCO 3 dissolves moderately (32% after 
7 days) and both Cu_Phtha locyanin nanoforms shed only negligible 
amounts of ions. The difference is evident by the comparison of daily Cu 
release of 456 µg from CuO compared to 0.66 µg from Cu_Phthalocya -
nin _nano (Pigment Blue 15). These traces of Cu from Pigment Blue 15 
are not necessari ly attributed to particle dissolution but rather to re -
maining Cu from the complexation syothesis of the technica l materia ls. 
Very interestingly , Fig. 2D demonstrates a small retardation (from 
day 2 to 5) of the dissolution kinetic for the ZnO nanoform with coating, 
ZnO NM-111. However , after this retardation , attributed to the dis-
solution of the coating , the overall dissolution of ZnO NM-111 is ac-
celerated (Table 2). 
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Transformation is frequently observed for zero-valent Ag- or Cu-
particles wi th numerous studies showing re -crysta llization, re-specia-
tion (changing the chemical composition) especia lly in environmental 
med ia (Gao and Lowry, 2018 ; Vencalek et al., 2016 ; Dale et al. , 2015 ; 
Mitrano and Nowack , 2017 ; Mitrano et al., 2015 ). Here we apply a 
standardized protocol of aging and samp le preparation (Fig. SI_S3), 
with representat ive results shown in Fig. 3. Comparing the first pair of 
images (Fig. 3a) , the TEM resu lts support the complete dissolution of 
ZnO NM-110 incurred from the addition of a ll ions in the elua tes, ob-
servations made for with the disso lution setup, as no particles could be 
found. In contrast, Fe2Os..nano _B (Fig. 3b) showed no significant dif-
ference between the pristine material and the mater ial after a week of 
exposure to PSF. Cu_Phtha locyanin _nano tended to form aggregates, as 
no smaller part icles remained (Fig. 3c). TEM images of SiO2_untreated 
nanoparticles (Fig. 3d) revea led a moderate shrinkage. Fur thermore , 
the homogeneous electron density of the particles transformed into an 
electron dense core and a less electron dense surface layer, which may 
be interpreted as gel-like and is not unexpected for SiO2 under acidic 
conditio ns (Iler , 1979 ). 
In addition to the representative cases (potential benchmark mate-
ria ls) in Fig. 3, more ENM have been ana lyzed with TEM of initial solids 
vs. remaining solids (Fig. 4). For Cu_Phthalocyanin_halogenated we 
observed the same behavior as for Cu_Phthalocyanin _nano, because the 
remaining particles were strong ly aggregated. When comparing the 
TEM image of the pristine particles of Cu2(OHhCO 3 with the TEM after 
the treatment with PSF, we observed that pristine particles had dis-
appeared , while very few secondary part icles were visib le which con-
sisted mainly of Si, but were devoid of Cu. SiO2 NM-203 was found to 
disso lve faster than colloida l silica of roughly the same constituent 
particle size (SiO2..untreated_200) , and forms different intermediate 
structures (Fig. 4c). This may be due to the aggregate structure with 
negative radii of curvature (necks between primary particles) (Iler, 
1979 ). As CuO and ZnO underwent complete disso lution within 7 days , 
an "infinite dilution " approach was emp loyed to study transformation 
processes: we repeatedly dipped the grids into PSF and successive ly 
imaged the same spot of a TEM grid. The results on ZnO nicely de-
monstrate how its disso lution behavior is complete ly different from 
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Table 1 
Nanoform physical-chemical descriptors of the 24 test mat erials. 
M inimwn external Shape (I'EM) Specific Composition/crystalli nity/ Surface modificati on 
dimension (TEM or surface area impurit ies (.)(RD, ICP-MS, 
AUC") 
[nm] Descripti ve 
BaSO4 NM-220 32 Spheroidal 
BaSO4 IRMM381 253 Sphero idal 
CeO2 NM-211 4- 15 Sph ero idal 
Ceo , NM-212 40 Mixed 
sphero idal + platelets 
Cu2(OH)2CO3 34• Platelets 
Cu_Phth alo_halogen 14 Platelets 
Cu_Ph thal o_nano 17 Sph ero idal 
CuO 40 Sphe ro idal 
Fe2O3_large:r 48 ± 27 Spher oidal 
Fe20 3...nano_A 15- 130 X 4- 21 Rod shaped 
Fe20 3-nano_B 37 Sphe roi dal 
SiO2 NM-203 20 Spher oidal 
Si0 2....aminated 154 Spheroidal 
Si02..Pho sphon ate d 154 Sphero idal 
SiO2...untreated_S0 55• Sph ero idal 
SiO2.untreated_ l00 304 Spheroidal 
SiO2...untreated_200 15• Spheroidal 
SiOz....tmtreated_300 9• Sph ero idal 
srco , 13- 19 Rod shaped 
TiO2 NM-104 21 Sphe ro idal 
TiO2 NM-105 25 Spheroidal 
ZnO NM-110 42 Mixed spheroidal and rod 
shaped 





























Pur ity > 93.8%; Na, Ca, Sr, 
F, Cl, organ ic compoun ds 
Ba 58.8% 0 27.4 % S 13.7% 
Pur ity > 95% 
Pur ity > 99 .5%, 0.7 % 
organic cont ami nations 
Cu 57% 
Cu 5% 
Cu 10.4 % 
Pur ity > 99%, Al, Si 0.1- 1% 
Predominantly Fe20 3 , 
hematite ; traces of mag netite 
(cubic) Fe3O4 
Fe20 3 , hemat ite 
Fe 20 3 , hem atite 
Pur ity > 99%, Al 0.43 % 
Si0 2 amorphou s 
Si0 2 amorphou s 
Si0 2 amorphou s 
Si0 2 amorphou s 
Si0 2 amorphou s 
Si0 2 amorphou s 
Sr: 21.1 %; C 27.1%; 0 : 
51. 3% 
Ti0 2 rutile 
Ti0 2 mix rutile/anatase 
ZnO > 99 % 














covalent surface functionalization with low -
molar-mass silane having a pos. charged amino 
end group 
covalent surface functionalization with low -
molar-mass silane having a neg. charged 






Alz0 3 coating + 2% Polydimethylsil oxan 
None 
None 
Trieth oxycaprylsilan e silicone coating 
' Following the NanoDefine e-tool (http:// www.n anodefine .eu/ index.php/ nanodefiner-e -tool), materials that are originally pro duced as colloidal suspensions 
wer e characterized by Analytical Wtracentrifug ation (AUC) (Mehn et al., 2018), and powders by Transmission Electron Microscopy (TEM). 
BaSO4 NM-220 (Keller et al., 2018), as ZnO reduces the radii of cur-
vature until complete disappearance (Fig. SI_54). No dissolution was 
quantified with our ICP-OES limit of detection for TiO2 NM-104, CeO2 
NM-212 or Fe2O3_nano _A. The absence of major dissolution or trans-
formation was also confirmed through th e analyzation of the crystal 
structure through selected area electron diffraction (SAD, Fig. SI_S7). 
The SAD graph showed unique Cerianite (CeO2) signals and thus con-
firmed that transformation remained limited , although especially Ce111-
rich surface layers may have undergone transformations . In contrast to 
the case of BaSO4 NM-220 (Fig. SI_S6 reproduced from (Keller et al. , 
2018)) no Ostwald ripening has occurred for BaSO4 non-nano (Fig. 
SI_S7). 
3.2. Uptake of nanomaterials by NR8383 cells and cell-assisted dissolution 
In the next step we explored in as much macrophage-assisted dis-
solution differs from the abiotic flow-through dissolution . In contrast to 
former experiments with AMs (Krey ling et al., 1979 ), we used culti-
vated NR8383 rat AMs to avoid animal consumption necessary for the 
use of primary cells. NR8383 cells are actively moving phagocytic cells 
which gather particles from the bottom of the cell culture vessels . The 
cells can be transiently cultivated under low serum-condition s. How-
ever , as NR8383 cells are not firmly attached to the substrate, a change 
of medium may lead to cell loss, such that their incubation with SrCO3 
and BaSO4 in wells of a 96 well plate was limited to 1- 2 days. To in-
crease the yield of dissolved ions under these conditions , a compara-
tively high concentration of 45 µg/mL was used which , in case of 
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BaSO4 , were found to be non-toxic under the condition s of the macro-
phage assay ((Wiemann et al., 20 16), see Supplement Table SI 1 for 
SrCO3 ). Exposure of the cells to the particle was accelerated by brief 
centrifugation of ENM onto the bottom of the 96-well plate (Fig. Sa). 
This procedure had no obvious influence on cell shape or motility but 
circumvented the phase of gravitational settling and , therefore , pro-
vided a common starting point for the time-lapse study of particle 
dissolution. Under these conditions AMs had entir ely engulfed micro -
scopically visible SrCO3 agglomerates from the bottom of the wells after 
<'= 3 h and this situation persisted until the end of incubation (Fig. Sb). 
To measure the total amount of intra- and extracellular Sr ions by 
ICP-MS analy sis, cells within each well were completely lysed with 
Triton X-100 and proteinase K after 3, 6, 12, 24 and 48 h and the 
homogenates were separated from any particulate constituents by 
passing through a 3 kDa filter unit. Incubation of SrCO3 with NR8383 
cells significantly increased the concentration of dissolved material in 
the medium compared to cell-free control at any point in time. For 
example , after 24h concentrations of 21.87 ± 0 mg/kg (49% of total 
mass) and 6. 71 ± 0 mg/kg (15 % of total ma ss, n = 3) were mea sured 
for the macrophage-mediated dissolution and the cell-free medium 
control , respectively. Of note , the macrophage-mediated increase in 
dissolved SrCO3 developed progressively up to 48 h , indicating ongoing 
cellular activity . In contrast , the incubation of SrCO3 ENM in acidic PSF 
for 24 h led to a rapid dissolution of 97% of the total SrCO3 mass 
( 43. 79 ± 0 mg/kg) and these high values remained fairly constant 
over time (Fig. 6, Table SI Sla). To analyze cytotoxic effects during 
SrCO3 incubation , the activity of LDH was monitored in the cell culture 
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Table 2 
Cumula tive evaluat ion ofbiodissolution of ENM in flow cells with pH 4.5 media at 2mL/h flow-through . For many materials, the ion concentration remained below 
the limit of detection (LoD), but could be improved by using dedica ted ICP-MS instruments. Significant disso lution is marked bold. 
Mo Max. ion concentration 
Unit [mg] [mg/1] 
BaSO4 NM-220 (nano) 1.05 1.3 
BaSO, NM-220 (nano) 0.17 0.8 
BaSO4 IRMM381 (non-nan o) 1.78 0.49 
CeO2 NM-211 1.1 < 0.1 (.loD) 
Ceo , NM-212 1.02 < 0.1 (.loD) 
cu , (OH), CO3 1.07 3.0 
Cu_Phth alo_halogen 1 < 0.1 (.loD) 
cu_phthalo_nano 0.98 0.05 
CuO 1.56 37 
Fe20 3Jarger 1.09 < 0.1 (.loD) 
Fe2 0 1-nano _A 1.07 < 0.1 (.loD) 
Fe20 i_nano_B 0.99 < 0.1 (.loD) 
SiO2 NM-203 1.12 0.3 
SiO2 NM-200 1.01 0.45 
SiO2...amino_200 1.06 0.28 
SiO,..pho sphon ate_200 1.01 0.18 
SiO2...untreated_S0 1.17 0.03 
SiO,_untr eated_l00 1.08 0.04 
SiO,..untreated_200 1.0 0.05 
SiO,_un treated_3 00 1.05 0.06 
SrC0 3 1.08 12.7 
TiO2 NM-104 1.09 < 0.1 (.loD) 
TiO2 NM-105 1.04 < 0.01 (.loD) 
ZnONM- 110 1.12 18 
ZnONM- 111 1.12 17 
supernatants. LDH activity was low after 3 hand 24h (9.8 ± 6.5% of 
Triton X-100 control), but increased to 81.0 ± 38.1 o/o of positive 
control at 48 h. At this point in time light microscopic inspection re -
vealed cells with many pseudopodia and smooth surface, devoid of any 
signs of cell deterioration (Fig. Sb). 1n summary, SrCO3 , whose solu-
bility is known to be pH-dependent , showed an enhanced and pro-
gressive dissolution upon uptake and digestion by live macrophages in 
vitro. 
1n the next step we analyzed whether the dissolution of BaSO4, a 
material with a low solubility at neutral pH, might be also enhanced 
after uptake by macro phages. Following the same procedure as de-
scribed for SrCO3 , 45 µg/m L BaSO4 ENM suspension was applied to 
NR8383 AMs. Phase contrast micrograph s confirmed the settling of 
BaSO4 to the bottom of the wells after centrifugation (Fig. 7a). No 
BaSO4 agglomerates remained visible between the cells at all tinle-
points <': 3 h (Fig. 7b ). ICP-MS analysis of the filtrated cell homogenates 
and respective controls revealed that , after 24h incubation of BaSO4 
with NR8383 cells, 1.88 ± 0.38 mg/kg materi al had dissolved, com-
pared to 1.33 ± 0.37mg/kg in the cell-free medium control, which 
corresponds to 4.18 % and 2. 95% of applied material , respectively. 
Exposure of BaSO4 ENM to acidic PSF for 24 h led to dissolved material 
fractions of 2.4 ± 0.08 mg/kg, which corresponds to a dissolution of 
5.34 % (Figs. 8 and SI Slb). 1n accord with the well-known poor solu-
bility of BaSO4 , we found low amounts of dissolved materia l in F-12K 
medium for all time points investigated , namely 2. 98% of applied 
material in average. Although very subtle, NR8383 AM increased the 
dissolved mat erial portion up to 6.13 % at the 48 h tinlepoint. Sinlilarly , 
PSF accelerated the dissolution up to 5.34 % after 48 h. 
The release of LDH 3, 6, 12, and 24 h post administration was very 
moderate (9.53 ± 4.05% of positive control) but raised to 
48.86 ± 10.22 % of positive control values after 48h. Again, the mi-
croscopic inspection of BaSO4-treated cells showed no signs of cell 
deterioration. 
We finally assessed the ma crophage-assi sted dissolution of uncoated 
ZnO (NM-110) and surface-coated ZnO (NM-111). Both materials show 
a high solubility under in vivo conditions, i.e. at near neutral pH. 
NR8383 cells were exposed to only 5.6 µg/mL ZnO NM-110 and ZnO 
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Dissolved per 7 days k M,on/f 
[%] [ng/cm 2/h] [µg/day] 
58 10 51 
100 45 18 
9 53 16 
< 3 < 0.28 (.loD) < 3.9 (.loD) 
< 3 < 0.73 (.loD) < 3.6 (.loD) 
32 172 24 
< 35 (.loD) < 3.7 (.loD) < 2.4 (.loD) 
0.4 0.531 0.66 
100 283 456 
< 3 (LoD) < 1.56 (.loD) < 3.7 (.loD) 
< 3 (LoD) < 0.17 (.loD) < 3.2 (.loD) 
< 3 (LoD) < 0.65 (.loD) < 3.6 (.loD) 
8 0.23 11 
11 0.383 7.76 
7 0.216 4.83 
8 0.2.75 5.76 
0.5 0.088 1.6 
0.9 0.066 1.7 
1.2 0.044 2.1 
1.4 0.034 2.6 
100 108 240 
< 0.03 (.loD) < 0.0 31 (LoD) < 2.4 (.loD) 
< 0.1 (.loD) < 0.013 (LoD) < 0.1 (.loD) 
100 204 217 
100 177 150 
NM-lll. At this concentration , cytotoxic effects of both ENM were 
moderate after 24h (ZnO NM-110: 33.59 %; ZnO NM-111: 33.69%) and 
were not influenced by stimulation with lipopolysaccharide (data not 
shown). ZnO agglomerates of either quality were not visible on the 
bottom of the cell culture vessel between the cells (not shown) after 
24 h. At thi s timepoint 2.86 ± 0.1 mg/kg (51 o/o dissolution) and 
2. 7 ± 0.12 mg/kg ZnO NM-110 ( 48% dissolution) were detected in the 
supernatant in the presence and absence of NR8383 cells, respectively. 
Compared to the medium control a significantly higher amount of ZnO 
NM-110 (p = 0.005) was dissolved in PSF (3.78 ± 0.06mg/kg , 67% 
dissolution). Likewise, concentrations of ZnO NM-111 amounted to 
2.2 ± 0.06mg/kg in the NR8383 sample (39%), 2.2 ± 0.38mg/kg in 
the medium control (39%), and 2.86 ± 0.35 mg/kg in PSF (51 %). Due 
to these results we abstained from measuring after 48 h. 
1n summary , while the high solubility of both ZnO ENM was con-
firmed and shown to be increased in acidic PSF, phagolysosomal pro-
cesses of live macrophages had no major influence on the solubilization 
of Zn ions (Fig. SI Slc and d). 
4. Discussion 
4.1. Discussion of macrophage-assisred mechanisms 
As previously shown for the dissolution of poorly soluble , radi-
olabeled 57 Co3O4 by primary alveolar macrophages (AMs) from humans 
and dogs (Kreyling et al., 1979), we found that also cultured AMs can 
accelerate the biodissolution of particulate matter . This was most ob-
vious for SrCO3 , which is known to be soluble only under acidic con-
ditions. Whereas SrCO3 was readily soluble in PSF after 3 h incubation , 
only a minor fraction was dissolved after 3 h incubation with NR8383 
macrophages . However, w ith longer incubation periods the dissolved 
fraction incre ased continuously . This might be due to the gradual 
acidification of the macrophage's phagolysosomes. 1n contrast , no sig-
nificant dissolution occurred in the control experiment of medium 
without macrophage s. 
BaSO4 was tested in comparable static (beaker) super-saturation 
condition in acidic PSF and in pH neutral medium. 1n this static 
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b) 200 nm 1 µm 
200nm 200 nm 
1 µm 1 µm 
100 nm 100 nm 
Fig. 3. Electron microscopic analysis of representati ve cases of ENM transfor-
mation. Comparison between TEM images of the pristine state (left column) and 
after the recovery from the flow-through cell after 7 days of treatment (right 
column). a) ZnO NM-110 (complete dissolution), b) Fe2O,..nano _B (no dis-
solution, no transformation), c) Cu_Phtalo_nano (no dissolution, aggregating 
transformation) , d) SiO2_untreated _200 (low dissolution, reprecipitation trans-
formation). 
experiment, Ba ion concentration was slightly higher in acidic PSF than 
in pH neutral medium control. Interestingly, the total dissolved fraction 
was considerably higher in the flow-through system (Keller et al. , 
2018 ). However, a trend of acceleration was hardly discernible after 
incubation with NR8383 cells. Because of the trace concentrations of Ba 
to be measured the analytical uncertainty might mask subtle cellular 
effects. In addition, the incubation time was limited to 48 h (to prevent 
a change of medium), and this is a major difference to the study of 
36 
Nanolmpact 12 (201 8) 29--41 
Kreyling and co-workers on the in vitro dissolution of 57 Co3O4, who 
exposed AMs for 14 days and measured dissolved Co ions by gamma 
counting. 
To compare the dissolution efficiency of AMs in vivo, we approx-
imate the deposited dose per AM for an inhalation exposure of rats to 
50 mg/m 3 BaSO4 for 5 days , resulting in a lung burden of 1055. 7 µg/ 
lung. After a post-exposure period of 21 days the lung burden decreased 
to 239.7 µg/lung (difference 816 µg) (Landsiedel et al. , 2014 ). The 
average AM cell count of female Wistar rats is approximately 1 x 107 
(Rehn et al. , 1992 ). Assuming a stable AM number throughout the post-
exposure period, each macrophage engulfed/cleared 3.9 x 10- 6 µg 
BaSO4 per day, partially by dissolution. In the present study, 3 x 105 
NR8383 cells were exposed to 9 µg BaSO4 ( 45 µg/mL) . After 24 h each 
macrophage dissolved 1.3 x 10 - 6 µg BaSO4 . Hence, the in vivo dis-
solution was augmented approximately by a factor of 3 compared to the 
in vitro situation. The in vivo clearance of particulate matter from the 
alveolar surface is primarily triggered by AMs, as particles are known to 
be phagocytosed within a few hours. Besides AM-associated muco-
ciliaty clearance , dissolution may conttibute significantly to the clear-
ance in vivo, which is obviously dependent on additional factors like 
surfactant turnover, lymphatic flow, and lung perfusion. This complex 
process cannot be mimicked in vitro. We conclude that for materials 
with a low solubility limit, an increase of biological complexity e.g. 
using macrophages of the testing method, compared to the abiotic 
dissolution system , is not beneficial. 
This is also true for the ZnO ENM investigated . The dynamic in vivo 
situation which leads to a fast ZnO clearance from rat lungs could not 
be simulated in the static cell culture approach. It should be noted, that 
LOH activity was increased after 48 h incubation with SrCO3 and BaSO4 
possibly pointing at beginning cytotoxicity although there were no 
visible signs of reduced viability or deteriorated cells. Apart from Sr, Ba, 
or Zn ions high LOH activity or membrane leakage may be caused by 
the comparatively high cell density under static culture conditions. 
Moreover, the AM approach suffers from unknown effective doses. Even 
if dissolution in phagolysosome occurs, reprecipitation and low-dose 
effects may occur, as shown for Ni-containing particles (Latvala et al. , 
2016 ). The dose uncertainties are especially relevant for materials that 
are partially soluble in the medium (ZnO) and/or well dispersed na-
noparticles (such as colloidal silica) whose gravitational settling cannot 
be monitored by light microscopy (Wiemann et al. , 2018 ). Complete 
transformation (by dissolution) during the in vitro incubation was 
confirmed for CuO and ZnO using advanced characterization with a 
synchrotron X-ray source (Ivask et al. , 2017 ). 
4.2. Discussion of abiotic dissolution vs. macrophage-assisted dissolution vs. 
in vivo pulmonary clearance 
For the three cases of direct abiotic-vs-in vitro comparison, BaSO4 
NM-220, SrCO3 and ZnO NM-111, the differentiation of dissolution 
rates from abiotic flow-through testing was consistent with differ-
entiation by the in vitro AM method, and quantitative rates were within 
a factor 2.4, 1.8 and 1.5, respectively (Table 3). Time-resolved in vivo 
clearance kinetics are available for CeO2 NM-212 and BaSO4 NM-220 
(from radio-activated intratracheal instillation), and are plotted against 
the dissolution rates of flow-through testing (Fig. 9) (Keller et al. , 2014 ; 
Konduru et al., 2014 ). For all other materials, the percentage of re-
maining solid after 7 days in abiotic flow-through testing is compared in 
Table 3 to the remaining lung burden after 21 days of recovery in vivo, 
because only this value is available from the standardized STIS in-
halation results. Thus our comparison in Table 3 targets consistency, 
not quantitative predictivity, and avoids modeling that would require 
several assumptions, such as mono-exponential decay , spherical shape 
etc. Assuming first-order kinetics (mono-exponential decay), the dis-
solution rate can be converted to half-times by Eq. SI_l, with the results 
given in Table 3. Assuming monodisperse size and spherical shape , Eqs. 
SI_ 4 to SI_5b reproduce the modeling of shrinking spheres from ISO 
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Fig. 6. Dissolution of SrCO3 subjected to neutra l and acidic pH conditions over 
time. F-12K cell culture med ium control without cells (white bars); NR8383 rat 
AM (black bars); PSF pH 4.5 (grey bars) ; n = 3; * means p :5 0.05. 
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Fig. 4. Transformation analysis of addi-
tional materials: TEM images of the pris-
tine materials (left) and after 7 days dis-
solution under standard conditions in PSF 
(right). a) CuPhthalocyanin_halogenated, 
b) Cu(OH)iCO3, c) SiO2 NM-203, d) CeO2 
NM-212, e) TiO2 NM-104, D non-nano 
BaSO4_1RMM381. By additional EDX, the 
structure in b) was found ID contain 
mainly Si, not Cu, and is thus not as-
signed ID the test material. 
Fig. 5. Exposure of NR8383 alveolar macrophages to 
SrCO3 ENM. Contrast-enhanced phase contrast mi-
crograph showing (a) numerous SrCO3 ENM ag-
glomerates settled onto the bottom of the culture 
vessel post centrifugation under cell-free conditions, 
and (b) NR8383 cells after a 48 h incubation period 
with SrCO3 ENM. Note that cells appear healthy with 
smooth outer contours (arrows). The space between 
cells is devoid of visible particles. 
TR19057:2017. With polydispersity, however, the time course of mass 
and surface area may result in multiphase kinetics , such as observed for 
ZnO (Fig. 2D); the in situ TEM (Fig. S1_4) confirms that this materia l is 
initially polydisperse in size and shape, and deviates even stronger from 
spherical shape during dissolution and transformation. 
The measured reduction of lung burden was available for CuO 
(Gosens et al., 2016 ), ZnO NM-111 and TiO2 NM-105 (Landsiedel et al., 
2010 ), CeO2 NM-212, NM-211 (Keller et al. , 2014 ), SiOz_untreated, and 
SiO2_amino (Landsiedel et al. , 2014 ). Most of these studies were also 
summarized as case studies of the DF4nanogrouping framework (Arts 
et al., 2016 ). 
For all materials, the abiotic dissolution is consistent with in vivo 
observations, considering that both physical clearance and chemical 
dissolution contribute. For TiO2 NM-105 and both nanoforms of SiO2, 
dissolution means a marginal contribution to clearance, indicating that 
in vivo clearance is dominated by macrophage-mediated transport. 
However, for BaSO4 NM-220, CuO, ZnO NM-110 and ZnO NM-111 lung 
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Fig. 8. Dissolution of BaSO4 subjected to neutral and acidic pH conditions over 
time. F-12K cell culture medium control without cells (white bars); NR8383 rat 
AM (black bars); PSF pH 4.5 (grey bars); n = 3. 
clearance is dominated by dissolution. The dynamic dissolution flow-
through system is the method of choice to predict the contribution of 
dissolution for in vivo clearance. Materials that were identified as of low 
dissolution rate in this system (e.g. TiO2 NM-105) will be removed in 
vivo from the lungs mainly by AM-assisted mucociliary clearance . The 
physical clearance as well as the mobility of particles within the rat 
lungs may also be influenced by agglomeration in situ, whose me-
chanisms are beyond the scope of this discussion. For a read-across on 
low dissolution ENM (see group ranges proposed below) , extrinsic 
properties such as dispersion stability, heteroagglomeration , affinity 
need to be considered to appropriately frame the mobility in the body. 
E.g., affinity to phospholipids is higher for SiO2_amino than for 
SiO,_untreated (Woh lleben et al., 2016 ), and may contribute to the 
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Fig. 7. Exposure of NR8383 alveolar macrophages to 
BaSO4 ENM. Contrast-enhanced phase contrast mi-
crographs showing (a) numerous BaSO4 ENM ag-
glomerates settled onto the bottom of the culture 
vessel post centrifugation under cell-free conditions 
and (b) NR8383 cells after a 48 h incubation period 
with BaSO4 ENM. Note that cells have numerous 
pseudopodia (arrows). The space between cells is 
devoid of particles. 
50 100 150 
time [h] 
Fig. 9. Comparison of in vivo clearance vs. abiotic flow-through dissolution in 
PSF on BaSO4 NM-220, CuO and CeO2 NM-212. Red: Ce0 2 NM-212 in vivo 
(Molina et al., 2014 ), yellow: BaSO4 NM-220 abiotic flow-through, black: 
BaSO4 NM-220 in vivo (Konduru et al., 2014 ), blue: CuO abiotic flow-through. 
After 504 h, the in vivo remai ning CuO solids are zero or maximally 15% (LoD in 
vivo), consistent with the abiotic results (Gosens et al., 2016). Throughout the 
abiotic test from Oh to 168h, the dissol ved Ce0 2 is < 3% (LoD abiotic), con-
sistent with the in vivo result. 
transformation has been observed also in vivo (Graham et al., 2017a,b ), 
and specifically for the case of BaSO4 we showed that the Ostwald ri-
pening is consistently observed in the flow-through setup and in vivo 
(Keller et al., 2018 ). In principle, the remaining solids that we recover 
by the centrifugation procedure could be administered to cell cultures 
to test the response to the transformed material, as was done for static 
transformation in stomach/intestine simulants (DeLoid et al., 2017 ) . 
However, our system cannot currently predict reprecipitation after 
systemic circulation, as has been observed on some ceria species 
(Graham et a l., 2014 ) . 
lt should be noted that the recommended conditions of (M 0 = 1 mg, 
Comparison of 7-day abiotic dissolution (standard conditions) with 1-day alveolar macrophage -assisted dissolution and 28-day clearance in vivo STIS. 
Dissolution rate macrophage-
assisted (24 h) [ng/cm 2 /h] 
BaSO4 NM-220 4.2 
Ceo, NM-211 




Ti0 2 NM-105 
ZnO NM -111 117 
sreo, 61 
Dissolution rate 
Abiotic flow-throu gh, 
pH 4.5 [ng/ cm2 /hi 
10 
< 0.28 (LoD) 




< 0.013 (LoD) 
177 
108 
LoD: level of detection. STIS: short term inhalation study. 
Half-time calculated Dissolution rate In vivo pulmonary clearance in STIS 
from k [days] Abiotic flow-throu gh, pH 4.5 recovery [% per 21 days] 
[% per 7 days] 
7 58% 52% 
> 156 < 3% (LoD) 7% 
> 146 < 3% (LoD) 5% 
0.7 100 % > 85% (LoD) 
66 7% 34% 
328 1.2% 39% 
> 4356 < 0.1% (LoD) 26% 
1.2 100 % 93% 
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V = 2 mL/h) are appropriate for many materials, but no universal op-
timum. As a quality control, it is recommended to check that mea-
surement at two different SA/V leads to the same grouping. If SA/V was 
lower , then for several materials in our test set (e.g. the Cu-
Phthalocyanins , the SiO2 materials), the ion concentration in the eluate 
drops below the limit of detection of ICP-OES as a method that is highly 
established and robust against the high matrix concentrations of phy-
siological buffers. ICP-MS and more optimization would allow to 
measure at lower SA/V. In contrast , for higher SA/V more materials 
may be limited by saturation. The specific SA/V conditions are selected 
to reproduce on the critical test case of BaSO4 the in vivo transformation 
and dissolution behavior (Fig. 9) (Keller et al., 2018 ). 
Flow-through systems are described by ISO 19057:2017 as "seen to 
be the best method of measuring durability in vitro" (Nti, 20 17). Re-
cently , flow-systems have been used to study gastro-intestinal dissolu-
tion of nanomaterials (without the exact same flow cells) (Bove et al. , 
2017a ,b), and with the same flow cells (De Jong et al. , 2018 ), and to 
study environmental dissolution (Pantano et al., 2018 ). To capture re-
actions of highly instable ENM-medium combinations on a time scale of 
minutes, it appears possible to eliminate fraction collection, and instead 
to hyphenate flow-cells directly to an ICP-MS; however , we adapted 
sampling times to physiological time scales (hours to days), guided by 
earlier evidence on other oxide materials. More specifically , flow-
through systems have previously been used to study the pulmonary 
biodissolution of respirable man-made vitreous fibers (MMVF) (Nti, 
20 17). A large collection of abiotic dissolution rates and associated in 
vivo lung clearance rates has been made available for natural and man-
made mineral fibers in a WHO report (!ARC, 2002 ) which lists, among 
others , the following biodissolution rates of MMVF: 
• MMVF34 "biosoluble stone wool" with a lung clearance half-life 
time of 6 days and k = 620 ng/cm 2 /h (at pH 4.5) and k = 59 ng/ 
cm2 /h (at pH 7.4); 
• MMVFll glass wool with a lung clearance half-life time of 9 days 
and k = 25ng / cm2/h (at pH4.5) and k = 100ng / cm2/h (at 
pH7.4); 
• MMVF32 E-glass-wool with half-life time of 79 days and k = 9 ng/ 
cm2/h (at pH4.5) and k = 7ng / cm2/h (at pH 7.4); 
• crocidolite and amosite asbestos with half-life time of > 400 days 
and k < 1 ng/cm 2 /h (at both pH). 
It is interesting to note that many of the nanomaterials have dis-
solution rates (k values) at the lower end of the range spanned by the 
partially amorphous , partially crystalline aluminosilicates (stone wool , 
glass wool, asbestos). This is plausible considering the chemical com-
position. On the other hand , the BET surface of ENM is > 100 x larger 
than that of typical glass or mineral fibers (which range around 0.2 m2 / 
g, due to several micrometer diameter) and this favors a low bio-
persistence of ENM, because half-times are given by the inverse ofk and 
lung-deposited specific surface area (Eq. SI_l). 
4.3. Discussion grouping and read-across 
The results of the abiotic flow-through dissolution can be essential 
to substantiate a grouping hypothesis via the similarity of dissolution 
rates: The degree of biodissolution is similar for families of Fe2 O3 
(nano)forms, SiO2 nanoforms, CeO2 nanoforms, ZnO nanoforms, thus 
primarily determined by the substance , but shows significant modula-
tion by production routes and surface coatings. In contrast , the mod-
ulation by shape or size is limited. Nanoforms although different in 
shape (Fe2O3), size (CeO2, Fe2O3) or coatings (SiO2 , ZnO) can be 
grouped for pulmonary persistence, if their dissolution is sufficiently 
similar. 
On the contrary , a dissimilarity of dissolution may be used to dif-
ferentiate between ENM which are seemingly similar due to toxic 
components: Thus the four Cu-containing materials fall into different 
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groups as CuO and Cu2(OH),CO 3 exhibit a significant or complete 
dissolution after 7 days, whereas both Cu-Phthalocyanine ENM do not 
show significant solubility. Accordingly , the in vivo potency (mediated 
by Cu ions) was high for CuO (Gosens et al., 2016 ) but low for Cu-
Phthalocyanine (Arts et al., 2016 ). Similarly, a differential lung toxicity 
was observed for a set of NiO nanoparticles after intratracheal in-
stillation. Also in this case there was a strong correlation of in-
flammation parameters with solubility in artificial lysosomal fluid 
(Shin ohara et al., 2017 ). 
Especially coatings or functionalization modulated the dissolution 
rate within an order of magnitude in our dataset. Stronger modulation 
is expected only for closed shells, such as oxide coatings on more so-
luble core particles. For those materials with a very low equilibrium 
solubility limit under lysosomal conditions, the local dose of the ENM is 
another important parameter affecting the dissolution rate. This was 
the case for BaSO4 , but not for the other materials. Accordingly, also in 
vitro the dissolution rate can depend on initial mass , and this needs to 
be considered in screening and grouping strategies, e.g. for im-
plementation of the DF4nanoGrouping framework: 
• Tier 1 Solubility: The method for Tier 1 should be stirring of the 
suspension in a beaker , followed by ultrafiltration and ICP-OES (or 
-MS) analysis, as established by (Avramescu et al., 2016 ) for their 
enhancement of the DF4nanoGrouping framework A cutoff between 
soluble and non-soluble ENM should be defined as absolute con-
centration , e.g. 100mg / L, as by the DF4nanoGrouping framework. 
O If already at Tier 1 the intended use and the critical route of 
exposure are known , then it is an option to perform the same test 
in the most relevant biological medium. 
O For environmental hazard assessment purposes, the same method 
with simple media ranging from pH 4 to pH 9, and a cutoff at 
9mg / L (at l0mg / mL initial solids) is discussed in the OECD task 
group on dissolution (Rasmussen et al. , 2018 ). 
• Tier 2 Dissolution: For a more detailed measurement and a re-
finement in Tier 2 a flow-through dissolution setup is recommended . 
Dissolution rates are thus tested out of equilibrium using relevant 
media that are derived from the intended exposure scenario of the 
ENM, such as pH 4.5 PSF for mimicking the dissolution within al-
veolar macrophages. The flow-through setup (consisting of an ultra-
filtration cell , subsequent JCP-MS analysis of the eluate , and TEM 
analysis of the remaining solids) has been standardized and 
benchmarked against inhalation results with the following para-
meters: 1 mg of ENM initial solids, relevant medium (for inhalation 
concern: PSF at pH 4.5) and a continuous flow-rate of 2 mL/h for 7 
consecutive days. However , the dose of ENM, the medium and the 
flow-rate used for the flow-through dissolution can be adapted to 
the requirements of other exposure scenarios , such as investigation 
of the dissolution in the gastrointestinal tract, requiring independent 
validation. 
• Tier 2 Transformation: The analysis of changes during dissolution 
can be integrated into this strategy by our medium-removing TEM 
sample preparation after completion of the flow-through dissolution 
test. In a companion paper , we show that also complex transfor-
mations of a borderline soluble material (BaSO4) are assessed cor-
rectly (Keller et al., 2018 ). The results presented here for 21 addi-
tional materials furthermore support the plausibility of 
transformation detection. No quantitative evaluation of crystallinity 
or composition can be proposed yet, but changes of the constituent 
particle size are quantified by automated image analysis (N > 300, 
e.g. using the NanoDefine tools). 
Contrary to the hypothesis that AMs in vitro dissolution provides a 
more realistic model than the abiotic simulation of the AM lysosome 
alone, we found that macrophage-assisted dissolution in vitro is ap-
plicable only for a limited exposure period (1- 2 days) and , therefore , 
may liberate comparatively low amounts of ions from ENM. Since the 
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method, as performed here, provided no further predictive value, we 
suggest that the Tier 2 "assessment of ENM similarity' ' can stick to 
abiotic flow-through dissolution at standardized conditions (initial 
mass of 1 mg, flow 2 mL/h) for grouping and read-across purposes. This 
experimental setup is in line with standards for evaluating biodissolu-
tion of mineral fibers. However , mechanistic investigations in Tier 3 
may still require in vivo and cell-assisted studies. 
The results of this study allow us to propose quantitative ranges to 
assign the tested nanomaterials in four distinct groups for the purpose 
of grouping of inhalation hazards. 
1. The first group are non-persistent materials showing a high dis-
solution rate k > 100ng/cm 2/h and no remaining original parti-
cles in TEM, including Cua , Cu(aHhCa 3 , SrCa 3 , Zna NM-110 and 
coated Zna NM-111. This cutoff corresponds to an abiotic dissolu-
tion ranging from 30% to 100% after 7 days. Materials in this group 
are cleared completely (down to LoD) during a STIS inhalation re-
covery period. 
2. The second group are non-persistent materials showing a k ranging 
from 1 ng/cm 2 /h to 100ng/cm 2 /h and also significant trans-
formation or reprecipitation. The range corresponds to a significant 
dissolution above 10% per 7 days. This group comprises both (nano) 
forms nano-BaSa 4 NM-220 and non-nano BaSa 4 IRMM381. 
Chemical clearance (dissolution) dominates, but physical clearance 
(transport) and reprecipitation contribute to the processes in a re-
latively complex interplay. 
3. The third group of nanomaterials shows a very low dissolution 
(k < 1 ng/cm 2/h or below LoD) but a significant transforma-
tion during the test period. This corresponds to an abiotic dissolu-
tion « 30% (or even no apparent dissolution). Examples are both 
nanoforms of Cu-Phthalocyanine and all tested silica materials , 
where differences may be related to the silica production process. 
For these materials the physical clearance from the lung (transport) 
is accompanied by aggregation and/ or reprecipitation. 
4. The fourth group contains all biopersistent materials that show very 
low or no dissolution (k < 1 ng/cm 2/h or below LoD) and no 
significant transformation. All tested (nano)forms of Fe2a 3 (A, B, 
larger) as well as both Cea 2 (NM-211, NM-212) and both Tia 2 NM-
104 and NM-105 belong to this group. Physical clearance (transport) 
dominates the pulmonary clearance. 
Alternatively , group ranges might be defined by k values given in 
ng/ cm 2/h , or by the more pragmatic "% dissolution per 7 days" which 
requires no BET measurement of the specific surface area of the ENM 
for evaluation of the flow-through raw data. The consideration of the 
specific surface area in case of the "k metric " is the major difference 
between the two metrics , and allows us to motivate the decadic group 
ranges with a rich body of mineral fiber literature (see discussion 
above). The k metric also favors the read-across between nanoform and 
non-nanoform , because it eliminates the dissimilarity of the specific 
surface and focuses on differences beyond size and surface area . 
5. Conclusions 
In this work , the flow-through dissolution system was used to in-
vestigate the out of equilibrium dissolution behavior of a broad set of 
ENM and compared to alveolar macrophage-assisted dissolution as well 
as the in vivo clearance in rats. A high degree of consistency of the 
abiotic dissolution and the in vivo clearance has been achieved for Cea 2 
NM-212, two forms of colloidal Sia 2 , Tia 2 NM-105, Cua , nano BaSa 4 
NM-220 and Zna NM-111. This method and benchmark materials can 
be used to implement grouping frameworks such as those of ECHA 
(2017b) or ECETaC (Arts et al., 2015 ): For Tier 1 testing the in-
vestigation of the dissolution under static conditions is sufficient as 
proposed by (Avramescu et al. , 2016 ). However, for Tier 2 testing the 
a biotic flow-through setup in relevant media is required , as proposed in 
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this work on the example of pulmonary biodissolution. Cultured al-
veolar macrophage-assisted dissolution is acknowledged as a potential 
method for very specific Tier 3 investigations but needs to be further 
explored to achieve sufficiently long exposure periods. 
The flow-through dissolution setup and protocol used in this work 
combines an integrated quantification of dissolution by ICP-MS/ -aES 
and detection of transformation through TEM. Using our 24 case stu-
dies , we proposed four groups based on decadic ranges of quantitative 
dissolution rates and on a qualitative analysis of transformation. The 
representatives of the four groups (benchmark materials) are Zna NM-
110 (complete dissolution), BaSa 4 NM-220 (slow dissolution , re-
precipitation transformation) , Sia 2 NM-203 (very low dissolution, re-
precipitation / aggregation transformation) , Tia 2 NM-105 or 
Fe2a 3_nano _B (very low dissolution , very low transformation). Finally, 
the method can be employed for testing of dissolution and transfor-
mation in environmental media. 
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Numerous recent reviews have highlighted the urgent need for methods to determine the biodissolution of 
nanomaterials in relevant lung fluids, and to validate the results against the bioprocessing in vivo. Moreover, 
it is largely unknown to what extent (nano)forms of a substance that differ in size, shape, or coating also 
differ in biodissolution. Here we apply a previously optimized abiotic flow-through method to 24 
(nano)forms of 6 substances and compare the results with alveolar macrophage-assisted biodissolution of a 
subset of these nanomaterials in vitro and short-term inhalation results in vivo. As a main result we found 
that the results obtained with the flow-through method for the lung were consistent to the results of in vivo 
studies and were not improved by measuring alveolar macrophage-assisted biodissolution for up to 48 h. 
Based on selected benchmark materials we propose four groups of materials according to quantitative 
biodissolution rates (1 ng/cm²/h to 100 ng/cm²/h cutoffs) and qualitative transformation parameters, as 
detected by TEM analysis. These groups were also reflected by different lung clearance rates, as previously 
determined in short term inhalation studies. Biodissolution was similar within substance (nano)forms of 
Fe2O3, SiO2, CeO2, ZnO, though slightly varied upon surface area/coating. But the difference of 
biodissolution between the substances was in some cases more than 1000-fold. In contrast, Cu-containing 
nanoforms behaved heterogeneously and require case-by-case testing of dissolution and transformation. 
Different production routes and/or surface coatings significantly modulated biodissolution, whereas effects 
of shape or size were limited. In summary, we refined a protocol for the abiotic determination of 
biodissolution along with an integrated assessment of nanomaterial transformation. The protocol is suggested 
as tier 2 methodology for grouping and read-across purposes. 
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Addendum to "Abiotic dissolution rates of 24 (nano)forms of 6 substances 
compared to macrophage-assisted dissolution and in vivo pulmonary 
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We recently refined a protocol for the abiotic determination of 
biodissolution along with an integrated assessment of nanomaterial 
transformations , and explored the level of similarity across 24 (nano) 
forms (Koltermann -Jiilly et al., 2018 ). Based on benchmark materials 
we proposed four groups of materials according to quantitative bio-
dissolution rates (1 ng/ cm2 /h to 100 ng/cm 2 / h cutoffs) and qualitative 
transformation parameters. The "continuous flow system" consists of a 
flow-cell with 5 kDa ultrafiltration membrane. The elemental con-
centration is determined in the eluate and is considered as dissolved 
ions. 
In our original contribution, the limit of detection (LoD) of the in-
ductively coupled plasma optical emission spectroscopy (ICP-OES) was 
not sufficiently sensitive to quantify the very low ion concentrations of 
several materials such as TiO,, CeO2 , Fe2O3 and Cu_Phthalocyanine. 
The lowest range of dissolution rates could thus not be explored. To 
close this gap, we repeated the flow-cell dissolution experiments under 
the same conditions as the original experiments, and quantified the 
dissolved ions by inductively coupled plasma mass-spectrometry (ICP-
MS, Perkin Elmer Nexion 20008). Furthermore , the ranking within the 
SiO2 materials was not entirely identical if ranked by either the daily 
ion mass M;0 n/ d or by the dissolution constant k. This minor incon-
sistency was tracked to a mixed reporting of integral vs. interpolated 
dissolution. We have now made this entirely consistent by reporting 
values of integral dissolution both fork and M;0 n/d. Apart from the ion 
detection technique, the protocol of the measurements was kept iden-
tical. The samples were diluted by a factor of 10 to 100 with 50 ms 
integration time on each mass. External calibration used concentrations 
of 0, 0.01, 0.1, 1, 10 µg L - l for Fe, Ti, Ce and Cu and 1, 10, 100, 
DOI of original article: https:// doi.org/ 10.1016/ j.impact.2018.08.005 
• Corresponding author. 
1000 µg L - l for Si with matrix-matched standards. The ultra-high 
purity quartz nebulizer had an argon flow of 0. 94 mL min - l and a 
sample flow rate of 0. 29 mL min - l. With ICP-MS the limit of detection 
was 1.0 µg L - 1 for Si and below 0.01 µg L - 1 for the other elements. We 
therefore recommend using ICP-MS in further studies. 
The corrected version of Table 2 of the original article is presented 
below. The results improve our understanding of slow or stagnant 
dissolution processes, and lend further support to the grouping scheme 
of the original article. Si is challenging in elemental analysis and the 
actual ion concentration detected by ICP-MS was above the nominal 
LoD by ICP-OES. Within the SiO2 family, the differences between un-
treated and functionalized nanoforms are still observed with the en-
hanced detection, but at a reduced spread. We continue to observe that 
pyrogenic silica (NM-203) has a very similar , but slightly lower dis-
solution rate than the precipitated silica (NM-200) of roughly the same 
specific surface area, whereas an opposite trend is observed in dis-
solution without flow.( ECETOC, 2006 ) This does not prevent grouping 
of SiO2 nanoforms. Due to the high surface area , clearance of SiO2 
nanoforms is mediated significantly by dissolution with up to 12% per 
7 days (Table 2), despite low dissolution rates. 
At even lower rates, the new results confirm the similarity within 
the CeO2 nanoforms, within Fe2O3 (nano)forms , within the TiO2 na-
noforms , and between CuPhthalo_nano and CuPhthalo_halogen: The 
comparison of rates does not exceed a factor of about two between 
different (nano)forms of the same substance, but varies between sub-
stances. All of the above materials remain below the 1 ng/cm 2 / h level, 
and the corresponding dissolution half-life values are always above 
500 days. This indicates that dissolution might not significantly 
E-mail addresses: johanna.koltermann-juelly@basf.com (J. Koltermann-Jiilly), johannes-georg.keller@basf.com (J.G. Keller), 
vennemann@ibe-ms.de (A. Vennemann), kai.werle@basf.com (K. Werle), Ian.ma-hock@basf.com (L. Ma-Hock), robert.landsiedel@basf.com (R. Landsiedel), 
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Table 2 
Cumulative evaluation ofbiodissolution of ENM in flow cells with pH 4.5 media at 2 mL h 1 flow-through. New results of the present addendum (by ICP-MS aoalysis) 
are compared to original results (by ICP-OES aoalysis if not marked otherwise) . 
Mo Max. ion concentration 
Unit [mg] [mg/L ] 
BaSO4 NM-220 (nano ) 1.05 1.3 
BaSO, NM-220 (nano ) 0.17 0.8 
BaSO4 IRMM381 (non -nano ) 1.78 0.49 
Ceo , NM-211 (ICP-MS) 1.06 0.071 
(ICP-OES) 1.1 < 0.1 (LoD) 
Ceo , NM-212 (ICP-MS) 1.03 0.0094 
(ICP-OES) 1.02 < 0.1 (LoD) 
cu , (OH), CO, 1.07 3.0 
Cu_Phth alo_halogen (ICP-MS) 1.0 2 0.0 28 
(ICP-OES) 1 < 0.1 (LoD) 
Cu_Phth alo_nano (ICP-MS) 1.06 0.07 
(ICP-OES) 0.98 0.05 
CuO 1.56 37 
Fe2 O,_!ar ger (ICP-MS) 1.00 0.01 3 
(ICP-OES) 1.09 < 0.1 (LoD) 
Fe2 O,_nano _A (ICP-MS) 1.00 0.049 
(ICP-OES) 1.07 < 0.1 (LoD) 
Fe, o ,_nano _B (ICP-MS) 0.97 0.015 
(ICP-OES) 0.99 < 0.1 (LoD) 
SiO2 NM-203 (ICP-MS) 1.00 0.58 
(ICP-OES) 1.1 2 0.3 
SiO2 NM-200 (ICP-MS) 0.95 0.49 
(ICP-OES) 1.01 0.45 
Si0 ,_amino _200 (ICP-MS) 1.10 0.45 
(ICP-OES) 1.06 0.28 
SiO,..pho sphona t e_200 (ICP-MS) 1.10 0.27 
(ICP-OES) 1.01 0.18 
SiOz...untreated_S0 1.17 0.03 
SiO,_un treated_ l00 1.08 0.04 
SiO,_un treated_2 00 (ICP-MS) 1.26 0.27 
(ICP-OES) 1.0 0.05 
SiO2...untreate d_300 1.05 0.06 
s rco , 1.08 12.7 
TiO2 NM-104 (ICP-MS) 1.00 0.052 
(ICP-OES) 1.09 < 0.1 (LoD) 
TiO2 NM-105 (ICP-MS) 1.01 0.011 
(ICP-OES) 1.04 < 0.01 (LoD) 
ZnO NM-110 1.12 18 
ZnO NM-111 1.1 2 17 
contribute to clearance from the lungs for any measured nanoform of 
the above substances , as confirmed by comparison to pulmonary 
clearance data of in vivo studies (Table 3 in the original contribution). 
References 
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Dissolve d per 7 days k Mion/d 
[%] [ng/ cm2/h l [µg/d ay] 
58 10 51 
100 45 18 
9 53 16 
1.1 0.14 1.7 
< 3 < 0.28 (LoD) < 3.9 (LoD) 
0.19 0.059 0.28 
< 3 < 0.73 (LoD) < 3.6 (LoD) 
32 172 24 
3.6 0.4 2 5.0 
< 350..oD) < 3.7(LoD) < 2.4(LoD) 
4.9 0.76 7.4 
4.1 0.64 5.7 
100 283 456 
0.14 0.097 0.20 
< 3 Q..oD) < 1.56 (LoD) < 3.7 (LoD) 
0.53 0.041 0.76 
< 3 Q..oD) < 0.17 (LoD) < 3.2 (LoD) 
0.16 0.044 0.2 2 
< 3 Q..oD) < 0.65 (LoD) < 3.6 (LoD) 
10.1 0.39 14 
8 0.23 11 
11.7 0.58 16 
11 0.38 7.76 
18.6 0.268 10.2 
7 0.22 4.8 
10.8 0.45 16.9 
8 0.28 5.9 
0.5 0.088 1.6 
0.9 0.066 1.7 
7.2 0.20 9.0 
1.2 0.044 2.1 
1.4 0.034 2.6 
100 108 240 
1.3 0.17 1.64 
< 0.03 Q..oD) < 0.0 31 (LoD) < 2.4 (LoD) 
0.35 0.056 a.so 
< 0.1 (LoD) < 0.013 (LoD) < 0.1 (LoD) 
100 204 217 
100 177 150 
Koltermann -Jillly, J., Keller, J.G., Vennemann, A., Werle, K., Milller, P., Ma-Hock, L., 
Landsiedel, R., Wiemann, M., Wohlleben, W., 2018. Abiotic dissolution rates of 24 
(nano)fonns of 6 substan.ces compared to macrophage -assisted dissolution and in 
vivo pulmonary clearance: grouping by biodissolution and transformation. 
Nanohnpact 12, 29-41. 
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Barium sulfate (BaSO4) was considered to be poorly soluble and toxicologically inert, but BaSO4 NM-220 
showed a surprisingly short retention after intratracheal instillation in rat lungs, and incorporation of Ba 
within the bones. Here we show that static abiotic dissolution cannot rationalize this result, whereas two 
dynamic abiotic dissolution systems (one flow-through and one flow-by) indicated 50 % dissolution after 5 
to 6 days at non-saturating conditions regardless of flow orientation, which is close to the in vivo half-time 
of 9.6 days. Non-equilibrium conditions were thus essential to simulate in vivo biodissolution. Instead of 
shrinking from 32 nm to 23 nm (to match the mass loss to ions), TEM scans of particles retrieved from flow-
cells showed an increase to 40 nm. Such transformation suggested either material transport through interfacial 
contact or Ostwald ripening at super-saturating conditions and was also observed in vivo inside macrophages 
by high-resolution TEM following 12 months inhalation exposure. The abiotic flow cells thus adequately 
predicted the overall pulmonary biopersistence of the particles that was mediated by non-equilibrium 
dissolution and recrystallization. The present methodology for dissolution and transformation fills a high 
priority gap in nanomaterial hazard assessment and is proposed for the implementation of grouping and read 
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Predicting dissolution and 
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Barium sulfate (Ba5O 4) was considered to be poorly -soluble and of low toxicity, but Ba5O4 N M-220 
showed a surprisingly short retention after intratracheal inst illat ion in rat lungs, and incorporation of 
Ba within the bones. Here we show that stat ic a biotic dissolution cannot rationalize this result , whereas 
two dynamic a biotic dissolution systems (one flow-through and one flow-by) indicated 50% dissolution 
after 5 to 6 days at non-saturating condit ions regardless of flow orientation, which is close to the in vivo 
half-time of 9.6 days. Non-equilibrium conditions were thus essential to simulate in vivo biodissolution. 
Instead of shrinking from 32 nm to 23 nm (to mat ch the mass loss to ions), TEM scans of particles 
retrieved from flow-cells showed an increase to 40 nm. Such transformation suggested either material 
transport through interfacial contact or Ostwald ripening at super -saturating conditions and was also 
observed in vivo inside macrophages by high -resolution TEM following 12 months inhalation exposure . 
The a biotic flow cells thus adequately pred icted the overall pulmonary biopersistence of the particles 
that was mediated by non -equilibrium dissolution and recrystallization. The present methodology 
for dissolution and transformation fills a high priority gap in nanomaterial hazard assessment and is 
proposed for the implem e ntation of group ing and read-ac ross by dissolution rat es. 
Knowledge about pulmonary retention kinetics of inhaled particles is an essential element of hazard assessment 
and of understanding the mechanisms by which adverse health outcomes may occur. Barium sulfate was gener-
ally assumed to be poorly -soluble and of!ow toxicity unless delivered at high concentrations over an extended 
period l;2_ However, Konduru and colleagues reported that intratracheally instilled l3lBaSO4 NM -220 exhibited a 
lung retention half-time of only 9.6 days in rats and that t3lBa was incorporated into the bones, suggesting nano -
particle dissolution and /or translocation to extrapulmonary sites 3. A subsequent 90-day inhalation study in rats 
with a high concentration ofaerosolized BaSO4 NM -220 (50 mg/m3) 4 revealed no signs oflung overload and a 
retention half-time of 56 days, which is close to the normal range for the rat lung4. A two-year rat inhalation study 
with BaSO 4 NM -220 (50 mg/m 3), however, demonstrated an increase of retained Ba in the lung during the first 
year of expos ure, after which a steady-state was achieved 5. Since significant Ba accum ulation in bone and bone 
marrow was also observed and, given that the measurements of Ba distribution [1- 3] provide no information 
about its physicochemical characteristics, the complex in vivo dissolution and/or transformation ofBaSO 4 sec-
ondary to inhalation exposure require more detailed investigation . 
1Department Experimenta l Tox ico logy and Eco logy and Department Mater ial Physics, BASF SE, 67056, 
Ludw igshafen, Germany. ' Inst itut e of Pharmacy, Faculty of Biology, Chem ist ry & Pharmacy, Freie Univers ita t 
Ber lin, 14195, Berlin, Germany. 3Nat ional Inst itute of Occupatio nal Safety and Healt h, Cincinnat i, Ohio, 45226, USA. 
4Biopharmaceut ics and Pharmaceutica lTechno logy, Saarland University, 66123, Saarbrucken, Germany. 51BE R&D 
Institute for Lung Healt h gGmbH, Mende lstr. 11, 48149, Munster, Germany. 6UniversityofRoc hesterMed ical Center, 
Rochester, New York, USA. 7T hese aut hors contr ibuted equa lly: Johannes G. Keller and Uschi M. Graham. * emai l: 
alison_elder@urmc .rochester.edu ; wende l.wohlleben@basf .com 
(2020) 70:458 I https://do i.org/10.1038/s4 1598-019-56872 -3 
RESULTS 
58 
www.nature.com/sci e ntificreports/ 
SCIENTIFIC REPORTS I 
Particle clearance from the lun g involves absorptive (dissolution) and non-absorptive (physical) mechanisms. 
For poorly -soluble particles, physical clearance mechanisms - involving macrophage engulfment, transport, and 
mucociliary propulsion toward s the oropharynx - dominate the pattern of overall clearance. Kreyling6 dem on-
strated a retention half-time of70 days in the rat for poorly -soluble particles 7. For metal or metal oxide nanopar -
ticles that under go in vivo dissolution, clearance may not be immediate due to biotransformation and binding 
events (proteins or other biomolecules) that prolong retention 8-L0_ When dissolution starts at the oxidized surface 
layer of a metallic nanoparticle , there is a continuou s process of ion-leaching and oxidation. After the origina l 
oxide layer was leached, a second-generation oxide layer forms on the shrinking particle. The binding events may 
slow down physical transp ort to compartments of more aggressive acidity, thus also slowing down the onset of 
dissolution after inhalation. Thus, the collective in vivo observations with lung -deposited BaSO 4 suggest that it is 
more biosoluble than assumed and, therefore, in vivo dissolution and processing must be considered. 
The evaluation of particle solubility is a key element of many integrated testing strategies lO-lZ and of frame-
works for categorizing broad classes of materials, such as engineered nanomaterials (ENMs), in terms of their 
physicochemical properties L3- t 9_ Methods to assess the equilibrium (or quasi -dynamic) solubility ofENMs that 
are suspended in water or physiological buffers - as was done with BaSO 4 and supported the conclusion regarding 
its low solubility - are relatively well developed20.2t _ The OECD draft guidelin e under curr ent discussion involves 
suspending particles in a medium , incubation , removal of remaining solids by centrif ugation or ultrafiltration , 
and measurement of the analyte in solution 22. These approaches could be adequately predictive of particle dis-
solution in a closed system, e.g., a cell cultur e well for in vitro exposure studi es2l . There are several drawbacks 
with these approaches, however, when the model in question is an in vivo one. First, the lung is not a stat ic 
(equilibri um) system, as the ions that are liberated from the particles via dissolution are continuous ly removed 
from the compartment where deposition originally occurred , or they become bound to biomolecules or may 
form secondary nanoparticles via reprecipitation. Secondly, if the closed system reaches the solubility limit in 
the selected medium, the dissolution rate is easily und erestimated and particles with some solubility may appear 
as very poorly -soluble. Thirdly, commonly -used methods generally lack a means for evaluating the structural 
transformation of remaining solids, i.e., physicochemical modifications that could impact clearance and particle 
disposition. Lastly, any abiotic system does not fully reflect disposition in lung because the lining and interstitial 
fluids throughout the respiratory tract are pH -balanced, complex mixtur es of salts, serum proteins, and other 
biomolecules. Most importantly, phagocytosis by macrophages or other cell types intr oduces particles to the 
lysosomal microenvironment with an acidic pH . Thus, a dynamic (non -equilibrium) system with more realistic 
media composition that simulates extra- and intracellular lung environments with both fluid phase and solid 
phase product analysis may be better suited to an evaluation of the in vivo bioprocessing of deposited particles 
in the lung, particularly ifboth the intraphagolysosomal and lung surface microenvironments are considered. 
Indeed, dynamic systems were developed and validated to estimate the biopersistence of mineral fibers23- 25• 
In these systems, dissolved ions pass through a membrane with a pore size that excludes the parent particles. 
The ions on the other side ofthe membrane are continually removed from the system using flow-through or 
flow-by macrodialysis , th us achieving non -equilibrium conditions over the time course - hours to days - of the 
study. The dialysate is collected in discrete volumes, after which the target analyte is quantitated in the collected 
fractions and the waste that was not sampled. Adaptation to ENMs mainly requires the choice of appropriate 
separation membrane s. Stefaniak and colleagues employed a membrane to separate the suspended particles from 
a larger volume of particle -free receptor medium , thus gaining size exclusion in addition to the flow-mediated 
concentration gradient that provided sh ort-term disruption of equilibrium conditions2l _ Another quasi -dynamic 
system with relatively large volume was explored and a setup patented for oral expos ure purposes 26, demon -
strating that dynamic setups can also be employed to study the struct ural transformations of remaining solids27• 
Transformation of nanoparticles by in vivo processing has been directly observed for the relatively biosoluble 
amorphous SiO2 in the pulmonary compartment 9. Transition metal oxides, specifically CeOz, have also demon -
strated the potential to recrystallize inlysosomal conditions28 or in extracellular medium 9, and bioprocessingwas 
observed to be organ-specific29. Such modulations ofbiopersistence by local physiological conditions could, thus, 
contribute significantly to the unusual biokinetics of nanoscale BaSO 4 4,5,3o_ 
We hypothesize that both the shedding of ions and in vivo biotransformation of remaining solids contribute 
to the biokinetics of nanoparticles. We describe here methodology to evaluate the abiotic dissolution ofBaSO 4, 
thought to be a poorly -soluble ENM, and explore the extent of agreement that can be reached in comparison to 
in vivo results. 
Materials 
Previous in vivo studies on BaSO4 NM -220 have already been cond ucted3•4 and their physicochemical properties 
published in multiple reports 3 t - 33_ BaSO4 NM-220 is a benchmark material of the OECD sponsorship program. 
Table ! lists physicochemical properties ofNM -220 as relevant for ECHA nanoforms 34. 
Methods 
Static solubility or quasi-dynamic abiotic dissolution. Details for testing the solubilit y of BaSO4 in 
phagolysosomal simulant fluid (PSF) under static conditions are provided in the Supplementary Information. In 
short, BaSO4 was suspended in 200 mL PSF (composition described in2l ) at a concentration of l 0mg/mL, then 
incubated for 7 or 28 days at 37 °C with stirring. The remaining particulate matter was separated from the ions in 
solution using ultracentrifugation at 67,000 x g for 2 h, and the Ba concentration in the supernatant fraction was 
analyzed by inductively-coupled plasma mass spectrometry (ICP-MS). Particle dissolution under quasi-dynamic 
conditions was performed by suspending BaSO4 in PSF (10 mg/mL) and injecting the suspension into a 2 mL 
dialysis cassette with a cut-off at 7kDa (Supplementary Information). The dialysis cassette was placed horizontally 
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Property BaSO, NM-220 
purity > 93.8%; Na, 
Composition/ crystallinity/impuriti es (XRD*) Ca, Sr, F, Cl, organic 
compounds 
Minimum external dimen sion (TEM**) 32nm 
Shape (TEM**) Sph eroidal 
Specific surface area (BET***) 41 m' /g 
Surface modification None 
Contact angle (water ) < 10" (hydrophilic) 
Table 1. Physicochemical properties ofBaSO 4 NM-220. ' X-ray diffraction (XRD); **Transmission electron 
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Figure 1. Dissoluti on method in a biotic flow cells (adapted from 37) . The medium was selected to match the 
conditions of either the phagolysosomal (pH 4.5) or lung lining fluid (pH 7.4) micro environment. Particles are 
in direct contact with the membrane. The choice of the ultrafiltration membrane permeation cutoff is essential; 
a range 3 kDa to 5 kDa is recommended. This represents a size cut-off of ~ 1-2 nm (Ren et al., 2006). Smaller 
cutoffs could induce excess pressure drops and are not recommended. Other options include (recommended): 
(1) especially for flow-through operation, anti-clogging filters on inlet tubing in the reservoir and elevation 
of the reservoir by roughly 30 cm, such that hydrostatic pressure compensates for the pressure drop by ultra -
high molecular-weight polyethylene (UHMWPE) ultrafiltration membranes. (2) In one implementation, we 
operated five cells in parallel with a programmable autosampler. Each cell then has its own reservoir inlet tube, 
peristaltic pump tubing, and sampling. 
in a glass vessel filled with 200 mL PSF as receptor medium at 3 7 °C with stirring. The receptor medium was 
exchanged daily and analyzed by ICP-MS. The methodological limit of detection for Ba was 0.1 mg/L. 
Flow-by a biotic dissolution. The setup implements a Continuous Flow System (CFS) according to ISO 
TR 19057. A dynamic flow-by macrodialysis system 23•24 has been employed to estimate the in vivo dissolution 
of ENMs 35 . Here (Fig. 1), BaSO4 ( ~ 1 mg/mL) was suspended in dissolution buffer before being injected into 
the upper chamber of a dialysis cell fitted with a 3.5 kDa cellulose ester symmetric membrane (Spectra/Pore® , 
Gardena, CA; effective pore size ~ 1.4 nm). The Ba-free dissolution buffers simulated extracellular lung lining 
fluid (pH maintained at 7.4 by bubbling 5% carbon dioxide into the buffer reservoir) or intraphagolysosomal 
fluid (pH adjusted to 4.5 with HCl) . The latter of the two buffers is termed EU pH4.5 herein (see composition in 
Supplementary Information). The dialysis cells were submerged in a 37°C water bath in a dark room. The buffers 
flowed by the dialysis cells at a rate of 60 µUmin, or ~3 mL/h. A fraction collector with metal-free, pre-weighed 
polypropylene tubes was used to collect the dialysates over the course of7 days. For the first 24h, two-hour frac-
tions were collected (so, 12 fractions for Day l); thereafter, the fractions were combined such that there were 6 
daily fractions. The sample weight for each tube was recorded. After 7 days, the following additiona l samples were 
collected in ultra-clean polypropylene digestion tubes for analysis: the remaining solids in the upper chamber; 
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three rinses with 18 MO deionized water; and the dialysis membrane. The tubes were placed in a 90 °C heating 
block. Ultra -pure nitric acid was added to dissolve the membrane and the BaSO 4 nanopartide s. The Ba remaining 
in the upper cell after 7 days, the Ba left in the dialysis membrane, and the Ba found in each fraction was quanti -
tated via atomic emission spectroscopy (Beckman Spectraspan V, Fullerton, CA; instrum ent limit of detecti on. 
~ 10 µg/ L). 
Flow-through abiotic dissolution and transformation. The flow-thr ough setup (Fig. 1) was recently 
descr ibed in detail as another implementation of a CFS according to ISO TR 19057 36•37• CFS is established as a 
screening method of the dissoluti on kinetics of mineral fibers25•38.39. Unless otherwi se mentioned, an ENM mass 
ofM 0 = I mg was weighed onto a membrane (cellulose triacetate, Sartorius Stedim Biotech GmbH, Goettingen, 
Germany: 47 mm diameter, 5kDa pore size), topped by another membrane, and enclosed in flow-through cells. 
The flow through cells were kept upri ght within a tempered water bath to ensure that emerging air bubbles can 
leave the system and do not accumulate within the cell. The initial surface area SA is M 0*BET (Table I). The 
flow rate (V) was 48 mL/d, but was varied up to 100 mL/d. For the lower flow rate, this corresponds to a rati o, 
SA/V = 0.02h/cm. The compo sition s of sim ulant fluids vary significantly in literature 4°. With the compositions 
documented in Table SI, the EU pH4 .5 medium with a whole range oforganic acid s, or the simpler PSF medium 
- previ ously validated for the purp ose of particle dissolution 2l - were employed at 37 ± 0.5 °C. The programmable 
sampler drew 10 mL eluates once per day from the total 100 mL collected. The Ba concentration in the eluates was 
determined by ICP optical emission spectr ometry (ICP-OES, Agilent 5100). After the experiment, the cells were 
flushed with deionized water before opening them to rin se the remaining solids off the membrane . The resulting 
suspension was then pelleted onto a transmission electron microsc opy (TEM) grid held at the bottom of a centri -
fuge vial within 30 min and then dried 37 so that the morphology of the remaining solids could be inspected with a 
reduction ofi nterferen ce from drying artifacts of PSF salts , which are removed by this preparation . Particle mor-
ph ology was analyzed by TEM with a Tecnai G2-F20ST or Tecnai Osiris Microscope (FEI Co mpan y, Hillsboro, 
USA) at an acceleration voltage of 200 ke V under bright -field conditions . X-ray photoelectron spectr osco py 
(XPS) was done using a Phi Versa Probe 5000 spectrometer using m onochromatic Al Ka radiation. 
Derivation of dissolution rates. For both of the flow-cell setups, we multiplied the measured Ba concen -
tration of each eluate by the elut ed volume to obtain a mass of dissolved Ba ions per sample and then stoichiomet -
rically adjusted this value to obta in the dissolved mass ofBaSO 4 at each sampling interval, nt. We then analyzed 
the dissoluti on kinetics in three alternative ways: 
Cumulative rate: The amount of dissolved BaSO4 at each time point M;0 .(T), is expressed as a fraction of the 
initial mass loading (M0= 100%) and cumulated from all samp lin gs with concentration c;, flow V; and sam-
pling inter val 1'.t;, and include s the stoichiometry ofBaSO 4: 
k = M ion(T) __ 1 __ 
M0 T * BET 
(la) 
The rate k incorporate s the BET value in order to report result s with a foc us on composition or coating 
dependence, instead of size dependence. The conventional units ofk are ng/cm 2/h25•4l. We typically determine k 
by the cumulated ions at the end of the test. 
Curve fitting: To verify first -order dissoluti on kinetics 4l , the cumulative dissolved BaSO4 mass is expressed 
as an inverse relationship , i.e., decreasing solid retained BaSO 4 mass (M;0n(T) - M0)/M 0, and pl otted against 
time on a semi -log scale. The dissoluti on rate - expressed as a fraction per hour - is calculated from the slope 
of this line and then converted to percent per day using the total system available starting mas s. Dissolution 
rate and half-time (t'l/2, 50% dissolved) are inversely related and can be expressed in two alternative metrics 
(below) as given for first order modeling in ISO 19057:201736•4l . The BaSO 4 dissoluti on half-time allows direct 
extrapolation and comparison to the in vivo dissolution t l/2 ofi nhaled BaSO4, which is derived from the tot al 
invivotl/2: 
b _ ln2 or t'l/2 = ln2 
'diss- ;;;;; bdiss 
ln2 ln2 
kdiss = ---- or t l/2 = ----
t l/2 * BET kdiss * BET 
(2a) 
(2b) 
Instantane ous rates: For each sampling interval nt, the instantane ous dissolution rate k was constructed as: 
k(t) = M;0n(t)/SA(t)/1'.t. (3) 
We approximated the instantaneous surface area 
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SA(t) = BET(t = 0) * (Mo - Mion(t)) (4) 
and, thus, ignored changes of the size distributi on and shape (see Disc ussion). Elsewhere 37 we explore modeling 
ofSA(t) via the assumption of shrinking sphere s36.4t, which doe s not apply for particl es with a tendency to trans -
form, such as BaSO4. 
It should be noted that the BET value that is used in Eq. (2b) for the determination of t l/2 cancels out with 
BET in Eq. ( I b ). According ly, the two evaluati on approaches (fitting vs. cumulated rate) sho uld coincide if the 
assump tion of exponential decay (first order kinetics) is true. Also, the cumulative rate and the instanta neous rate 
should coincide in the absence of transformation during the test. 
Expression of the rate as koiss favors the read -across between nan oform and non-nanoform, because it elim -
inate s the dissimilarity of the specific surface and focuses on modulation of the rate by different coatings or dif-
ferent crystallinities. The expression of the rate as bdiss avoids uncertaintie s regarding changes in particle surface 
area during the test and indicates a fraction of mass loss per unit time, which can readily be compared to in vivo 
dissoluti on rates - or to predict them - with the assumption of rapid clearance (no binding) of the dissolved ions. 
Evaluation of in vivo structural transformations via high-resolution analytical TEM. Rat lung 
bl ocks from the 24-month s inhalati on study at 50 mg/m 3 ofB aSO 4 NM -220 5 were cut to 50 to 70nm thick sec-
ti ons and collecte d on 200 mesh Formvar/carbon coated copper grids. For ultra struct ural and elemental charac -
terization of selected lung sections high resoluti on scanning transmission micro scopy (HRSTEM) was performed 
using a JEOL 2100 F field emission TEM/STEM operated at 200keV with an analytic p ole piece . Tissue sect ions 
for HRSTEM were prepared with out staining or osmication since OsO 4 nanoparticles form and can bind to select 
ti ssue regions, which makes it difficult to optically distinguish those from potentially inhaled BaSO 4 nanoparti -
cles or second -generation particles from in vivo processing. Images were recorded with a Gatan Ultras can 4kx 4k 
CCD camera and data analysis and pr ocess ing used Gatan Digital Micrograph software (Gatan, Inc .). HRSTEM 
ima ging and Energy -disper sive X-ray spectroscopy (EDS) were performed with a GATAN HAADF detect or, 
Digiscan II, Gatan 2000 Ima ge Filter (GIF), and an Oxford Aztec EDS system (Oxford Instrument s, Oxfordshire, 
United Kingdom) respectively . All HRSTEM images were acquired using an analytical pr obe with 0. 17 nm. A FE! 
Talos transmission and scanning electron microscope was used for fast EDS mapping with a high degree of sen -
sitivity due to the wrap -around style EDS detect or m ounted on the objective lens. Maps generally to ok 1 to 2 min 
to acquire with a sensitivity great eno ugh to detect elemental concentrat ions in 4-nm size particles. EDS provides 
the mean s to determine the relationship between elementa l accumulati on and tiss ue reg ions, particularly in a 
situation where dynamic processes may be in play such as in vivo processin g9. 
Ethics approval and consent to participate. All experiments were performed in accordance with rele-
van t guidelines and regulations. The long -term two -year inhalation study with interim sacrificing after 12 month s 
expos ur e was approved by th e local authorizing agency for an im al exper im ent s (Landes unt ersuchungsamt 
Koblenz , Germany) as referenced by the approva l number G 12-3 028. 
Consent for publication. All authors read and approved the final manuscript. 
Results 
Static abiotic solubility. Data on the water solubility ofBaSO 4 (2.45 ppm Ba ions at 20 °C42) cannot explain 
the in vivo observat ions. Even when solubilit y was meas ured in a medium that mimicked the intraphagolyso so-
mal space , BaSO 4 was classified as insoluble with less than 0.1% dissolved(1000 ppm Ba ions )3. Here we replicated 
th e static solubili ty measurement s in different media and found 8mg/L BaSO 4 (or 0.08%, nominal) dissolved 
in pH 4.5 phag olysoso mal simulant fluid (PSF) over 7 days , stagnating at 5 mg/L (or 0.05%, nom inal) after 28 
days. We hypothesize it is not appropriate to express the data from a known static system as a rate but indicate 
nominal rates here to test the hypothesis. One sample ofBaSO 4 was left to sett le in PSF for near ly 2 years in a 200-
mL beaker . The resulti ng ion concentrati on after nearly 2 years was identical to the concentration after 7 day s. 
The additi on of EDTA, to mimic alkalin e earth metal -tran sporting protein s, only minimally increased BaSO 4 
solubili ty to 9 mg /L within 28 day s (or 0.09%). This is in contrast to recent investigations on Zn -ENM , for which 
adjustment of the relevant medium was sufficient to induce dissolution , th us better -matching the lack of in vivo 
bioper sistence20. 
We also evaluated the quasi -dynami c dissoluti on ofBaSO 4 using dialysis 43. The ion concentration in the recep -
tor medium remained roughly constant in this system: 1.3 mg/L, 1.2 mg/L, I.I mg /L, 1.0 mg/L, and 2.0 mg/ L on 
days 1, 2, 3, 4 and 7, respectively. The cumul ative di ssolution of 0.07% over 7 days and an apparent dis soluti on 
rate of k = 0.01 ng /cm2 /h remained on the same level as the static solubilit y system, but below in vivo rates. This 
indicate s that an equilibrium Ba concentration of about I to 2 mg /L in the pH 4. 5 PSF medium is the limiting 
factor preventing further dissolution. 
Dynamic abiotic dissolution. Motivated by a correlation between the in vivo biopersistence of mineral fib-
ers and their abiotic dynamic dissoluti on rates, two laborat ories independently evaluate d the dissolution ofBaSO 4 
NM -220 using similar macrodialysi s systems: one flow-by and one flow-thro ugh (Fig. 1). While a flow-by system 
with the EU pH4.5 medi um (composition in Table SI ) was used at the University of Roche ster, a flow-thro ugh 
system with PSF medium (Table Sl ) was used at BASF SE. The initial mass ( ~ 1 mg BaSO 4) was the same and 
the flow rates (2- 3 mL/h) were sim ilar. Both lab s found that BaSO 4 NM -220 exh ibited a sign ificant dissolution 
(2:20% over 7 days) und er dynamic conditions (Fig. 2A). The dissolution rate s and half -time s for the two setup s 
do not agree quantitatively despite similar initial mass load ings and flow rates. Exponential fits (Fig. 2A) indicate 
dissolution t l/2 values of 5.9 days (flow-thro ugh, pH 4.5 PSF) and 28.9 days (flow-by, EU pH4.5) , estimating abo ut 
(2020) 10:458 I https://do i.org/10.1038/s41598-019-56872-3 
RESULTS 
62 
www. nature . com/scie ntificre ports/ 
































0 200 400 
time [h] 
600 800 
Figure 2. Dissolution kinetics ofBaSO 4 (starting mass, ~ l mg) in pH 4.5 medium , tested by two dynamic 
dissolution methods: (A) flow-through (BASF, blue boxes) or flow-by (Rochester, orange crosses) macrodialysis. 
(B) comparison of both simulant fluids in the flow-through geometry (starting mass, 50 mg): PSF (blue boxes) , 
EU pH4.5 (orange boxes). Note the different ranges of they-axes . 
M1ofT ,,,2 kdw 11112 bdw 
Mo [pg/d] [d] [ng/cm'/h] [d] [%/d] 
0.17 mg 17.5 2.6 44.7 1.6 43.3 
1m g 51.1 5.9 10.3 6.8 10.2 
Flow-through, PSF pH4.5 
10 mg 53.6 72.1 0.9 78 0.89 
50mg 58.0 247 0.2 346 0.2 
0.08mg 3.9 5 13.8 5.6 12.4 
Flow-by, EU pH4 .5 0.8mg 13.7 28.9 3.4 25.7 2.7 
8 mg 14.7 72.2 0.32 53.3 1.3 
Table 2. Evaluati on of cumulative dissolution of BaSO4 in flow cells with pH 4.5 media using flow-thr ough or 
flow-by methodology. The half-times t' 112 are obtained from b d;» by direct fitting of the decay curve on a semi-
log plot using Eq. (2a), whereas the half-times t112 are derived via conversion of the cumulative rate k by 
Eq. (26). 
10% uncertainty due to extrapolation of surface areas for the flow-by data. Factors that could slightly impact the 
comparabilit y of dissolution tests for partia lly-biosoluble materials such as BaSO4 include temperature, different 
composition of pH4.5 media , flow geometry , membrane pore size, and initial loading. In flow-by geometry, the 
diffusion of ions from the sample compartment through the membrane int o the flow (recept or) compartment 
could add another rate -limiting step that tends to reduce the apparent dissolution rate as observed from the ion 
concentrations in the flow compartment. 
We replicated the experiment at BASF using EU pH4.5 and the flow-through system, keeping all other param-
eters unchanged except that the starting mass was increased to 50 mg. The dissolution kinetics in th e flow-through 
setup were identic al between the more comp lex EU pH4 .5 and the simpler PSF pH4.5 media over the first few 
days (Fig. 2B). After 7 days, the dissolution rate in the PSF medium slowed down slightly as compared to the rates 
in the EU pH4.5 medium. Although it is possible that the phthalates in the PSF acted as ion scavengers - which 
would increase the solubility limit - PSF seems to slightly favor re-precipitati on, thus reducing the apparent disso-
lution rate. To confirm this hypothesis, we changed the temperature during flow-through dissolution from 37°C 
to 4 °C but started with the same initial mass of 1 mg. The apparent dissolution rate was reduced significantly by a 
factor of 2.5 (data not shown). Also, dissolution in neutral pH medium at 37°C demonstrated significantly lower 
rates compa red to media with pH 4.5 (Figs. SI and S3), whereas an omission of organic acid and salts resulted in 
slight acceleration of apparent dissolution by 7% (data not shown). 
Both labs observed that the dissolution kinetics depend on the initial mass ofBaSO 4 (Table 2). Specifically, 
both labs observed that the Ba ion concentrati on was limited to a maximum of ~ l mg/Lin the eluate from 
flow-through cells and to ~0.3 mg/Lin the dialysate from flow-by cells. 1his limit is better reflected by the integral 
of the total mass of ions over the entire duration of the dissolution period, M10 0 /T (Eq. la ), which turns out to be 
limited to about 60 µg/day in flow-thr ough and about 15 µg/day in flow-by geometry (Table 2) at the specific flow 
rates used here. See also Figs. 2B and S2, demonstrating that higher Mc leads to system saturation. 
Although the mass loadings in abiotic dissolution experiments are not likely to mimic realistic in vivo expo-
sure conditi ons, an observed solubility limit may be predictive of saturation-re lated events that occur in vivo. This 
is discussed further below, but first we rationaliz e the solubility limit by considering the ion sources (by particle 
dissolution) and ion losses (by flow36, flow cell geometries and reprecipitation). 
The maximum obser ved ion concentration in flow-through geometry is close to the pH 4.5 solubil ity limit 
observed in the static and quasi-dynamic geometries but is about an order of magnitude higher than in flow-by 
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Figure 3. Instantaneous rate evaluation ofbiodissolution ofBaSO 4 in flow-through cells with pH 4.5 PSF 
media. Each cloud of stepwise rates stems from separate experiment ofinitia l mass M0 and volume flow V. Five 
experiments for BaSO4 (orange) and two for CuO (black). See Table 2 for conventional evaluation (cumulative 
rates) of the same raw data. 
geometry. The lower threshold of the flow-by system is attributed to the ion concentration in the local vicinity 
of the particles reaching the pH 4.5 solubility limit. We interpret the data to suggest that upon reaching the pH 
4.5 solubility limit locally, ions reprecipitate before the flow removes them. Particle growth in the presence of 
dissolved ions under supersaturation conditions can lead to the growth of select NPs by the driving force of a 
lower-energy state of the overall system (Ostwald ripening proces s). The process matures further when the mobile 
ionic species (dissolved ions) are exchanged with and precipitated at immobile NPs surfaces and this process is 
driven by the difference in chemical potential at select NPs surfaces in confined spaces . The overall result can 
be a particle size increase and various structural and morphological changes (shape, size, crystallinity) of the 
affected NPs. This phenomenon can indeed be observed in both the flow-through and flow-by systems, i.e., only 
the measurements at lowest Mo (0.17 mg or 0.08 mg , respective ly) remain below this limit. We also doubled the 
flow rate to V = 4mL/h for Mo= 10mg and observed an increase in M;00 /T to 102µg/day , which is roughly twice 
the observed value at a flow rate ofV = 2 mL/h (Table 2). In summary, the cumulative apparent dissoluti on rates 
k and b (Table 2) scale roughly linearly with the SA/V ratio. Thus, to avoid reaching the solubility limit , either the 
initial mass can be reduced, or the flow can be increased. 
We extensively tested both the reducti on of initial mass or the increase of flow independently and in combina-
tion and analyzed both cumulative and instantaneous dissolution rates of the identica l raw data. Ifwe determine 
for each sampling interval the instantaneous rates k (in units ofng/cm 2/h , Eq. 3) and the instantaneous surface 
area per volume flow SA/V (in units of h/cm , Eq. 4), hundreds of instantane ous release rates collapse on a single 
linear relationship, regardless ifSA/V was modulated by initial surface area or by flow rate or by gradua l dissolu-
tion (Fig. 3). The best match of the predicted halftime with the in vivo halftime is obtained for SA/V ratios around 
0.01 to 0.03 h/cm. To ensure that this wrnsual observation is not an artifact of the experimental parameters , but 
truly a materia l-specific phenomenon, we tested another nanomaterial under identical conditions. We chose 
10-nm CuO because it is a benchmark material in the draft OECD guideline on nanomaterial solubility and 
dissolution 22 and in the DF4nanoGrouping framework 44. Like BaSO 4, no redox processes are involved in CuO 
dissoluti on, whereas other benchmark materials might differ by oxidative or reductive dissolution mechanisms 12. 
If the CuO dissolution process is mediated by the ENM surface, re-precipitation remains irre levant , and our cal-
culation is corr ect , then k(t) of CuO should be constant for all t until full dissolution. Indeed, the instan taneous 
dissoluti on rates k ofC uO were inde pendent of SA/V across many orders of magnitude (Fig. 3), contrasting to 
the BaSO4 NM-220 behavior. Both CuO and BaSO4 do not change their redox state upon dissolution , and are 
thus non-reactive dissolution processes: in other cases, e.g. metallic Cu, Ag, MoS2, CdS etc., the electron exchange 
with a reaction partner from the surrounding medium may impose a rate -limiting step. In depth work on metal 
nanoparticles with a scope on the redox reaction forming the soluble product was done in by Gray et al. in 201812• 
Table 2 also highlights that the half-timest 112 obtained by direct fitting on a semi-log plot are in close agree-
ment with the half-time s t1112 derived from conversion of the cumulative dissolution rate via Eq. 2a. Of note, th e 
conversion assumes an exponentia l shape of the decay curve. Only for the highest initia l loadings M0 :::0: 8mg, the 
values disagree significantly , because the saturation processes are reflected by linear (not exponential) kinetics 
(Fig. S3). 
We also investigated the transformation of the shape and speciation of solids after a biotic testing: We flushed 
the flow-through cells with water, then opened the cells and rinsed off the remaining solids into a centrifuge vial 
with a TEM grid at the bottom as described in methodical detail in a recent paper and SI37. By centrifugati on, all 
solid > 10 nm was spun onto the TEM grid and the supernatant with its buffer salts was discarded. Compared to 
as-produced BaSO4 NM-220 (Fig. 4A), there was a shift towards larger particle diameters (Fig. 4B). Structural 
rearrangement towards a loss of small radii of curvature are observed (Fig. 4B), and occasionally , very large 
spherical structures were observed (Fig. 4D). Two different transformati on processes are possible reasons for this 
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Figure 4. TEM images of BaSO 4 transferred from remaining solids onto TEM grids (scale bar corresponds to 
500nm for (A,B) and 1 µm for (D). Panels: A as-produced particles; (B,D) after 72hours of treatment in the 
flow-through cells with PSF. C shows the TEM particle size analysis of pristine BaSO4 particles (orange) and 
BaSO4 particles after treatment in PSF (blue) (NA= 331; N8 = 280). 
observation. Ostwald ripening , which is generally explained as a minimization of interfacial energy by an overall 
increase of the radii of curvature mediated by a minimal solubility of ions first described in 45. Or secondly, com-
peting intermolecular forces at the particle-particle interface inducing a material transport between particles of 
different sizes, as deduced from the study of perfluorocarbon blood substitutes 46 . Both processes are driven by the 
reduction of free energy. When comparing the TEM median particle size before and after continuous flow in PSF 
(Fig. 4C), a size shift from 32.2 ± 16nm to 39.9 ± 16.4nm was measured (by manual evaluation of approximately 
300 particles). In contrast, the "shrinking sphere" mode l36 would predict a diameter of23 nm to match the 60% 
mass loss that is quantified as dissolved ions in the same experiment. XPS analysis confirmed that the preferred 
recrystallization species is BaSO4 (Figs. 5 and S4), in accord with the in vivo EDS observations (see next section). 
With the present protocol, the flow conditions are highly controlled, but it is not possible to image the same 
nano particle over time. We also explored an alternative approach, where we repeatedly imaged the same ensemble 
of nano particle very far below the solubility limit at pH 4.5, but without controlling flow. The repeat scan shows 
that the sphericity of the remaining structures increases at the expense of structures with smaller radius of curva-
ture (Fig. S5), consistent with either of the material transp ort mechanisms. 
Bio processing of Ba50 4 particles in lung tissue: contributions to overall retention kinetics. 
Long-term inhalati on exposures (12-24 months) to BaSO4 NM-220 (Fig. 6a,b) at a high aerosol concentration 
(50 mg/m3) resulted in significant accumulation ofBaSO 4 in lung macrophages (Fig. 6c,d). The retention ofBaSO 4 
particles in the lung had reached a maximum at~ 12 months of exposure. At 12 months of continued inhalation 
exposure, the retained dose ofBaSO 4 did not increase further , despite continued exposure. It appears that the con-
tinued pulmonary deposition of inhaled BaSO4 was counterbalanced by removal ( dissolution of the nano particles 
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Figure 5. XPS results for BaSO4 after flow-through testing in pH 4.5 PSF for 72h. (A) Photoelectron energy 
line for Ba (3 days). (B) Photoelectron energy line for S (2p). The spectra can be fitted quantitatively with the 
benchmark chemical shifts ofBaSO 4• The elemental composition (Fig. S4) confirms a ratio Ba:S of 1:1.023, all 
consistent with an identification of the transformati on product as BaSO4. Data was acquired and averaged on 
N = 5 measurements. 
due to shedding of ions from the particle surfaces and elimination from the lung). The retained Ba in the lun g 
was, thus, at an equilibrium between 12 and 24 months of exposure. TI1e lung macrophages (Fig. 6c) contained 
nanoparticles that were identified with high resolution EDS to correspond to BaSO4 (Fig. 6e). The spacing or 
relative distance between BaSO 4 particles inside the macrophages was rather small, with many particles seeded 
side-by-side (Fig. 6c- e). Surprisingly, the particle size distribution ofBaSO 4 inside macrophages was significantly 
larger as compared with the parent material (Fig. 6a,b). This indicates that Ba and SO4 ion concentrations inside 
the macrophage environment that contained many densely packed BaSO4 particles, approached supersaturation 
conditions following the long -term inhalation exposure at a very high aeroso l concentration (50 mg/m 3). This 
resulted in the transformation and recrystallization of particles inside the lung macrophages. Material transport 
between particles had also occurred, whereby smaller particles dissolved faster, and the released ions were not 
removed, but rather deposited onto neighboring particle surfaces, allowing selective particle growth to take place 
(Fig. 6d,e). This is the first documentation of an inter-particle material transport mechanism of nano part icles 
after uptake in vivo. In addition, BaSO4 particles exhibited a greater size range (from sub-nano to micron scale) 
as compared with that of the starting materials which is in good agreement with observations from the abiotic 
flow thr ough cells. Transformation ofBaSO 4 involved a particle size effect and a recrystallizati on of the particles 
which was controlled by the saturation and supersaturation condit ions in the macrophage microenvironment. 
The shedding of ions drove not only the in vivo dissolution kinetics, but also controlled the shape , morphol-
ogy, and size distribution of retained BaSO4 in the lung. This indicates that BaSO4 underg oes transformation 
mediated by non-equilibrium dissolution (in line with the observed incorporation of Ba in bones within days 
after intratracheal instillation) and recrystallization, thus modulating the overall biopersistence of the particles. 
Not all macrophages contain copious amounts of densely packed BaSO4 and it is important to point out that 
each macrophage represents a unique system where dissoluti on and supersaturation conditi ons are subject to 
the nanoparticle accumulation rate. Only when enough BaSO4 nanoparticles collect inside a macrophage can 
transformation occur. 
Discussion 
We posit that the measurement of dynamic particle dissoluti on should be an import ant element of predictive 
toxicity testing, i.e., the determination of dissolution rates in a biotic systems as opposed to static solubility. The 
solubility categorizes BaSO4 (including the specific NM-220 grade) as poorly-soluble in water. However, sol-
ubility in water does not reflect in vivo reality in terms of 1) ongoing dynamic processes and 2) composition 
and pH of physiological fluids. The dissolution rates in physiological media better reflect an important com-
ponent of in vivo particle clearance, considering that both absorptive chemica l and phy sical clearance mecha-
nisms are always working in tandem to affect total particle clearance (see below). Dissolution rates determined 
in appropriately-designed abiotic systems will be useful for grouping and classification of EN Ms. From these 
predictive testing results, we also gain insight into the mechanisms that underlie biosolubility, which may explain 
experimental findings, e.g., the incorporation ofBa 2+ in bones (as Ca2+ analogue). 
Concerning the methodology, a solubility limit of ~ 100 mg/L has been proposed for testing strategies30A7 and 
grouping frameworks 13 to define readily-soluble particles that would quickly lose their particulate nature. A cur-
rently developing OECD guideline describes a "screening test" that fulfills the requirements for Tier 1 grouping 
frameworks 22. For purpose of initial screening of equilibrium solubility, the test could be performed in water, 
and then in the most relevant medium for exposure-specific testing 20• For ENMs with solubili ty limits below 
100 mg/L, for hazard assessment of inn ovative nan o materials, or for endpoint-specific grouping and read-across 
between nanoforms, flow-by or flow-through dynamic dissolution (both are continuous flow systems36) in rele-
vant media can offer predictivity of in vivo dissolution behavior 10, but not necessarily total in vivo clearance rates. 
In order to best model the contribution of dissolution to in vivo clearance, it makes good sense to focus on the 
intr aphagolysosomal environment at pH 4.5 (although dissolution in extracellular fluid (at neutral pH) could also 
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Figure 6. HRTEM/STEM structural characterization of as-produced BaSO4 nanoparticles and in rat lung 
sections. (a,b) pristine BaSO4 NM-220 ; (c) BaSO4 after 12 months inhalation exposure: accumulation in lung 
macrophage ; (d) Transformation ofBaSO 4 in macrophage showing particle growth with crystalline facets. 
(e) HRSTEM of recrystallized BaSO4 in macr ophage with corresponding high-res oluti on EDS mapping for S, 
Ba, OandC. 
be considered and included in kinetic model equations) . Additional information about the impact of different 
flow rates and starting masses would provide insight regarding saturation, which could be predictive of in vivo 
events. TI1e selected meth ods for ion analysis should ideally have a limit of detection of 10 µg/L or below for the 
target analyte. Methods for morphological analysis of remaining solids require sample preparation, which was 
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Exposure Particle type and Total Retention Dissolution 
duration method of delivery 111,(d) b.,,(d- 1) Retention 111, (d) b,.,, (d- 1) 
131BaSO 4 NM -220 
---- 0 ) lntratracheal 9.6 7.23% 11.1 6.23% 
instillation 
90 daysC•> BaSO 4 NM -220 56 1.24% 289 0.24% 
nose -only inhalation 
2 years <5> BaSO,NM -220 45• 1.54% 128 0.54% 
head -nose inhalation 
Table 3. Pulmonary dissolution rates and associated half-times for BaSO 4 derived from acute and repeated rat 
exposure studies. *At steady-state. 
developed here based on the NanoDefine D6.3 protocol for TEM analysis, using centrifugal pelleting of remain -
ing solids onto a TEM grid (which inherently is a purification from dissolved species). To assess the extent of 
transformation, we recommend TEM-based morphological and size distribution analyses (N»l00), with optional 
confirmation of chemical speciation, e.g., via SAD or XPS or XANES. For materials other than BaSO4, more 
complex re-speciations must be expected, e.g. Ag sulfidation, Cu oxidation 48·49, CeO2 re-speciation to CePO 3 
need les29). Reprecipitation in flow-cells has been observed frequently during d issolution testing of stone wool 
mineral fibers, where especially Si tends to reprecipitate as gel on the surface of the fibers50-53• Most interestingly, 
a faster flow (lower SA/V ratio) is known to suppress gel formation and to increase the apparent stone wool dis-
solution rate54. These reports are analogo us to our findings with BaSO4• 
Dissolution should be expressed in terms of rate (e.g., kin units of ng/cm 2/h or %/day) for which ample liter-
ature on dusts exists 1°. This approach challenges the cutoffs for categorization and grouping of ENMs, typically 
expressed in% dissolved or mg/L concentrations. BaSO4 is clearly "insoluble" in mg/L metrics as determined 
using stat ic systems but is correctly predicted to dissolve in vivo by the dynamic dissolution methods. 
The findings from these studies could be used to propose alternative categories for grouping approaches of 
ENMs. For the rat, lung retention half-times (t112) for 'poorly -soluble low-toxicity' particles (PSLTs) are ~ 70 days 
and, by definition, reflect mechanical, macrophage -mediated clearance, generally following first-order kinetics 1°. 
Half-time and rate constants are inversely related to each other via Eq. (2). Using this equation to determine a rate 
constant for PSLTs yields ~0.01/day or roughly 1 % of starting material - as expressed using any metric of choice 
- per day for the mechanical component of clearance. Knowing that total lung particle clearance reflects the sum 
of mechan ical and dissolut ion clearance, one can der ive gro ups of disso lution clearance rates such that faster 
rates would indicate readily- or partially -bioso luble particles. In a previous paper we applied the contin uous flow 
system to 24 different ENMs, and suggested decadic ranges of the dissolution rates between < 1 ng/cm 2 /h (insig-
nificant dissolution - also asbestos falls into this group) and > 100 ng/cm 2 /h (half-times on the order of 1 day)37. 
Expressing dissolution rates in percent per day enables comparisons to and predictions of in vivo clearance rates. 
The preceding discussion is based on results from studies that were cond ucted in rats but could be adapted 
to human hazard characterization via the use of human -specific rate constants or retention half -times. While 
mechanica l clearance rates exhibit species specificity and also be impacted by inflammatory responses, it is pre-
dicted that dissolution rates are similar between humans and rodents 10. The method could be used to enhance 
the DF4nanoGro uping 13, and to implement the ECHA grouping guidance 55 pending further validation by more 
varied case studies as proposed elsewhere37. 
With regard specifically to BaSO4 pulmonary clearance and transformation, Konduru and colleagues reported 
that intratracheally instilled 131BaSO4 NM -220 exhibited a lung retention half -time of 9.6 days in rats and that 
131Ba was incorporated into the bones, suggesting nanoparticle dissolution and/or extrap ulmonary transloca -
tion 3. A subsequent 90-day inhalation study in rats with aerosolized BaSO4 of the same grade (50 mg/m3, full 
physicochemical equivalence to NM -2204) showed the gradual accumulation of Ba in lung tissue during exposure 
followed by steady clearance over a 90-day post-exposure period, with a reported retention half -time of 56 days, 
indicative oflow in vivo solubility of BaSO 4 affecting its overall lung clearance. A two -year rat inhalation study 
in rats with BaSO4 NM -220 (50mg /m3) confirmed a steady increase of retained Ba in the lung up to one year of 
exposure, with no further increase during subsequent contin ued exposure up to two years5. The equilibrium lung 
burden of Ba over the exposure period (12- 24 months) is explained by the fact that the daily deposited dose in the 
lung is equal to the amo unt being cleared daily, i.e., deposit ion and clearance rates are in equilibri um. Knowing 
the BaSO4 aerosol characteristics (mass median aerodynamic diameter, geometric standard deviation, exposure 
concentration) and exposure durat ion, the da ily deposition rate can be estimated using the MPPD model for rats 
with body weight-adjusted respiratory parameters, which results in a daily BaSO4 lung clearance rate of 0.0154% 
of the daily deposited dose. This is equivalent to a retention half-time of 45 days (Eq. 2a). Since the lung clearance 
rate for biosol uble particles is the sum of mechanical and dissolution clearance rates, the difference between the 
normal rat clearance rate for PSLT particles (0.01/day) and the observed clearance rate in the equilibrium phase 
(0.0154/day) is the BaSO4 in vivo dissolution clearance rate (0.0054/day; t 112 = 128 d) (Table 3). The available data 
show that, for acute expos ures, rapid clearance ofBaSO 4 occurs and that dissolution contrib utes significantly to 
the total clearance. Following subchronic or chronic exposures, total lung clearance is slower, but is neverthe less 
faster than mechanical clearance alone. Of note is that the predicted dissolution rates and associated half-times 
for the 90-day and two -year studies are prolonged as compared to acute expos ures, suggesting a saturation event. 
Both the fast, short -term in vivo dissolution at a lower 'dose' and the saturation at higher 'doses' were predicted by 
the abiotic assay (Table 2). The bioavailability of ion ic Ba could pred ict secondary organ uptake with the caveat 
that there could be macromolecule binding events that might limit the clearance of Ba. 
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Depending on the initial loading, flow rate and flow cell geometry, the bd~s in the abiotic test ranges from 0.2% 
at strong saturation to 43% well below saturation, and abiotic dissolution half-times range from 350 days to 2 days 
(Table 2). The range of the half-time and rate values includes that which was found in the different in vivo studies. 
0 ne might interpret that the intra tracheal instillation study induced no or only mild saturation (locally), whereas 
the 90-day and two-year inhalation studies induced sign ificant saturat ion, consistent with the morphological 
observations (Fig. 6). 
The collective in vivo findings and those from the present dissolution studies suggest that Ba ions dissolved 
from lung -deposited particles - as opposed to the particles themselves - and were transported throughout 
the body and incorporated in bone epiphysi 56- 58• Furthermore, the long -term inhalation study results can be 
explained by a phenomenon whereby bone tissue - with its limited capacity and varying demand for bivalent cat-
ions over time - was saturated 59, after which the net transport of Ba from lungs to bone decreased and, ultimately, 
the accumulation of Ba in the lungs increased. Within the (local) environment of the lungs , the ion removal rate 
depends on many factors, e.g., binding to biomolecules, that may affect the clearance rate. 
Whether there is a specific or non -specific transport mechanism of Ba ions from the lung or a key trigger 
whose signaling results in the reduced removal of Ba from the lung remains to be elucidated. The measurement 
of Ba blood levels might help to shed light onto these questions. In addition, local clearance mechanisms in the 
lungs , such as mucociliary clearance and the clearance by alveolar macrophages, might be prolonged. We quali -
tatively observed significant accumulation ofBaSO 4 in rat lung macrophages exposed for 12 months or longer to 
BaSO 4• Of note, the acidic pH of the macrophage lysosome is essential to BaSO 4 dissolution, which is very signifi-
cantly reduced at pH 7.4 (Fig. Sl ), by ~ 35% as compared to pH 4.5. Furthermore , removing the organics from the 
PSF pH 4. 5 medium results in a significant decrease in dissolution (Fig. S3) and thus points to the ion scavenging 
effect of organic acids in lysosomal fluids. Taken together, uptake in macrophages and active transport of the ions 
are most likely steps in the clearance pathway, but dissolution in the neutral linin g fluid may also contribute to 
total in vivo clearance. 
Since the time -resolved abiotic dissolution shows that saturati on conditions are reached , and furthermore 
crystalline particle growth was observed in vivo as well as in abiotic conditions , the struct ural transformation pro -
cess are best described as Ostwald ripening. 0 nee the net transport ceases, accumulation entails supersaturation 
conditions leading to the Ostwald ripening in macrophages that have accumulated BaSO 4 particle s in phagolyso -
somes. Since each macrophage harbors unique concentrations ofBaSO 4 particles, there are just as many systems 
(local supersaturation) to be considered. In this concept, the structure formation process is a self-catalyzing phe -
nomenon: once the local ion concentration exceeds the solubility, triggering particle growth, the specific surface 
area of the deposited particles decreases, thus slowing dissolution until equilibrium is reached between removal 
via dissolution and addition by deposition. Further evidence for in vivo Ostwald ripening of inhaled BaSO4 par -
ticles in lung tissue was recently presented 60• Families of (nano)forms that share each one substance but differ 
in sizes, coatings or shapes, have been assessed by the same methodology for dissoluti on and transformation 37. 
The BaSO4 dissolution rate is intermed iate in comparison, and materials such as amorphous silica show related 
reprecipitation phenomena , albeit at slower rate37. 
Although the present study was designed to rationalize the clearance ofBaSO 4 after inhalation , we note that 
the same concepts oflocal supersat uration (reaching the solubility limit of the specific ion in the lung medium) 
may be relevant to understand biokinetics after any other uptake routes. Accumulation of Ba in the lungs was 
reported after IV injection 3•61: Giese 1934 and 1935 found after IV injection ofBaSO 4 deposition in bone marrow, 
liver, spleen and lungs. Konduru et al. found 20% of the administered dose in lungs at 2 days post IV injection 3. 
Ba ions are likely to have precipitated, similar to the observation via HRTEM of newly forme d Ce-containing 
(nano)part icles in the liver43•62. Huston et al. observed the format ion of"refract ile masses" after instillation of a Ba 
containing solution Veriopaque, which was accompanied by inhibited removal of Ba by macrophages. 
Ba2+ ions elicit systemic toxicity mainly via hypokalemia that is caused by the blocking of rectifying potas -
sium channels in many cell types 63• Although these effects do not necessarily require cellular uptak e, it should 
be pointed out that Ba2+ ions, similar to Sr2+ ions, are capable of permeating specific Ca channels as well as 
non-selective cation channels of the cell membrane 64- 66, and some of these channels have been shown to be 
essential for macrophage function 67- 69• Ba2+ ions may also be actively transported against an electrochemical 
gradient by Caz+ ATPases70• Once inside a cell, Ba2+ ions may further pass to the different cell organelles such as 
endop lasmic reticulum, mitochondria, and lysosomes 71. Thus, Ba2+ ions dissolving from BaSO 4 nanoparticles 
may distribute across membranes between subcellular compartments with the net fluxes being determined by 
electrochemical driving forces: of note, phagoly sosomes are acidified by an active transport of H+ ions carried 
out by V-ATPases69, resulting in a positive potential of approximately 30 m V. This potential may act as an outward 
driving force for Ba2+ ions, while at the same time creating an inward driving force for chloride ions, e.g., via CLC 
channels 68•69• Although not yet proven it is tempting to speculate that these processes may be involved in fostering 
dissolution and/or recrystallization processes ofBaSO 4 nanoparticles trapped in a macrophage's phagolysosome. 
Conclusion 
Our result s confirmed the previous findings that prediction of dissolution rates requires the use of relevant 
biological/physiological fluids rather than water2°. The methodologies described herein for measuring abiotic 
dynamic particle dissolution and transformation involve a number of improvements: 
The use of contin uous flow, rather than static incubation; 
The integrated assessment of residual solids with respect to transformations of shape, size distribution, and 
crystallinity by prot ocols for preparation, analysis and statistical image analysis, using TEM, optional ly sup-
ported by XPS and EDX. 
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The ready comparison , using the same experimental system, to compare to rapidly - and po orly-soluble 
benchmark particles , for grouping purpo ses as demonstrated elsewhere 37; 
Ability to predict in v ivo dissolution rates (with the acknowledged limitati on that dissolved ions could be 
retained in tissues via binding to other molecules); 
The observation of dependence on initial loading mass could be useful for estimating in vivo solubility limit s 
and , thus, provide insight regarding supersaturation that would impact total clearance rates. 
Specifically, to BaSO 4 we propose that the unu sual biokinetic s of the long-term, high concentration BaSO 4 
rat inhalation studies indicate a) the release of Ba ions via in vivo dissolution of phagocyto sed particle s, with 
transport to and uptake into the bone and b) recrystallization in lung s as additional transformation proce ss that 
modifies ENM lung retention. The proces s is a self-catalyzing phen omenon as the specific surface area of the 
transforming particle s decreases, thu s slowing down dissolution. Especially the second year of the two-year inha -
lati on study was, thu s, cond ucted at significant saturation. Control measurem ents on CuO demon strated that 
Ostwald ripening and supersaturation phenomena are not a methodical artifact, but characteristic of the BaSO4 
properties , and were reproducible in two labs and different lysosomal simulant s. The rates and the transformation 
and the Ba speciati on were verified in vivo, with the only limitation that in vivo processing resulted in less sphe -
ricity and more crystalline facets. The dynamic dissolution results thus qualitatively predicted the in vivo BaSO4 
dissoluti on, as well as the concentration -dependent Ostwald ripening pr ocess observed within the rat lung. 
Data availability 
The test material BaSO4 NM -220 is available from the OECD sponsor ship repo sitory at Fraunhofer Institute, 
Schmallenberg. The same-grade -later-batch used for the long-term inhalation study is available as JRCNMS000 la 
in the frame of the PATROLS project from the JRC repo sitory, Ispra. 
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3.1.5 Understanding Dissolution Rates via Continuous Flow Systems with 
Physiologically Relevant Metal Ion Saturation in Lysosome 
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Dissolution rates of nanomaterials can be decisive for acute in vivo toxicity (via the released ions) and for 
biopersistence (of the remaining particles). Continuous flow systems (CFSs) can screen for both aspects, but 
operational parameters need to be adjusted to the specific physiological compartment, including local metal 
ion saturation. CFSs have two adjustable parameters: the volume flowrate and the initial particle loading. 
Here we explore the pulmonary lysosomal dissolution of nanomaterials containing the metals Al, Ba, Zn, Cu 
over a wide range of volume flowrates in a single experiment. We identify the ratio of particle surface area 
(SA) per volume flowrate (SA/V) as critical parameter that superimposes all dissolution rates of the same 
material. Three complementary benchmark materials—ZnO (quick dissolution), TiO2 (very slow 
dissolution), and BaSO4 (partial dissolution)—consistently identify the SA/V range of 0.01 to 0.03 h/µm as 
predictive for lysosomal pulmonary biodissolution. We then apply the identified method to compare against 
non-nanoforms of the same substances and test aluminosilicates. For BaSO4 and TiO2, we find high similarity 
of the dissolution rates of their respective nanoform and non-nanoform, governed by the local ion solubility 
limit at relevant SA/V ranges. For aluminosilicates, we find high similarity of the dissolution rates of two 
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Abstract: Dissolution rates of nanomaterials can be decisive for acute in vivo toxicity (via the released 
ions) and for biopersistence (of the remaining particles). Continuous flow systems (CFSs) can 
screen for both aspects, but operational parameters need to be adjusted to the specific physiological 
compartment, including local metal ion saturation. CFSs have two adjustable parameters: the volume 
flow-rate and the initial particle loading. Here we explore the pulmonary lysosomal dissolution 
of nanomaterials containing the metals Al, Ba, Zn, Cu over a wide range of volume flow-rates in a 
single experiment. We identify the ratio of particle surface area (SA) per volume flow-rate (SA/V) as 
critical parameter that superimposes all dissolution rates of the same material. Three complementary 
benchmark materials-ZnO (quick dissolution), Ti02 (very slow dissolution), and BaS0 4 (partial 
dissolution)-con sistently identify the SA/V range of 0.01 to 0.03 h/µm as predictive for lysosomal 
pulmonary biodissolution. We then apply the identified method to compare against non-nanoforms 
of the same substances and test aluminosilicates. For BaS0 4 and Ti02, we find high similarity of the 
dissolution rates of their respective nanoform and non-nanoform, governed by the local ion solubility 
limit at relevant SA/V ranges. For aluminosilicates , we find high similarity of the dissolution rates of 
two Kaolin nanoforms but significant dissimilarity against Bentonite despite the similar composition. 
Keywords: dissolution; dissolution rate; nanomaterial grouping; risk assessment; 3R method; 
regulatory hazard assessment 
1. Introduction 
With a steadily increasing demand for engineered nano materials (ENMs) for industrial applications, 
the ENM production volumes reported by industry are a significant share of the total particle 
production [1]. The properties of the nanomaterials are specifically designed for their different intended 
uses and are therefore varied in surface treatment, composition, size, and morphology. Often one 
substance exists in many different nanoforms. The vast amount of nanoforms makes it impossible to 
investigate the risk potential of each individual nanoform [1,2]; therefore, grouping and read across 
approaches are urgently needed to reduce the uncertainty related to the risk of nanomaterials [3- 5]. 
The nanoform is described through chemical composition, surface properties, size, and shape [6]. 
Nanomaterials 2020, 10,311; doi:10.3390/na nol0020311 www.mdpi.com/journaVnanomaterials 
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However, these properties are insufficient to forecast potential environmenta l and human health-related 
hazards and do not take into account the comp lex mechanism of pulmonary retention, clearance, and 
translocation that particles are exposed to upon inhalation [7- 10]. Thus, the European Chemica ls 
Agency (ECHA) as well as the Environmenta l Protection Agency (EPA) are prioritizing the dissolution 
rate as a key criterion for the assessment of the risk potential of nanomaterials (11]. This criterion can 
then be used to compare different nanoforms of a substan ce . Nevertheless, it is not sufficient to group 
the nanomaterials into solub le and inso lubl e (12] as the dissolution kinetic spans over many orders 
of magnitude from fast dissolving ENMs such as our benchmark materials ZnO and CuO to poorly 
solubl e materials such as TiO2 and Fe2O3 (13]. The dissolution rate is measured in ion mass per solid 
particle surface per time and is designated ask [ng/cm2/h ] [14]. In contrast, the solub ility is measured 
in equilibrium saturated suspensions to yield the conventiona l solubility limit [4]. Low solubility 
should not be interpreted as a sufficient indication of biopersistence, because the static setup does not 
represent the conditions that particles are exposed to when being taken up into a physiological system. 
In comparison to the static system, the physiological system is an open system with both passive 
and active transport away from the remaining particles. The continuous flow-through system for 
nanomaterials is currently used for quantifying environmenta l (15] as well as oral dissolution (14,16] 
and was adapted from a system used for man-made vitreous fibers (MMVF) [17- 19]. One might 
anticipate that the testing has to be done with a range of initial ENM mass concentrations at the same 
flow-rate in order to verify that the results are truly not limited by local concentrations reaching the 
solubil ity limit. Otherwise, a false negative result of apparently low dissolution rate might occur. The 
results on MMVF have highlighted that the solubility limit can be avoided by increasing the flow-rate 
at the same initial mass [20]. However, false positive results of overestimating the physio logica l ion 
transport and, hence, overestimating the biodissolution are also imaginable. Continuous flow systems 
(CFSs) have two adjustable parameters that can be used to prevent false predictions: the volume 
flow-rate and the initial particle loading . The decisive parameter in MMVF testing was the ratio SA/V 
of surface area per flow-rate, but this has not been explored yet for nanomaterials. 
Here we propose and demonstrate a more efficient alternative to verify predictive conditions by 
ramping the fluid flow of the continuous flow system at the same initial ENM mass . The ramped 
flow-rates are applied to a set of nanoforms and non-nanoforms containing the critica l metals Al, Ba, 
Zn, Cu with existing in vivo inhalation clearance results (12,21,22] to validate the dissolution results 
with three different benchmark materials for quick ly soluble, solub le, and insoluble with ZnO, BaSO4, 
and TiO2, respectively. 
2. Materials and Methods 
The assessment of the dissolution rate of ENMs through flow-rate ramping is a complimenting 
technique to the current dissolution setup as described in Koltermann-Jully et al. 2018 and Keller et al. 
2020 (14,23]. The continuous flow-system was deve loped to assess the dissolution far from equilibrium . 
However, the solubility limit of the tested ENMs requires the tester to run multiple tests with varying 
initial masses in order to verify that the dissolution is not limited by local concentrations reaching the 
solubility limit. Therefore, the technique of flow-rate ramping is presented as an advanced technique 
that can be transferred to all materials and cannot fully be described by measuring at a single initial 
mass. The fundamentals of this testing methods are described in the next section. 
Ten different materials were selected with high industrial relevance. Their basic nanoform 
descriptors and other properties have been published recent ly (24] and are reproduced in Table Sl. 
These materials consist of two different kinds of BaSO4, one nanosized material provided by the 
Organization for Economic Co-operation and Development (OECD) sponsorship program and the 
non-nanosized BaSO4 IRMM381 as a non-nanosized form provided by the Institute for Reference 
Materials and Measurement (IRMM), with permission of Solvay [25,26]. CuO was produced by 
PlasmaChem GmbH, Germany [22]. Furthermore, two kinds of Kaolin IRMM-385 (JRC-IRMM, Geel) 
and Kaolin (BASF SE, Ludwigshafen) were used, whi ch both differ in size and form and were provided 
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by the OECD sponsorship program. Additionally, Bentonite NM600 was provided by the OECD 
sponsorship program. ZnO NMl 10 and NMl 11 were kindly provided by the Joint Research Center 
(JRC) repository of the OECD sponsorship program and differed in their surface coating. ZnO NMll 1 
is used as a benchmark material for a quickly dissolving nanomaterial as per the available inhalation 
in vivo results and has a hydrophobic triethoxycaprylsilane coating [27,28]. 
2.1. Continuous Flow System with Programmable Sampling, ICP-OES or ICP-MS Analysis 
The setup (Figure 1) implements a "continuous flow system" described in ISO 19057:2017 (29]. It is 
essentially a replication of the established flow-through testing of the dissolution kinetics of mineral 
fibers [19,301' was described for this purpose [3lt and was used here with minor adaptations to match 
the specifics of ENMs: The ENM mass of 1 mg was weighed onto a membrane (cellulose triacetate, 
Sartorius Stedim Biotech GmbH, Goettingen, Germany): 47 mm diameter, 5 kDa, and a pore size of 
- 1 nm, topped by another membrane, and enclosed in flow-through cells. Standard conditions are 1 mg 
initial solid mass in the flow-through celt and 2 mL/h flow. The phagolysosomal simulant fluid (PSF) 
pH 4.5 (composition in Table S2), which is an acidic buffer simulating the phagolysosomal compartment 
of macrophages (31,32], and which was previously validated for the purpose of inhaled beryllium 
dissolution by National Institute of Standards and Technology (NIST) laboratories [321' was employed 
at 37 ± 0.5 °C. In contrast to the larger volume flow cells used by Bove et al. for oral dissolution 
testing (16], in our setup the ENMs were in direct contact with the ultrafiltrahon membrane. In contrast 
to the flow cells used by Kent et al., our cells held industrially produced ENMs, not lab-grown arrays of 
similar chemical composition (15]. The core idea of separating ions from remaining solids was shared 
by all three setups . The programmable sampler drew 4-10 mL of the eluate once to two times per day 
for seven days. Depending on the flow-rate (Table 1) the samples were drawn for 3-44 h per sample 
in order to fill the vials . The rest of the eluate was collected in a container. The ion concentrations 
of the eluates from different time points were determined by inductively coupled plasma - optical 
emission spectrometry (ICP-OES Agilent 5100 and Varian 725 ES) with a limit of detection of 0.1 mg/L, 
or alternatively by inductively coupled plasma - mass spectrometry (ICP-MS Perkin Elmer Nexion 
20006, Perkin Elmer Inc., Waltham, USA) with a limit of detection of 0.1 ppb. Prior to taking the 
measurement, the instrument was optimized in accordance with the manufacturer's specification. 
Duplicate measurements were taken and averaged. We measured with 10 s integration time, and the 
dilution factors were between 1 and 10. External calibration used concentrations of 0/1/5 mg/L with 
matrix-matched standards. The nebulizer (Meinhard 1 mL) had a flow of 0.7 L/min at a pump rate 
of 15 rpm. For ICP-MS, duplicate measurements were taken and averaged. The eluate was diluted 
with a factor in between 100 and 1000 and the external calibration used concentrations of 0.1/1/10 ppb. 
The nebulizer had a flow of 0.92 L/min at a pump rate of 35 rpm. 
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el nanoparticle 
s s s 3-5 kDa membrane 
Figure 1. Dissolution setup. The reservoir for the physiological fluid was controlled at 37 °C, as well 
as the flow-through cells. The peristaltic pump regul ated th e flow-rate of up to eight cells in parallel, 
with a programmable autosampler for fluid collection. The flow-through cell was equipped with 5 kDa 
membranes to hold back particl es and only allow the flow of ions. The meniscus of the rese rvoir was 
elevated approx. 0.5 m above the cells such that the hydrostatic pressur e balanced the pressur e drop by 
the 5 kDa m embrane. 
Table 1. Ramped flow-rates in dependence of time. Ramp up des cribes an increasing flow-rate from 
0.1 to 3 mL/h, and ramp down des cribes a de creasing flow-rat e from 3 to 0.1 mL/h. 
Flow-Rate [mL/h] 
Sampling Time [h] Ramp Up i Ramp Down! 
24 0.1 3.0 
48 0.1 3.0 
72 0.2 2.0 
84 0.5 2.0 
96 0.5 1.0 
106 1.0 1.0 
120 1.0 0.5 
125 2.0 0.5 
135 2.0 0.2 
147 3.0 0.1 
168 3.0 0.1 
2.2. Continuous Flow System with Ramped Flow-Rates to Ensure Out-OJ-Equilibrium Conditions 
To further understand the dissolution behavior of nanomaterials, the dissolution conditions 
were varied in order to ensure non-equilibrium conditions. This was done by varying the flow-rate 
drastically between 0.1 and 3 mL/h within a sing le measurement. The precise flow-rates can be 
seen in Table 1. The flow-rate was gradually changed after either each or every second filled vial. 
Therefore, the sampling time of a single time point was varied between 3 and 24 h. Besides the varying 
flow-rate, adjusted through the flow-regulating pump, the measurements were done in accordance 
to the continuous flow-through system with constant flow-rate. After each run , the ion content was 
determined through ICP-MS. 
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There are three ways to express the dissolution rate of the nanoparticles . These three ways 
have been described in our previous contribution (23), each working best to describe the dissolution 
mechanism of a certain set of materials and are reproduced here for completeness of methodology. 
For this purpose, we multiplied the amount of eluate with the ion concentration to determine the total 
ion mass dissolved, as illustrated for BaSO4: 
• Cumulative rate: The amount of dissolved BaSO4 at each time point Mion(T) is expressed as 
a fraction of the initial mass loading (Mo = 100%) and cumulated from all samplings with 
concentration ci, flow Vi, and sampling interval Mi, and includes the stoichiometry of BaSO4: 




The rate k incorporates the Brunauer - Emmett - Teller (BET) value (33]. The BET method uses 
adsorption of gases at constant temperature to determine the surface area of particles, in order to 
report results with a focus on composition or coating dependence, instead of size dependence. 
The conventional units of k are ng/cm 2/h (30,34]. We typically determine k by the number of 
cumulated ions during a specific time interval at the end of the test. 
• Curve fitting: To verify first-order dissolution kinetics (34], the cumulative dissolved BaSO4 
mass is expressed as an inverse relationship, i.e., decreasing solid retained BaSO4 mass (Mion(T) -
Mo)/Mo, and plotted against time on a semi-log scale. The dissolution rate- expressed as a fraction 
per hour - is calculated from the slope of this line and then converted to percent per day using 
the total system 's available starting mass. Dissolution rate and half-time (t' l/2, 50% dissolved) are 
inversely related and can be expressed in two alternative metrics (below) as given for first-order 
modeling in ISO 19057:2017 (29,34]. The BaSO4 dissolution half-time allows direct extrapolation 
and comparison to the in vivo dissolution t112 of inhaled BaSO4, which is derived from the total 










• Instantaneous rates: For each sampling interval !'-i.t, the instantaneous dissolution rate k was 
constructed as: 
M;on(t) 
k(t) = SA(t) 
M' 
SA(t) = BET(to)(Mion(t)). 
(5) 
(6) 
We approximated the instantaneous surface area and, thus, ignored changes of the size distribution 
and shape (see Discussion). Elsewhere (14] we explored modeling of SA(t) via the assumption 
of shrinking spheres [29,34], which does not apply for particles with a tendency to undergo 
morphological transformation processes, such as BaSO4. 
2.3. Terminology of Modeling Nanomaterial Dissolution 
In this section, we recapitulate the relationship between the ENM, assumed to be a spherical 
particle, and the ion concentration . For this, we introduce the following notation: 
• R(T) : radius of a particle in cm with Ro = R(O) 
• v(t) = !n:R3 : volume of a particle 
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• A(t) = 4nR 2 : area of a particle 
• k: rate constant at which particle dissolves in ng/cm 2/h 
• p: density of particle g/cm 3 
• t: time in h 
• J (t) : ions present in the solution in g 
• m: mass of fluid in the flow cell, in g 
• m: flow of fluid per time, in g/h. 
Then when extending the model to a suspension of particles we use 
• CNp(t): concentration of particles at time tin g/L 
• C;on (t): concentration of ions at time tin g/L 
• No: number of NPs present in the solution per liter at t = 0 in 1/L. 
In this notation, the concentration of particles (NP) and ions are given by 
(7) 
(8) 
Due to dissolution, the well-established "shrinking sphere 11 model [35) links the generation of ions to a 
reduction of the particle volume: 
dCNP dv 2 -- = Nop- = - kANo = - k4nR No 
dt dt ' 
(9) 




Nine nanomaterials and one particle of bigger size were tested within the flow-through dissolution 
system with ramped flow-rates. The dissolution of the nan omaterials in phagolysosomal simulant fluid 
at pH 4.5 with increas ing flow-rate was compared against a run with decreasing flow-rate as shown 
in Figure 2. The blue data points display the ascending flow-rate ramp from 0.1 to 3 mL, whereas 
orange dots indicate the descending flow-rate from 3 to 0.1 mL/h. Similar time-re so lved dissolution 
curves were obtained for the nan omaterials ZnO NMll 1 and CuO. Both materials dis solve completely 
after a time period of 7 days either with the ramp up or the ramp down, consider ing that the acidic 
conditions of pH 4.5 are the driving force of this complete dissolution. Both materials could easily be 
measured with the He kineti c energy discrimination (KED) mode [35,36) of the ICP-MS since their 
limit of dete ction (LoD) is rather low, even traces up to 0.01 ppb could be measured. However, despite 
their similarity, the difference between the ascending and descending curve is significant. Interestingly, 
the ascending flow-rate forms an S-shaped curve while the descending flow-rate describes a rapid 
decrease of nan oma terial and after less than 50 h 100% of the nanomaterial is already dissolved. Thus, 
the descending flow-rate ramp cannot be used to better describe the dissolution for quickly dissolving 
nanomaterials. At the beginning phase of the ascending flow-through measurement, a high initial 
mass, which goes along with high surface area is exposed to a low flow-rate, resulting in a slower 
dissolution . The data points for the ascending flow-rate ramping are spread over a broader distribution 
of surface area to flow-rate (Figure 3). These graphs also prove that the measurement was done under 
out-of-equilibrium conditions and the saturation limit of the ions was not reached. Upon reaching 
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Figure 2. Time-resolved dissolution kinetics of CuO (left) and ZnO NM 111 (right). The b lue curve 
indicates the ascending flow-rate ramping, whereas the orange curve indicates a descending flow-rate 
ramping. Unfilled circles indicate points with remaining mass calculated to be <10%; the corresponding 
instantaneous rates are equally marked not sufficiently reliable in Figure 3 . 
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Figure 3. Dissolution rate depending on surface area and flow-rate. CuO (left) and ZnO NMl 11 
(right). Blue curve indicates ascending and orange curve descending flow-rate ramping. Unfilled 
circles indicate points with low reliability due to remaining mass <10%. Note the superimposed orange 
and blue dots. 
The resu lts on the disso lution with ramped flow-rate on two different BaSO4 particles, BaSO4 
NM220 and BaSO4 non-nano are displayed in Figure 4. Two initial masses for the ramp down (dashed 
line) of BaSO4 NM220 (green) and one for BaSO4 IRMM381 (yellow) were compared to the ramp up 
(solid line) for one initial mass of BaSO4 NM220 and two initial masses of BaSO4 IRMM381. The graph 
shows the plot of SA/V versus the dissolution rate k with dissolution rates that differ by a few orders of 
magnitude. This difference can be due to the difference in BET, as for instance the nano BaSO4 possess 
a 16-fold higher surface area than the non-nano form. Furthermore, this observation is confirmed 
by the time-resolved dissolution curve as seen on the left-hand side of Figure 4. However, when 
normalizing the surface area with different initial masses for the ramp up (BaSO4 NM220 0.11 mg 
PSF vs. BaSO4 IRMM381 1.42 mg PSF) as well as for the ramp down (BaSO4 NM220 0.14 mg PSF 
vs. BaSO4 IRMM381 0.86 mg), similar values for the dissolution rate can be observed for the two 
different nanoforms. Therefore, the results for the increasing flow-rate as well as the results for the 
static flow-rate do achieve a good predictability for dissolution rates between 0.01 and 0.03 h/µm; 
whereas the decreasing flow-rate as seen in Figure 4 cannot be applied. 
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Figure 4. Dissolution rate of BaS04 NM220 (green) and BaS04 IRMM381 (yellow) . The SA/Vis plotted 
against the dissolution rate k [ng/cm 2/h ]. The dashed line indicates the ramp down with decreasing 
flow-rate 3--0.l mL/h and the solid line represents the ramp up with increasing flow-rate from 0.1 to 
3 mL/h . The two different dashed green curves vary in initial mass. The dashed green curve with the 
square has an initial mass of 1.01 mg, whereas the curve with the round symbol has an initial mass of 
0.14 mg. The two yellow solid curves vary from 1.42 mg initial mass for the square to 0.12 mg for the 
triangle. Both darker spots represent the dissolution rate for the dynamic dissolution with constant 
flow-rate for nano BaS04 NM220 yellow and BaS04 IRMM381 dark green. 
The consistency between the instantaneous dissolution rates determined with fixed flow vs. 
ramped (increasing) flow has been assessed for BaS04 NM220, Cu 0, ZnO NMl 10, and ZnO NMl 11, 
and the results in the SI (Figure S4) demonstrate a) that the rule of 10% remaining mass successfully 
removes unreliable data and b) that the ramped flow enlarges the range of SA/V that is accessible in a 
single measurement. Data below 10% remaining mass are considered unreliable since weighing in 
1 mg of ENM into the flow-through cell always induces uncertainties . Furthermore, by calculating the 
dissolved fraction for quickly dissolving materials, often no ions can be detected anymore even though 
dissolution has not reached 100% yet. 
The apparent inverse linear relationship between the dissolution rate and SA/V was found for 
BaS0 4 NM220 before [23], but the new finding that this behavior extends to the non-nanoform and 
across a wide range of volume flow-rates (Figure 4) deserves a mechanistic understanding. Here we 
develop a model of partial and very slow dissolution in the continuous flow system, where a fraction 
of the fluid mass m/ m is exchanged during each time interval. To represent the influence of saturation, 
J(Cwn) is a function that decays to zero at the ion solubility limit, and/ (0) = 1: 
(11) 
Compared to Equation (9), the saturation term in Equation (11) limits the ion concentration, 
where the curve shape of f(C ian) of course depends on substance and medium . Importantly, the flow 
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introduces an additional loss term to the ions (not to the particles, due to the ultrafiltration membrane!), 
leading from Equation (11) to Equation (12): 
dCian dl m ( )2 ( ) m -- = No- - Nol- = 4knR t Nof C- -No l-. dt dt m tan m (12) 
This assumes that the ion concentration is homogeneous in the volume of the flow cell. We can now 
introduce the experimental observation that, for partial and very slow dissolution, the concentration of 
ions Cian does not change over time: d~r = 0, and obtain: 
m 2 
I-No = 4knR(t) Nof(Cian)-
m 
(13) 
Using the notation from MMVF literature SA(t) := 4nR(t) 2 and the volume flow-rate 
V fluid : = m Ip fluid this expression transforms to 
/fluidV = kSA(t) f(Cian)-
m 
Solving fork, and simplifying Cian = JPf~ia, we obtain 
(14) 
(15) 
Hence the measured k is reduced by saturation and is inversely proportional to the SA/V ratio with: 
1 
k ex:. SA;v· (16) 
As a next step, we explored whether this universal relationship applies to partial and very slow 
dissolution of substances other than BaSO4. In total, 15 different flow-through dissolution measurements 
with an increasing flow-rate were conducted and combined within Figure 5. The dissolution rate 
of the quickly dissolving benchmark materials, CuO as well as three different kinds of ZnO were 
compared with moderately soluble Kaolin, Bentonite, BaSO4, and insoluble nanoforms of TiO2 NM105 
and food grade non-nano TiO2 E171. This graph especially shows that there is a significant differen ce 
of the dissolution rate between the quickly dissolving nan oforms of ZnO and CuO and the moderately 
soluble nanomaterials. All quickly dissolving materials exhibited an almost horizontal line in the 
graph which represents a continuous dissolution rate, which is not dependent on the surface area 
of the nanomaterial. Nevertheless, ZnO NMl 10 shows a significantly slower dissolution for cer tain 
flow-rates and therefore high SA(V values must be excluded. The graph shows that even quickly 
dissolving materials such as ZnO can show dissolution rates below 100 ng/cm 2/h if the dissolution 
is tested at SA/V values below 0.1 h/µ m. Howeve r, the plot additionally shows diagonal curves for 
BaSO4 NM220, BaSO4 IRMM381, Kaolin JRC-IRMM385, Kaolin, and Bentonite. 
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Figure 5. Cumulated SA/V plot vs. dissolution rate k [ng/cm 2/h ] of 10 different tested nanomaterials 
in 15 different runs with varying initial masses. The dots of each run are connected through a line 
with each other for visualization purpose only. The family of TiO2 (nano)forms is displayed in green, 
BaSO4 (nano)forms in yellow, CuO in blue, ZnO in shades of orange, and aluminosilicates Bentonite 
and Kaolin in grey. The vertical line displays the optimum SA/V. 
Both materials, ZnO NMl 10 and the surface-treated ZnO NMl 11 exhibited a similar dissolution 
process. Therefore, a significant impact of the hydrophobic triethoxycaprylsilane coating cou ld not 
be observed. Furthermore, Bentonite as well as both Kaolin materials showed a similar dissolution 
behavior with a diagonal line in the SA/V vs. k plot. The comparison of different dissolution rates of 
aluminosilicates depending on the ana lyzed ion is shown in Figure S3. The graphs S3A- C confirm 
the hypothesis that Si dissolves more readily than Al, with a factor of 100 between the respective 
dissolution rates. Therefore, the dissolution of Al is the rate-limiting step in the dissolution kinetics 
of aluminosilicates. 
The two insoluble materials, TIO2 E171 and TiO2 NM105, furthermore show a diagonal slope in 
Figure 5 just like the other partially soluble materials. This behavior is understood and explained 
in the previous mentioned equations. However, when both TiO2 particles were tested at low SA/V 
values below 0.001 hfµm false positive predictivities were observed which are not in agreement with 
observations made in in vivo studies [37], nor other previous dissolution experiments. Therefore, for 
the test, the flow-rate must ne adjusted tp keep SA(V above 0.001 h/µm. The quickly soluble ENMs, 
CuO and ZnO, exhibited horizontal lines within the SA(V against k plot at low SA(V ratios below 
0.001 h/µm. 
Both flow-rate operation modes (fixed and ramped) are compared against each (Figure S4). Here 
similar initial masses of BaSO4 NM220, CuO, ZnO NMll0, and ZnO NMlll were measured for both 
models. The flow-rate ramp with increasing flow increases the spread of the data points more than 
done by the fixed flow. This results in better spread data points of the dissolution. This characteristic 
can be best observed for BaSO4 NM220 in Figure S4A, where a cloud of data points is achieved through 
fixed flow-rate dissolution. 
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4.2. Method 
The modeling was based on the well-known 11shrinking sphere" assumption [34], but added a 
loss term of ion transport through the ultrafiltration membrane of the flow cell, and added a saturation 
limit of ion concentration. The model provided an analytical basis (Equation 16) for the inverse linear 
relationship between k and SA/V that was observed for all materials (BaSO4 (nano and non-nano), TiO2 
(nano and non-nano), Bentonite, Kaolin) as soon as saturation contributes: 
• The model confirms that the prefactor is specific to the solubility limit of the ions in the medium, 
but independent of the size R of the particles. 
• The model confirms that the slope of the inverse relationship to SA/Vis universal for all substances, 
all sizes thereof, and all medium compositions . This aspect is proven here with experimental data 
on pulmonary lysosomal dissolution but is predicted as well for gastro-intestina l dissolution. 
The screening of the different flow-rates within the dynamic flow-through dissolution setup 
with ramped flow-rates shows that flow-rates can be adapted in order to optimize the predictivity of 
the dissolution of nanomaterials. The advancements of the ramped flow-rate compared to the fixed 
flow-rate are clearly visible for BaSO4 NM220 (Figure S4A). Here the fixed flow-rate leads to a cloud of 
datapoints, whereas through the ramped flow the datapoints are more widespread, which leads to a 
better understanding of the dissolution mechanism. This observation was also made for both ZnO 
NMll0 and NMlll. Especially for these two quickly dissolving materials, an improvement of the 
datapoints could be achieved. Nevertheless, this increase is not as significant for the fast dissolving 
ENM CuO (Figure S4B). 
The aim of this setup was to match the dissolution rate of nanomaterials with the clearance 
measured within in vivo systems. Thus, through increasing or decreasing the flow-rate by a factor of 
100 the dissolution kinetics can be matched with the clearance in the rat lung. Though we observed 
false predictivities for some flow-rates (Figure 5), there were some flow-rates which led to a slower 
dissolution for ZnO nanoparticles but furthermore also to an increased dissolution of TIO2. These 
false predictivities can be excluded by sticking to a certain SA/V range between 0.01 and 0.03 h/µm. 
Within this SA/V range (Figure 5), the predicted biodissolution matches existing in vivo expectations: 
ZnO is cleared from lungs within days, whereas clearance of TiO2 is dominated by physical transport, 
not by dissolution [14,22,28]. For BaSO4 NM220, the relatively fast in vivo clearance with halftime 
of 9.6 days was attributed to partial dissolution with 11.1 days halftime [23,50]. With the BET of 
NM220, this halftime corresponds to k = 6.3 ng/cm2/h, which is obtained at SA/V = 0.02 h/µm (Figure 5). 
We thus recommend the SA/V range of 0.01--0.03 hjµm for optima l predi ctivity of biopersistence under 
pulmonary lysosomal conditions. This value is consistent with all ben chmark materials . 
However, based on the results seen in Figure 2, the ramp with decreasing flow-rate is not suitable 
for quickly dissolving materials and of limited reliability for the case of partially dissolving materials 
such as both BaSO4 (nano)forms . 
Even though the flow-through system is an advanced system for the analysis of the dissolution 
of nanomaterials there are still some drawbacks which could not be fixed until now. One of the 
major reasons of measurement uncertainties of quickly dissolving ENMs is the void volume of the 
flow-through cell. The cell consists of three different stages which are separated from each other 
through two 5 kDa membranes, the dissolution happens in stage two, where the medium interacts with 
the ENM. After dissolution the ions penetrate the membrane into stage three and are then transported 
away and samp led into vials. However, the first 3 mL of the measurement that are sampled into the 
vials are part of the void volume of the system and did not interacted with the nanomaterials yet. 
Therefore, these measurements can be discarded. Thus, in order to minimize errors, only samples after 
at least a volume exchange by a factor of two are used for calculations. 
Another reason for uncertainty arises from the interpolation of the remaining solids. Even 
though we created two different calculation systems for the dissolution process ("shrinking spheres" 
and "vanishing particles") the dissolution of an ENM cannot fully be described by either one of 
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4.2. Method 
The modeling was based on the well-known "shrinking sphere" assumption [34], but added a 
loss term of ion transport through the ultrafiltration membrane of the flow cell, and added a saturation 
limit of ion concentration . The model provided an analytical basis (Equation 16) for the inverse linear 
relationship between k and SA(V that was observed for all materials (BaSO4 (nano and non-nano), TiO2 
(nano and non-nano), Bentonite, Kaolin) as soon as saturation contributes: 
• The model confirms that the prefa ctor is specific to the solubility limit of the ions in the medium, 
but independent of the size R of the particles . 
• The model confirms that the slope of the inverse relationship to SA(V is universal for all substances, 
all sizes thereof, and all medium compositions. This aspect is proven here with experimental data 
on pulmonary lysosomal dissolution but is predicted as well for gastro-intestinal dissolution. 
The screening of the different flow-rates within the dynamic flow-through dissolution setup 
with ramped flow-rates shows that flow-rates can be adapted in order to optimize the predi ctivity of 
the dissolution of nanomaterials. The advancements of the ramped flow-rate compared to the fixed 
flow-rate are clearly visible for BaSO4 NM220 (Figure S4A). Here the fixed flow-rate leads to a cloud of 
data points, whereas through the ramped flow the datapoints are more widespread, which leads to a 
better understanding of the dissolution me chanism . This observation was also made for both ZnO 
NMl 10 and NMl 11. Especially for these two quickly dissolving materials , an improvement of the 
data points could be achieved. Nevertheless, this increase is not as significant for the fast dissolving 
ENM CuO (Figure S4B). 
The aim of this setup was to match the dissoluti on rate of nan oma terials with the clearance 
measured within in vivo systems . Thus, through increasing or decreasing the flow-rate by a factor of 
100 the dissolution kinetics can be matched with the clearance in the rat lung . Though we observed 
false predictivities for some flow-rates (Figure 5), there were some flow-rates which led to a slower 
dissolution for ZnO nanoparticles but furthermore also to an increased dissolution of TIO2. These 
false predictivities can be excluded by sticking to a certain SA/V range between 0.01 and 0.03 h/µm. 
Within this SA(V range (Figure 5), the predicted biodissolution matches existing in vivo expectations: 
ZnO is cleared from lungs within days, whereas clearance of TiO2 is dominated by physi cal transport, 
not by dissolution [14,22,28]. For BaSO4 NM220, the relatively fast in vivo clearance with halftime 
of 9.6 days was attributed to partial dissolution with 11.1 days halftime [23,50]. With the BET of 
NM220, this halftime correspo nds to k = 6.3 nglcm2/h, which is obta ined at SA(V = 0.02 h/ µm (Figure 5). 
We thus recommend the SA(V range of 0.01--0.03 h/µm for optimal predictivity of biopersisten ce under 
pulmonary lysosomal conditions. This value is consistent with all benchmark materials. 
However, based on the results seen in Figure 2, the ramp with decreasing flow-rate is not suitable 
for quickly dissolving materials and of limited reliability for the case of partially dissolving materials 
such as both BaSO4 (nano)forms. 
Even though the flow-through system is an advanced system for the analysis of the dissolution 
of nanomaterials there are still some drawbacks which could not be fixed until now . One of the 
major reasons of measurement un cer tainties of quickly dissolving ENMs is the void volume of the 
flow-through cell. The cell consists of three different stages which are separated from each other 
through two 5 kDa membranes, the dissoluti on happens in stage two, where the medium interacts with 
the ENM. After dissolution the ions penetrate the membrane into stage three and are then transported 
away and samp led into vials. However, the first 3 mL of the measurem ent that are sampled into the 
vials are part of the void volume of the system and did not interacted with the nanomaterials yet. 
Therefore, these measurements can be discarded. Thus, in order to minimize errors, only samples after 
at least a volume exchange by a factor of two are used for calculati ons . 
Another reason for un certainty arises from the interpolation of the remaining solids. Even 
though we created two different calculation systems for the dissolution process ("shrinking spheres" 
and "va nishing particles") the dissolution of an ENM cannot fully be described by either one of 
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these processes but might also be influenced by a combination of both scenarios. This calculation 
influences both the dissolution rate as well as the remaining mass. With decreasing remaining solid 
and increasing flow-rate the dissolution-rate, k increases significantly. This increase does not represent 
the median dissolution-rate and is often 2-4 times higher. Therefore, values with soluble ENMs with 
less than 10% remaining solid at any point in time were discarded and neither used for plots nor for 
further calculations. 
5. Conclusions 
Ramping the flow-rate is a promising approach to expand the range of regular out-of-equilibrium 
flow-through dissolution to nearly five orders of magnitude of the decisive parameter SA/V, which is 
the ratio of surface area and volume flow. This is especially relevant for slowly or partially dissolving 
ENM where the dissolution can be limited by saturation conditions. A model predicted a universal 
scaling of dissolution rates with SA/V and was confirmed by data on ENM dissolving to Al, Zn, Cu, 
Ba, Ti ions. The ramping allows the operator to investigate the dissolution properties within one 
single run and one initial mass which usually needs two to three different masses to fully describe 
the dissolution . The ramp with increasing flow-rate is useful as a screening tool for quickly dissolving 
ENMs because the wide range of flow-rates produces more relevant data points before complete 
dissolution compared to flow-through dissolution with fixed flow. The proposed benchmark materials 
for quick dissolution under acidic condition s-C uO, ZnO NMl 10- and the benchmark for very slow 
dissolution - TiO2 E171 and NM105-are confirmed as suitable benchmark materials, and are decisive 
to identify appropriate ranges of fluid flow velocities (V) and SA/V ratios: Extremes of SA/V below 
0.001 hjµm or above 0.1 h/µm are excluded by the calibration of the predicted biopersistence against the 
in vivo observed pulmonary biopersistence. The additional case of the partially dissolving material, 
BaSO4, allowed us to recommend the range 0.01- 0.03 h/µm for optimal predictivity of biopersistence 
under pulmonary lysosomal conditions. 
For the cases studied here, TiO2 and BaSO4, the nanoform and the non-nanoform had the same 
dissolution rate normalized to the specific surface area. For Kaolin, different nanoforms of the same 
substance had the same dissolution rate. For all aluminosilicates, significantly faster leaching of Si 
than of Al was observed, leading to the prediction of crystalline structure transformation, and faster 
release of ions from Bentonite than from Kaolin. The diagonal, in the k vs (SA/V) plot, as reported 
earlier for BaSO4 NM220 [SO], is not a unique phenomenon but is observed for all materials with partial 
dissolution limited by local ion solubility limits, even for (nano)forms of TiO2. The specific rates of the 
BaSO4 NM220 nanoform were also observed for the non-nanoform BaSO4 IRMM381. The dissolution 
of both materials is therefore governed by the same mechanism and by the same solubility limit. 
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BaSO4 NM220, B CuO, C ZnO NMll0, and D ZnO NMlll. Unfilled circles indicate points with low reliability 
due to remaining mass <10%. 
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3.1.6 Dosimetry in vitro – exploring the sensitivity of deposited dose predictions vs. 
affinity, polydispersity, freeze-thawing, and analytical methods. 
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Dose-response by in vitro testing is only valid if the fraction of the particle dose that deposits onto adherent 
cells is known. Modeling tools such as the ‘distorted grid’ (DG) code are common practices to predict that 
fraction. As another challenge, workflow efficiency depends on parallelized 
sample preparation, for which freeze-thaw protocols have been explored earlier, but not their implications on 
dosimetry. Here we assess the sensitivity of the DG code toward freeze thaw protocols and variations in user-
defined parameters, including the estimation of particle cell affinity and determination of agglomerate size, 
which we measure by DLS or AUC. We challenge the sensitivity by materials of varying composition, 
surface functionalization, and size (TiO2, CeO2, BaSO4, 2x Ag, 3x SiO2). We found that the average 
effective density is robust, but the dose predictions by different approaches varied typically 2-fold and up to 
10-fold; this uncertainty translates directly into the uncertainty of no-effect-concentrations. The use of 
standardized dispersion protocols increases the uncertainty in doses. The choice of a measurement method 
and minor details of the particle size distribution strongly influence the modeled dosimetry. Uncertainty is 
high for very well dispersed nanomaterials; since then, the assumed affinity of particles to cells has a decisive 
influence. Against this background, the modulation of deposited dose by freeze-thaw protocols is a minor 
factor that can be controlled by aligning the protocols of sample preparation. However, even then, the 
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ABSTRACT 
Dose-response by in vitro testing is only valid if the fraction of the particle dose that deposits 
onto adherent cells is known . Modeling tools such as the 'distorted grid ' (DG) code are common 
practices to predict that fraction . As another challenge, workflow effici ency depends on parallel-
ized sample preparation , for which freeze-thaw protocols have been explor ed earlier, but not 
their implications on dosim etry. Here we assess the sensitivity of the DG code toward freeze-
thaw protocols and variations in user-defined paramet ers, including th e estimation of particle-
cell affinity and determin ation of agglomerate size, which we measure by DLS or AUC. We chal-
lenge th e sensitivity by materials of varying composition, surface functionalization, and size 
(TiO2, CeO2, BaSO4, 2x Ag, 3x SiO:i). We found that the average effective density is robust , but 
the dose predictions by different approaches varied typically 2-fold and up to 10-fold ; this 
uncertainty translates directly into the uncertainty of no-effect-conc entrations . The use of stand-
ardized dispersion protocol s increases th e uncertainty in doses. The choice of a measurement 
method and minor details of th e particle size distribution strongly influence the modeled dosim-
etry . Uncertainty is high for very well dispersed nanomaterials ; since th en, the assumed affinity 
of particles to cells has a decisive influence . Against this background, the modulation of depos-
ited dose by freeze-thaw protocols is a minor factor that can be controlled by aligning the pro-
tocols of sample preparation . However , even then , th e uncertainty of deposited doses must be 
considered when comparing the in vitro toxicity of different nanomaterials . 
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As the demand for consumer products for daily life 
increases, the need for materials with advanced 
functionalities has continuosly been growing. These 
functionalities have resulted in improvements in a 
plethora of sectors, whether better color contrast in 
1V screens through core-shell quantum dots, 
sunscreens that use titanium oxide nanoparticles to 
be effective and yet transparent longer-lasting coat-
ings (Stark et al. 2015; Wohlleben, Kingston, et al. 
2017). These advances hold the use of nanomateri-
als at their core, and the production volumes of 
these engineered nanomaterials (ENM) represent a 
substantial share of the total production volume 
(Ministere de !'Environnement 2015; Wigger, 
Wohlleben, and Nowack 2018). Until recently , risk 
assessment of nanomaterials has been based on 
the risk assessment of the bulk material in question, 
whereas adapted methods are required to ensure 
that potential unique behaviors of nanoforms do 
not occur unnoticed (Donaldson and Poland 2013). 
Furthermore, traditional methods of regulatory toxi-
cology testing have heavily relied on in vivo experi-
ments. The sheer number of nanoforms makes 
in vivo testing of every material an untenable pro-
spect, logistically and ethically. Recent REACH regu-
lation, which was enacted in the European Union 
from January 2020, mandates that all entities pro-
ducing nanomaterials register these as nanoforms 
of the substance and demonstrate their safe use 
CONTACT Wendel Wohlleben Q wendel.wohlleben@basf.com ~ Department of Material Physics and Department of Experimental Toxicology and 
Ecology, BASF SE, Ludwigshafen 67056, Germany 
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(ECHA 2017; European Commission 2018). Thus, 
advances in the standardization of in vitro testing 
methods for the hazard assessment of ENM are 
needed to support grouping and read-across and 
thus build efficient regulatory frameworks (Oomen 
et al. 2018; Oomen et al. 2015; Arts et al. 2016; Arts 
et al. 2015; Wohlleben, Coleman, et al. 2019). 
Alternative testing methods to investigate the 
hazard potential of ENMs are currently under devel-
opment, based on several design requirements. 
First, they must be valid and robust. Second, they 
should be more straightforward and less expensive 
than current methods. Third, due to the large num-
ber of ENMs that need to be tested, it should be 
possible to test samples in parallel and thus 
increase the throughput. 
A freeze-thaw protocol addresses the second and 
third requirements. Freeze-thawing would enable 
samples prepared by the NANoREG sample prepar-
ation protocol with extended sonication to be run 
in parallel, which is more efficient than running 
multiple sonications, dynamic light scattering (DLS), 
and effective dose setups in parallel. In a recent 
publication by Vila et al., a freeze-thaw protocol to 
enable the parallel testing of different nanomateri-
als (NMs) was introduced. However, research needs 
were identified regarding potential variations in the 
effective density and dosimetry with the new 
freeze-thaw protocol (Vila et al. 201 7). 
The goal of dosimetry modeling is to use physi-
cochemical characteristics to predict the fraction of 
total dosed particles seen by cells. Only particles 
that accumulate at the cell's surface contribute to 
the effective dose . When ENMs or their agglomer-
ates come into spatial vicinity to the cell's surface, 
they may be repelled, in which case they are not 
likely to induce a cellular response, or they may 
stick to the cell's surface, which builds up the dose 
that reaches the cells, and as such is a prerequisite 
of internalization (Liu et al. 2012). The surface affin-
ity and stickiness can be calculated in principle 
(Wohlleben, Punckt, et al. 2017; Chen et al. 2014; 
Xia, Monteiro-Riviere , and Riviere 201 O), but in 
in vitro settings, EN Ms can have significant interac-
tions with biological media, unlike what is observed 
in small molecule-based systems. Unique ENM 
behaviors include the formation of a protein corona 
as well as particle dissolution, leading to changing 
settling and diffusion profiles. The properties of 
these ENM behaviors are dependent on environ-
mental factors such as temperature, media compos-
ition, media viscosity, and pH. A model which 
considers the different physical theories that govern 
diffusion and sedimentation, and allows for com-
plex data inputs such as size distributions and 
effective densities, would give a toxicologist with 
access to a characterization library the ability to 
consider ENM complexity allowing them to design 
experiments that produce relevant, accurate and 
translatable results. These type of in vitro dosimetry 
models have been under development for the past 
decade, with the field advanced significantly by the 
work of the Teeguarden and the Demokritou 
groups, who developed the In vitro Sedimentation, 
Diffusion and Dosimetry (ISSD) and Distorted Grid 
(DG) models of in vitro nanomaterial dosimetry, 
respectively (Teeguarden et al. 2007; Uson et al. 
2008; Deloid et al. 2015; Deloid , Cohen, et al. 2017; 
Deloid et al. 2014). However, the relevance of par-
ticle transport has also been questioned since fluid 
movement might dominate the transport in reality 
(Uson et al. 2008). Specifically, the DG model is an 
advanced MATLAB-based model that considers add-
itional variables, such as size distribution, as well as 
different behaviors and boundary conditions, such 
as diffusion, sticky and non-sticky bottoms, particle 
size distributions, and effective density. 
Here we assess the sensitivity of the distorted 
grid (DG) code toward freeze-thaw protocols and 
variations in user-defined parameters, including an 
estimation of particle affinity and an approximation 
of the polydisperse colloidal properties, for which 
we employ either DLS or AUC measurements. We 
challenge the sensitivity by materials of varying 
composition, surface functionalization, and size 
(TiO2, CeO2, BaSO4, 2x Ag, 3x SiO2). Our results shall 
support modeling in silica how the materials will 
behave in vitro. These results can ultimately guide 
the decision of whether a particular ENM needs 
additional testing in vivo. 
Materials and methods 
In total, eight different engineered nanomaterials 
were selected, which represent a variety of indus-
trial applied ENMs. These ENMs are used as pig-
ments, polishing agents for silicon wafers, catalytic 
additives in fuels, and fillers in the paint. TiO2 
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Sonicate following 
NANoREG protocol 
---- • Flash Freeze and store at ~BOC • 
Fresh Sample 
Takes 1 week to study: 
9 samples 
Measurement in series 
Flash Frozen Sample 
Takes 1 week to study: 
18 samples 
Measurement In parallel 
Dosimetry Data 
Model in silica using DG 
and AUC models 
Measure primary dispers ion size (DLS) l Dilute in cell media 
Characterize (DLS, VCM , AUC) 
Figure 1. Schematic summary of the workflow design. Including sample dispersion in the first step, with the sonication follow ing 
the NANoREG protocol followed by either direct DLS, VCM, and AUC measurement or after flash freezing at - 80 °C. With a con-
secutive analysis of the dosimetry data. 
NM-105 (21 nm), CeO2 NM-212 (40 nm), BaSO4 NM-
220 (32 nm), Ag NM-300k, and Ag NM-302 were 
provided as part of the OECD sponsorship program 
by the Joint Research Center (JRC) with the pristine 
median diameter given in brackets (Rasmussen et 
al. 2014). Amorphous SiO2 (8.8 nm) was provided by 
the Leibniz Research Institute for Environmental 
Medicine (IUF), Dusseldorf, Germany. Sigma_Ag 
(27.6 nm) was purchased from Sigma-Aldrich Inc. 
576832-5 G (Sigma Aldrich Inc., St. Louis, MO). SiO2 
DQl 2 (111.6 nm) was produced for the PATROLS 
project and provided by the Institute for 
Occupational Medicine (IOM, Edinburgh, United 
Kingdom) . All median diameters given in brackets 
were determined through transmission electron 
microscopy (TEM) with an FEI Tecnai F20 at an 
acceleration voltage of 200 kV (Figures S3). 
The approach taken in this set of experiments 
almost entirely relied on the Standard Operating 
Procedures (SOPs) optimized by the NANoREG pro-
ject (Jensen et al. 2011 ), along with selected recom-
mendations on settings for the DG model given by 
Delcid, Wang, et al. (2017) for the preparation of 
stock suspensions, followed by flash freezing treat-
ment (Figure 1; Vila et al. 2017). 
The goal was to use the SOP as a basis to build 
a workflow easy to replicate, providing reproducible 
results, and easy for partners to replicate (Figure 1 ). 
Any deviations from the SOP were noted . 
In summary, each material was weighed out to 
make 6 ml of a stock dispersion with a concentra-
tion of 2.56 mg/ml in 99.5 vol% sterile-filtered BSA-
water (0.05% w/v ), 0.5 vol% EtOH (96% pure; Jensen 
et al. 2011 ). BSA works as stabilization and dispers-
ing agent and helps to increase the dispersibility of 
the stock dispersion. EtOH enables the handling of 
hydrophobic materials. Each ENM was weighed out 
to be as close as possible to a total mass of 
15.36 mg and placed in 30 ml Scint- Burk glass vials. 
The vials had the same diameter as those recom-
mended by the NANoREG protocol and differed 
only in height, leading to an increased volume cap-
acity. Subsequently, the material was prewetted by 
the appropriate EtOH volume , followed by the add-
ition of BSA-water, taking care to wash down the 
sides of the vial for material recovery. The BSA-
water was prepared by first creating a 1% BSA-stock 
solution and then further dilute it with Millipore 
water to a total concentration of 0.05% (Jensen 
et al. 2011 ). 
NM-300K, NM-302, and Sigma Ag were all 
weighed out under argon atmosphere and stored 
under argon. NM-402 was weighed out using add-
itional precautions : the weighing out was 
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conducted in a hood specialized for Carbon 
Nano Tube (CNn use, using gloves and a 3M Aura 
Disposable Respirator (3M ID GT500073132, 3M 
Maplewood, NJ). All other materials were weighed 
out using a separate calibrated scale. 
A Branson 550 probe sonicator equipped with a 
3 mm tip was used for dispersion. The sonicator 
was calibrated following the SOP to deliver 7.35 W 
of critical sonication energy to each sample. All 
materials were sonicated for 16 min to create 6 ml 
of nanoparticle stock dispersion with a concentra-
tion of 2.56 mg/ml. For dispersions, care was taken 
to ensure that the tip of the sonicator was consist-
ently submerged to a similar depth across samples, 
between the upper quarter and upper half of the 
volume. All dispersions were submerged in an ice-
water bath during sonication. Between samples, the 
tip of the sonicator was washed by sonication for 
5 min in a 50:50 EtOH:DI H20 solution, followed by 
rinsing by EtOH and air drying to prevent cross-
contamination. 
Within 5 min following sonication, the particle 
dispersion was aliquoted into 1.5 ml microcentri-
fuge tubes (Eppendorf, 0030 120.191, Eppendorf 
AG, Hamburg, Germany) and flash-frozen in liquid 
nitrogen (LN2; Vila et al. 2017). The tubes were pre-
prepared by puncturing the cap with a small hole 
to prevent decompression at low temperatures. 
Cryo-protective gear, namely gloves and long twee -
zers were used to protect the user, and all work 
was done in a chemical hood. The tubes were kept 
in LN2 for at least 2 min and then placed in long 
term storage at - 80 °C. Our facilities did not have 
the standard - 80 °C freezers, and thus, we stored 
samples in dry ice (- 78.5 °(), which is considered 
an insignificant difference against the original 
protocol by Vila et al. 
After flash freezing, each aliquot was thawed as 
needed. This was done by placing each aliquot in a 
hot (~ 65 °C) bath sonicator for 1 min, or until a 
small ice core was left in the tube. Immediately fol-
lowing thawing, the ENM suspensions were diluted 
1 Ox in water (primary particles) and in cell media, 
with either Dulbecco Modified Eagle Medium 
(31053028, Gibco™, Thermo Fisher Scientific, 
Waltham, USA) + 10% Fetal Bovine Serum, 
(10500056, Gibco™ Thermo Fisher Scientific, 
Waltham, MA) + 1 % Minimal Essential Medium 
(11140068, Gibco ™, Thermo Fisher Scientific, 
Waltham, MA) + 1 % Penicillin/Streptomycin 1 OOx 
(15140122, Gibco™, Thermo Fisher Scientific, 
Waltham, USA) or RPMI (Rosewell Park Memorial 
Institute) (11835030, Gibco™, Thermo Fisher 
Scientific, Waltham, MA), once incubated for one 
hour at 37 °C. After the incubation , the samples 
were characterized using one of three techniques: 
dynamic light scattering (DLS), volumetric centrifu -
gation method (VCM,) or analytical ultracentrifuga-
tion (AUC); each particle type was processed and 
characterized in independent triplicates . 
Volumetric centrifugation method (VCMJ 
The effective densities of the ENMs dispersed in cell 
media were measured as previously described by 
Deloid et al. (2014). Briefly, after incubation at 
37 °C, 1 ml of sample was loaded into VCM tubes 
(87007, TPP Techno Plastic Products AG, 
Trasadingen, Switzerland) and centrifuged for one 
hour at 3000-G, unless otherwise detailed. After 
centrifugation, the volume of the pelleted ENMs 
was measured using a VCM 'easy read' measuring 
device (87010, TPP Techno Plastic Products AG, 
Trasadingen, Switzerland). The effective densities 
were then calculated using the equations described 
by Deloid et al. (2014). 
Dynamic light scattering (DLSJ 
Flash-frozen samples are rapidly thawed in a 65 °C 
bath sonicator until no ice crystals were left in the 
sample and diluted 1 Ox in the testing medium. 
Hydrodynamic size distributions of pristine and cell 
media dispersions were measured using Dynamic 
Light Scattering (DLS) using a Malvern Zetasizer 
ZEN1600 (Malvern Panalytical Ltd . Malvern, UK). 
Instrument settings were set as dictated by the 
NANoREG SOP. 
Analytical ultracentrifugation (AUCJ 
AUC implements an optical system synchronized 
with the centrifugal frequency to monitor the radial 
concentration profile during centrifugal separation. 
The samples were directly loaded in AUC cells with-
out further preparation. All measurements were 
done on a Beckman Coulter XLI Proteome Lab 
(Beckman Coulter Inc., Brea, CA). The cells were all 
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mounted on a 4-sample or 8-sample titanium rotor 
at 1000 rpm for 30 min, followed by 3000 rpm for 
30 min and 12,000 rpm for two hours. The samples 
were measured using either interference or absorb-
ance optics to detect sedimentation, as described 
by the NanoDefine project (Mehn et al. 2018). Both 
types of sedimentation data were evaluated with 
sedfit vl 5.0 software. 
Dosimetry by AUC sedimentation driven transport 
The raw sedimentation coefficients measured by 
AUC, as fitted by sedfit software, do not require any 
assumptions about particle size, density, or compos-
ition. Instead, the measured distribution of sedi-
mentation coefficients can be directly used to 
calculate the deposited dose. The AUC sedimenta-
tion coefficients are converted into delivered doses 
by integrating the sedimentation-driven transport 
to this model the deposited dose by a method that 
was already described in the literature (Sauer et al. 
2015; Wohlleben, Coleman, et al. 2019). The deliv-
ered doses measured by AUC and calculated by 
sedimentation-driven transport model were com -
pared with those calculated by the Distorted Grid in 
silico model. 
Dosimetry by DG in silico model 
The principle of DG modeling relies on successive 
modeling of diffusion and sedimentation based on 
the media height , with variable heights of the sub-
compartment from run to run, and the particle size 
distribution . The iterative modeling also accounts 
for the stickiness of the bottom of the wells, which 
can be tuned accordingly. The model results are 
given as delivered ENM mass. The particle number 
dictates the probability of particle -particle collisions 
but is not a conserved metric when particles 
agglomerate. 
If using AUC as an input of size distributions, the 
AUC sedimentation coefficient was first converted 
to size distribution using (a) the skeletal density of 
each material, (b) the fractal dimension, or (c) the 
effective density , for use as input data for the 
Distorted Grid model. This procedure is described in 
Wohlleben (2012). If using DLS as an input of size 
distributions, triplicate DLS measurements were 
averaged. In either case, VCM triplicate data were 
NANOTOXICOLOGY @ S 
Table 1. DLS hydrodynamic diameter size (z-average) and 
effective density of primary dispersion (H20 ) and after 1-h 
incubation in the medium after freeze-thawing. The medium 
was DMEM/FBS as specified in methods. 
z-Avera ge {nm ± o) 
Effective Density 
{g/ cm' ±o) 
ENM Wat er Medium Medium 
TiO2 NM-l0 S 274.9 ± 46.4 287.7 ±42.8 1.408 ± 0.009 
CeO2 NM-212 281.0 ± 18.9 242.6 ± 2.6 2.214 ± 0.029 
BaSO4 NM-220 176.4 ± 37.9 151.1 ± 27.5 2.034 ± 0.049 
Ag NM-300K 135. 1 ± 3.8 92.7 ± 14.7 2.004 ± 0.153 
Ag NM-302 1104.0 ± 114.6 1027.4 ± 44.0 8.617 ± 0.181 
Amorp hous SiO2 230.8 ± 26.8 1169.1 ± 155.2 1.156 ± 0.013 
Sigm a Ag 195.1 ±5.5 163.0 ± 2.7 2.465 ± 0.093 
DQ12 47 1.0 ± 19.7 402.4 ±44. 1 1.787±0.000 
averaged and used as input data for the Distorted 
Grid (DG) model developed by (Delcid et al. 2015; 
Deloid, Wang, et al. 2017). The model provided by 
Deloid et al. was run using an auxiliary MATLAB 
macro written to allow for data input using 
Microsoft Excel and batch processing multiple 
materials and conditions . The modified MATLAB 
code, auxiliary macro, and associated templates are 
available by request. The adjustable parameters 
used for the modeling are listed in Table S 1, and 
the resulting effective densities are reported in 
Table 1. 
Results 
Effects of flash freezing of ENM characteristics on 
dosimetry prediction by DG compared to freshly 
prepared samples 
To see how flash-freezing would affect dosimetry 
modeling, we compared fresh and flash-frozen dis-
persions of three ENMS: CeO2 NM-212, Ba5O4 NM-
220, and Amorphous SiO2. The particles were dis-
persed and then either immediately characterized 
or flash-frozen . Flash-frozen samples were thawed 
out after one week of storage at - 78.5 °( and then 
characterized. 
As seen in Figure 2, we found that while there 
were no large differences in the z-averages between 
the fresh samples and the flash-frozen samples 
(both for primary and 1-h media incubation sam-
ples, Table 1, there were differences in the hydro-
dynamic diameter size distributions. As shown in 
Figure 3, while the main effect seen in some materi-
als, such as CeO2 NM-212, was a small increase in 
the overall diameter , other materials developed a 
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Figure 2. Effect of fresh sample vs. flash freeze-thawing on the deposited dose of samples on A BaSO4 NM220, B CeO2 NM212, 
and C Amorphous SiO2. For A and B the lower curve indicates the fresh sample, whereas the upper curve indicates the sample 
prepared after the freeze-thawing protocol. For C the upper curve is the fresh sample, whereas the lower curve represents the 
sample prepared after the freeze-thawing protocol. 
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Figure 3. Effect of fresh sample vs. flash freeze-thawing on the hydrodynamic diameter on A BaSO4 NM-220, B CeO2 NM-212, 
and C Amorphous SiO2• Compared to the freeze-thawing protocol (blue in the onl ine pdf), the fresh sample (red in the online 
pdf) has lower deposited fraction in (A,B), but higher deposited fraction in (C). 
multimodal size distribution due to agglomeration. 
As shown in Table S2, the change in particle size 
distributions translated to large differences in some 
of the materials, with increases of 61.7, 50.3, and 
82.5 nm for CeO2 NM-212, BaSO4 NM-220, and 
Amorphous SiO2, respectively. Surprisingly, we 
found that effective density was much more resist-
ant to freezing-induced changes and found no dif-
ferences between fresh and flash-frozen samples. 
We compared the z-average after flash freezing in 
different media such as DMEM and RPMI media 
(Table S2). The data clearly shows that the differ-
ence between fresh and flash-freezing was more 
significant for RPMI than for DMEM/FBS. 
To investigate how the observed physiochemica l 
changes would affect dosimetry, the deposition of 
particles with and without flash freezing was mod-
eled using the DG mode l as described in the meth-
ods section. The deposited dose after 24 h was 
modeled for specific nanomaterials at a 
concentration of 0.256 mg/ml with reflective 
boundary conditions. 
Variability between triplicates 
Variability between different dispersions of the 
same material affected the DG modeling results in 
different magnitudes, depending on the material 
analyzed. Certain materials, such as NM-212, 
showed considerable variability in percent-depos-
ited after 24 h (Figure 4(8)). Other materials, such as 
NM-220 and Sigma Ag, showed much less variabi lity 
in the range of 7- 14% (Figure 4(A, C)). 
Quantitative differences between different 
thermodynamic boundary conditions 
The DG model has built into its capability to simu-
late different levels of 'stickiness' between nanopar-
ticles and the bottom of the well. Only exceptional 
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Figure 4. Variability of tripl icate sample preparation affects dosimetry modeling. DG model over 24 h for three materials: A BaSO4 
NM-220, B CeO2 NM-212, and C Sigma Ag. The model was set up to use the appropr iate variables for each material, with the 
only difference between each simulat ion being a different nanoparticle size distribution, as acquired by DLS, and different effect-
ive densities, measured using VCM .. 
Table 2. The fract ion of deposited dose after 24 h (%). 
Measured 
DG prediction (sedimentation 
transport only) x-Fold spread of all 
DLS input, DLS input, Adhesive AUC input, Adhesive AUC integration of approaches to 
Reflective Boundary Boundary sedimentation determine the 
Boundary (Kd = 1 x 10- 9 M) (Kd = 1 X 10- 9 M) coefficients deposited dose 
[% deposited dose after 24 hi 
Amorphous SiO2 73.57 74.77 56.0 60.50 1.3 
DQ12 49.02 60.64 30.88 68.67 2.2 
TiO2 NM-105 18.53 25.69 20.80 42.67 2.3 
CeO2 NM-212 4433 54.97 40.98 42.00 1.3 
BaSO4NM-220 9.05 23.67 1.9 15.33 12 
Ag NM-300K 31.93 41.81 17.02 2.5 
Ag Sigma 22.17 38.25 3.74 14.67 10 
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Figure 5. Assumptions on boundary condit ion simulations into the DG model can affect the predictions. We examined this by 
modeling deposition over 24 h in three materials: A BaSO4 NM-220, B, CeO2 NM-212and C Sigma Ag, and varying the boundary 
conditions. Here, the red curves correspond to a Kd (M) = 1 x 109, blue corresponds to Kd (M) = 1 x 108• and the yellow curve 
corresponds to no boundary condit ions, resulting in a reflective bottom . 
cases of nano-pharmaceutical carriers have well-
defined, targeted cellular interaction (Brenner et al. 
2018). Varying stickiness allows the model to 
account for the different ENM uptake rates based 
upon cell type. The method used to model this 
stickiness is described in the original publication for 
the DG model (Deloid et al. 2015; Deloid, Wang, 
et al. 2017). Briefly, stickiness is simulated using a 
Langmuir-isotherm adsorption process, where the 
particles are adsorbed and desorbed to the bottom 
of the well. Once adsorbed, the particles are 
removed from the system until desorbed . Once the 
stickiness is included, it is defined by ascribing an 
association constant, Kd, to the nanoparticles. Kd is 
assumed to be specific to each experimental condi-
tion and is not well understood, but it is thought to 
be cell-, ENM-, and media-dependent. Decreasing Kd 
will lead to higher particle adsorption to the 
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bottom of the well. We studied how significantly 
stickiness would affect dosimetry based upon 
experimental data (Table 2). We simulated dosim-
etry in the DG model over a 24-h period using 
three different materials. Each material was simu-
lated as described previously, with the boundary 
being either reflective (adsorption turned off), low-
adhesion (Kd = 1 x 10- 8), or high-adhesion (Kd = 
1 x 1 o- 9). The Kd values were chosen following the 
work done initially by (Deloid et al. 2015). Specific 
values (Figure 5 and Table 2) highlight that simula -
tions can differ by as much as 29.52% for Ag NM-
302, 14% for BaSO4 NM220, or as low as 1.2% for 
Amorphous SiO2. 
Quantitative differences between different 
methods used to provide a size distribution 
for modeling 
Since the measured polydispersity of the size distribu -
tion was critical for the DG predictions, we explored 
the model 's sensitivity to different methods of deter-
mining the size distribution . DLS is very reliable on 
the z-average diameter, but less so on the complete 
distribution . Fractionating methods instead have the 
advantage of quantification of few-percentage frac-
tions of agglomerates or individual constituent par-
ticles. Here we compare DLS to AUC size distributions, 
evaluated with the independently measured effective 
density, and find that the parity plot between AUC 
and DLS has a slope far below parity, indicating that 
the DLS differentiates the median size between differ-
ent ENMs less than AUC (Figure 6). 
The particle size distribution (PSD) from DLS vs. 
AUC with Dr can be seen in Figure 7. Here the PSD is 
shown for both silica-based materials, SiO2 amorphous 
and crystalline B DQl 2. The figure demonstrates the 
different particle size assumptions, based on the 
measurement method, which would strongly affect 
the deposited dose (Figure S2). We then employed 
the size distributions from AUC in the DG model and 
found (Table 2) significant differences in a deposited 
dose, which can be related to the differences in PSD. 
Discussion 
Flash freezing vs. fresh dosimetry measurements 
The NANoREG Protocol was developed as a stand -
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Figure 6. Parity plot of the mass median particle diameter 
with different density assumptions for AUC and DLS measure-
ments for Amorphous SiO2, DQ12, TiO2 NM105, CeO2 NM212, 
Ba5O4 NM220, Ag NM300K, and Ag Sigma. The solid red line 
corresponds to the DLS measurement. The red dashed line 
connecting the blue dots with a red outer shell corresponds 
to the AUC fractal dimension evaluation with D = 2.54. The 
green dashed line connecting the blue dots with a green 
outer shell corresponds to the AUC fractal dimension evalu-
ation with D = 2.1. The yellow dashed line connects the blue 
points with the yellow sphere and describes the AUC solid 
sphere evaluation with D = 3. Linear regression was used for 
the fits in the double log plot. 
repeatable nanoparticle dispersions of ENMs for 
nanotoxicological studies (Gao and Lowry 2018). 
While the protocol is straightforward and the 
required equipment is standard across most nano-
toxicology labs, it is time-consuming, taking 
approximately 10 min per dispersion and 5 min 
between samples. Additionally, it can be wasteful if 
a fresh dispersion is made for every experiment. 
The protocol produces 6 ml of particle dispersion at 
a concentration 1 00x more concentrated than the 
highest commonly used in toxicological in vitro 
assays, making approximately enough samples for 
30 96-well microwell plates with each dispersion. 
Flash freezing is more time-efficient, which is key 
for large scale batch characterizations (Vila et al. 
2017). While prior studies suggest the stability of 
ENM dispersions during flash-freezing (Vila et al. 
2017), all dosimetry models are based upon data 
collected from dispersions followed by immediate 
dosimetry measurements (T eeguarden et al. 2007; 
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Figure 7. Particle size distribution for A SiO2 Amorphous and B DQ12. The yellow curve indicates the PSD as measured by AUC, 
whereas the gray curve was measured through DLS. 
question of the potential biases of using similar 
models on flash-frozen samples. 
Therefore, we decided to test the flash freezing 
method for characterization and modeling. Here we 
observe only small differences in z-averages as seen 
in Table 52, from 219.3±2.3nm to 281.0±18.9nm 
for CeO2 NM-212 fresh vs. freeze-thaw and 
126.1 ± 1.0 nm to 176.4 ± 37.85 nm for Ba5O4 NM-
220. This results in an effective density of 
2.200±0.067g/cm 3 and 2.214±0.029g/cm 3 for 
CeO2 NM-212 and 2.174±0.000g/cm 3 and 
2.034 ± 0.049 g/cm 3 for Ba5O4 NM220 for fresh and 
flash-frozen, respectively. These discrepancies have 
a negligible effect on transport properties, but they 
are a correction to the finding by Vila et al. (2017), 
which reported no differences between flash-frozen 
and fresh samples. While their investigation found 
differences in z-average, which agree with our find-
ings, they did not report their particle size distribu -
tions. The flash freezing process seems to have 
promoted the aggregation of the ENMs, and as 
large ENM aggregates sediment at faster rates, this 
increases the effective delivered doses. 
We also evaluated the differences in z-average in 
two different media, DMEM/FBS and RPMI. The 
results are shown in Table 52 highlight significant 
differences between fresh and flash-frozen samples 
for CeO2 NM-212 and Amorphous SiO2 in RPMI, 
whereas Ba5O4 NM-220 does not exhibit differences 
by more than 10%. This can be attributed to the 
more vital protein interaction of the positively 
charged CeO2 (Chen et al. 2014; Wohlleben et al. 
2016; Schaefer et al. 2012). 
It is highly probable that flash-freezing methods 
will continue to be used within industrial and regu-
latory applications, enabling comparative toxicology 
by parallel testing. Our results clarified that even 
with identical standardized dispersion methods, 
flash freezing changes the dosimetry behavior of 
the materials . Thus the key for relevant results in 
toxicology experiments is that methods must be 
consistent between characterization, in silica model-
ing, and in vitro toxicology. 
DLS ENM replication explorations 
As measured through DLS, the particle size distribu-
tion is prone to be affected by small numbers of 
large agglomerates within the dispersion (Gollwitzer 
et al. 2016). Sigma_Ag was the only material to give 
a good reproducibility among three triplicates 
(Figure 4). The differences between triplicate one 
and triplicates two and three for CeO2 NM-212 are 
most likely due to poor dispersion of triplicate one 
with a z-average of 660 nm compared to 294 nm and 
267 nm for triplicate 2 and 3 with an effective dens-
ity only differing slightly from 2.24 g/cm 3 for tripli-
cate one to 2.19 g/ cm3 for triplicates two and three. 
A sample that is not correctly dispersed can result in 
a different deposition profile after modeling. While 
sample to sample variability is expected, these simu-
lations highlight the concern that variability may be 
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propagated and multiplied during experiments that 
rely on multiple dependent measurements. This type 
of error propagation can be calculated using 
accepted statistical tools. Thus, it is crucial for future 
experiments to investigate whether averaging n 
number of dispersions and subsequent characteriza-
tion will result in sufficiently accurate dosimetry data 
for biological experiments. These future experiments 
may focus on quantitatively measuring deposition in 
a controlled environment and comparing the meas-
ured deposited fraction to that predicted by simula-
tions using averaged characterization data. The 
experiment itself might look like those conducted by 
(Deloid et al. 2015) or an alternative method. Ideally, 
these experiments will reveal the required number 
of replicates for materials to result in an average 
that, when modeled, will reflect the average dose 
that reaches the cells. 
Particle size distribution measurement methods 
If the ENM has a high tendency to agglomerate, 
DLS is not the most suitable method for determin-
ing the particle size distribution (Gollwitzer et al. 
2016) since this experimental variance has a strong 
influence on the prediction of the deposited dose. 
We found that DLS tends to underestimate the dif-
ferentiation between ENMs in its size distribution 
measurements (Table 1), leading to possible false 
predictions of the deposited dose. Specifically, DLS 
shows tested materials having similar agglomera-
tions, whereas AUC indicates significant differences. 
Comparing the deposited dose (Figure 4) after six 
hours with the dose after 24 h, it is evident that 
after six hours, the largest fraction is already depos-
ited and that there is only a small change in depos-
ited dose after 24 h. We, therefore, suggest 
benchmarking modeling predictions through AUC, 
where available, especially for agglomerated par-
ticles. Agglomeration is most sensitively detected in 
mass metrics, which should be preferred over num-
ber metrics in the ENM dispersion characterization 
in the cell culture medium. For DLS and AUC, it also 
requires the least conversions. 
DG stickiness conditions and compartment height 
DG modeling shows a strong dependency on 
adjustable parameters, such as boundary conditions 
for sticky, non-sticky, and reflective bottoms, and 
the simulation of the height of the sub-compart-
ment. When using 0.01 mm, the suggested height 
of the sub-compartment, we interestingly observed 
some significant dips within the deposited dose 
curve over time, as seen in Figure S1. When adjust-
ing this height of the sub-compartment to 
0.0005 mm, the dips vanish - however, the comput-
ing time for modeling the dosimetry changes from 
a few hours to several days. 
Furthermore, the adjustment of the adhesive 
boundary has a significant effect on the deposited 
dose, with the boundary being either reflective 
(adsorption turned off), with low -adhesion (Kd = 
1 x 1 o-8 ), or high -adhesion (Kd 1 x 1 o- 9) . 
Affinities cannot be independently determined with 
certainty due to the modification of the surface by 
corona formation and unknown interaction with cel-
lular epitopes (Liu et al. 2012; Chen and Riviere 
2017). As expected, the resulting dosimetry curves 
(Figure 5) showed a higher deposited dose in high-
adhesion conditions, with a factor of up to 2.5 (23 
vs. 9% deposited) compared to the other conditions 
with otherwise identical input parameters, and a 
factor of 12 (23 vs. 1.9% deposited) if also the size 
input is varied. The results obtained by choosing 
the adhesive boundary emphasize the contribution 
of diffusion-driven transport but are dependent on 
an unsupported assumption of particle-
cell adhesion. 
Considering further that convection adds to par-
ticle transport but is not modeled (Uson et al. 
2008), one might accelerate the delivery of the 
entire dose onto the cells by minimizing the fluid's 
height above the cells. Alternatively, one might con-
sider the use of non-adherent cell lines, working in 
suspension with agitation. 
Varying PSD input parameters 
The significant impact of using the particle size dis-
tribution from two different characterization techni-
ques to model the deposited dose was previously 
described by (Petersen et al. 2019). Petersen et al. 
described that using the mean diameter instead of 
the PSD only shows a change in the deposited 
dose of about 10%. Using substantially different 
analytical techniques for the PSD determination 
causes more considerable differences due to the 
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agglomeration of the tested ENMs. The two differ-
ent methods used here to determine the deposited 
dose differ in their principle of particle transport. 
AUC only takes sedimentation into account (by dir-
ect measurement), whereas DG uses both diffusion 
and sedimentation (by calculation). 
Table 2 shows that the deposited dose, as mod-
eled by the DG model with DLS as input data for 
the particle size distribution, matches the deposited 
dose as determined directly by AUC quite well, 
whereas the DG model using AUC size distribution 
data differs overall by more than 30%. The spread 
of deposited dose predictions is about 10-fold for 
BaSO4 NM220 and Ag_sigma materials and about 2-
fold for the six others; this uncertainty translates 
directly into the uncertainty of no-effect -
concentrations. 
Furthermore, when comparing the modeled 
deposited dose to the sedimented dose measured 
directly from the Sved values as received by AUC-
measurements, the direct comparison of predicted 
deposited dose to AUC measurements (under accel-
erated gravitational forces, thus suppressing the dif-
fusional contribution) shows good agreement for 
Amorphous SiO2 and DQ12, for which sedimenta-
tion is the dominant transport. In contrast, the dis-
crepancy is significant for BaSO4 NM-220 and Ag 
NM-300K, for which diffusion dominates the trans-
port. This is consistent with the relatively narrow 
size distribution of BaSO4 NM-220 and Ag NM-300K 
at smaller sizes. We had expected that the depos-
ited dose for DG modeling should be as high as the 
deposited dose directly obtained by measuring the 
sedimentation by AUC but did not find that to be 
the case, even when using AUC size distributions as 
DG input (Table 2). 
In the previous modeling with the in vitro sedi-
mentation, diffusion, and dosimetry (ISDD) model, it 
was observed that for agglomerated particles, the 
robustness of predictions of the deposited dose 
was low. In contrast, well-dispersed single particles 
tended to have a high deposited dose by the ISDD 
model, in significant contrast to AUC measurement 
(Sauer et al. 2015). Based on the systematic vari-
ation of stickiness that we performed here (albeit in 
the analogous DG model), we can now attribute 
the earlier erroneous ISDD predictions to the 
assumption of the high affinity of the particles to 
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cells, which is assumed to be 'sticky' in the 
ISDD model. 
The fractal dimension of ENM-protein 
agglomerates 
Our complementary data by hydrodynamic charac-
terization with VCM, DLS, or AUC input can finally 
be interpreted in terms of the hydrodynamic prop-
erties of ENM-protein structures. Deloid et al. 
highlighted that the concept of effective density is 
related via the Stirling formula to the fractal 
dimension of ENM agglomerate (Deloid et al. 
2014). An existing implementation of fractal 
dimensions in AUC (Wohlleben 2012) can be used 
to match the fractal dimension in the Stirling for-
mula such that the median diameters agree with 
the evaluation by the effective measured density 
(Figure 6). Evaluation with Dr = 3 (corresponding 
to solid spheres) remains below parity, but also 
the results using the theory of reaction-limited col-
loidal aggregation (RLCA; Lin et al. 1990) does not 
fit because the evaluation with Dr = 2.1 remains 
above parity. The best approximation to parity is 
reached by Dr = 2.54. This value is nearly identical 
to the theoretical expectation for diffusion-limited 
colloidal aggregation (DLCA; Lin et al. 1990). Thus, 
we can interpret that the ENM-protein agglomer-
ates assemble with a high ENM-ENM stickiness 
(hence DLCA) upon each collision of protein-deco-
rated ENMs. 
Conclusions 
We explored the sample preparation and the dos-
imetry of ENM in vitro testing. Knowing the mass 
fraction of the dose that accumulates at the cells 
allows re-calculating dose-response curves 
(Teeguarden et al. 2007) and thus enhances the 
predictivity of in-vitro toxicology (Deloid, Cohen, 
et al. 2017; Deloid et al. 2014). Regarding the 
sample preparation, the freeze-thaw protocol 
enabled parallel testing by flash freezing the sam-
ples after sonication (Vila et al. 2017); this altered 
the presence of agglomerates in the particle size 
distribution of fresh dispersions up to 35% how-
ever, after 1-h incubation, the difference was 
below 25%. The effective density was only minim-
ally altered by + -0.15 g/cm 2 . Thus, overall it 
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modulated the dosimetry of the particles. The 
modulation tended to be lower in DMEM/FBS than 
in RPMI without serum. Nevertheless, characteriza-
tion and in silica modeling that reflected the 
actual colloidal properties during in vitro toxicol-
ogy can be obtained by matching the freeze-thaw 
protocols, which are reproducible. 
Regarding dosimetry, the fundamental notion 
that the deposited dose is lower than the total 
administered dose can be easily supported by sim-
ple measurements (DLS, VCM) and DG modeling. 
With a deposited dose ranging between 9-73% for 
the different nanomaterials with reflective boundary 
conditions, we observed that the prediction of 
deposited dose varied significantly. Especially for 
well-dispersed ENMs, uncertainty was introduced by 
choosing an arbitrary value of the affinity of par-
ticles to cells ('reflective' vs. 'adhesive' bottom). 
Additionally, for polydisperse ENMs, minor details of 
the particle size distribution strongly influence the 
modeled dosimetry, such that the choice of the 
measurement technique, for example, DLS or AUC-
introduces further uncertainties to the dosimetry 
modeling. For any polydisperse ENM, we found it 
necessary to increase the DG model computing 
resources by reducing the output compartment 
height to 0.0005 mm; otherwise, dips in the particle 
settling traces lead to erroneous predictions. 
However, even with optimized computing resour-
ces, the uncertainty of the actual deposited dose 
was considerable. Especially when using standar-
dized dispersion protocols (NANoREG) and polydis-
perse industrially relevant materials, the predictions 
of the model incurred an uncertainty of the depos-
ited dose due to uncertainty in the inputs. The 
dose-response that is obtained by the modeled pre-
diction of the deposited dose can thus shift signifi-
cantly: If the in vitro reactivity of different 
nanoforms differs by a factor of 2.5, one cannot 
conclude if the results are from a dissimilarity of 
biological interactions or the methodical uncertainty 
of dosimetry modeling. For very well dispersed 
nanoforms, the range of uncertainty extends to a 
factor of 10. 
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3.2 MANUSCRIPTS SUBMITTED OR UNDER PEER REVIEW 
Biodissolution in cascaded simulants of the gastro-intestinal tract: towards robust 
screening methods and nanomaterial grouping. 
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Ingested ENM pass through at least three clearly differentiated compartments: mouth (saliva), stomach, 
intestine. Especially pharmacological applications of targeted release particles often consider separately the 
sub compartments of small vs. large intestine vs. colon.[137] Substances in nanoform may become 
bioavailable by dissolution of the particles,[138] or, to a smaller extent, may be internalized as particles.[139] 
Ions that were dissolved in one compartment may be complexed and may re-precipitate in the next 
compartment.[140, 141] Reactive processes in the relatively aggressive compartments may induce 
transformation of the crystallinity, surface chemistry, particle size and state of agglomeration, to name the 
descriptors that are most important next to the dissolution rate. The transformed particles may induce local 
effects during the GIT passage[142] or after internalization and systemic availability to the liver and 
beyond.[143]  The food-grade TiO2 E171 with only >36% of the particles being below the size of 100 nm 
accumulated in the body to some extent[99] and a spurious signal was detected in placenta perfusates and in 
meconium (the first stool of newborns), the size distribution of which differed significantly with 70% to 
100% of particles below 100nm.[144] The in-vivo study alone cannot decide if the particles that became 
systemically available are a fraction of the pristine material, or a transformation thereof. Physical-chemical 
investigation is needed. When the specific ENM is susceptible[145] to the reaction partners in GIT 
conditions, it is important to assess transformation not only with regard to biokinetics, but also as element of 
a realistic hazard assessment: before dosing in-vitro experiments one must design the exposure identity by 
pre-treatments of ENM to mimic the in-vivo transformation.[146] 
Several implementations of cascaded GIT dissolution testing have been published.[141, 147-151] On that 
basis, two ongoing OECD projects are developing guidance and guidelines to simulate and assess the GIT 
dissolution and transformation; both are targeting a cascaded incubation in saliva, stomach and intestine 
simulants. However, the exact composition of simulant fluids, the most appropriate methods of sampling, of 
separation of ions from remaining particles, and analytics of both fractions, are a matter of debate.  
E.g., studies on Ag NM300 have shown that ions are complexed by enzymes acting as ion scavenger, thus 
shifting the dissolution towards ions and accelerating the kinetics rate of particle dissolution.[147] However, 
complex fluids with high concentrations of enzymes are challenging in fractionation and analytics. Food 
component may further increase realism but may not increase robustness of results. The guidance by EFSA 
does not require complex fluids, and it only indicates an assessment criterion for quickly dissolving ENM 
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(88% in 30 minutes), meaning that particles dissolve already during the diffusion through the mucus layer 
and do not even get in touch with any tissue. This can be considered as the upper limit of the biologically 
relevant range of dissolved fraction, and it triggers an exemption from the need to perform nano-specific risk 
assessment (i.e., read-across to the ionic form).  
Here we assess the relevance of the enzymes via their impact a) on ion dissolution and b) on particle 
transformation. We then apply a robust medium in a screening of case studies of different nanoforms and 
non-nanoforms of oxides of Zn, Si, Ce, Ti, and of organic pigments of DPP, ML2A, Isoindolinone substance 
classes. Our results can inform the assessment of GIT biodissolution by screening methods as required for 
grouping of different nanoforms and can be considered as more robust option for the OECD round robin that 
is planned in the frame of the NanoHarmony project. As corollary, we aim to explore if one can, be 
comparison between dissolution experiments and in-vivo literature, propose a practical lower limit of the 
biologically relevant range of dissolution.   
 
Methods 
The in-vitro setup consists of a stirred beaker with cascaded addition of simulants for saliva, stomach, 
intestine. The setup and its adaptation to nanomaterials adheres to ISO TS 19057. The chosen concentration 
matches the max daily intake of nanomaterials through food, as proposed by EFSA. 
The saliva dispersions were stirred for 5 min at a temperature of 37 °C. After removing a sample, gastric 
juice was added and set to a pH 2.0 to 2.5. During two hours of stirring at 37 °C, samples were collected, and 
finally intestinal fluid was added, and set to a pH of 6.4. Again, during two hours of stirring at 37 °C, samples 
were collected. Immediately after drawing the samples, they were split by ultrafiltration for analysis of 
dissolved components and of remaining particles. 
The simulant fluids are standardized in DIN 19738 [152] and currently being harmonized by the OECD 
project for a new TG “Determination of solubility and dissolution rate of nanomaterials in water and relevant 
synthetic biologically mediums” (lead by Denmark and Germany). The ENM were dispersed with a 
BRANSON Sonifier 450D at an amplitude of 30% for 16 minutes within an inverted cup-horn sonicator to 
deliver an energy output of 7.35 W. A 50 mL Nalgene® bottle was used to reduce inorganic impurities. For 
fluids with enzymes, the enzymes were added after the sonication process. The saliva dispersions were stirred 
for 5 min at a temperature of 37 °C. After removing 5 mL of the dispersion for ion and transformation 
analysis, 21 mL of gastric juice was added and adjusted to a pH 2.0. After two hours of stirring at 37 °C, the 
next 5 mL sample was drawn and analyzed, and 25 mL of intestinal fluid was added, and the pH was adjusted 
to 6.4. Again, after two hours of stirring, the last sample was drawn and analyzed. Immediately after drawing 
the samples, they were split for analysis of dissolved components and of remaining particles.  
For dissolution analysis, the dispersion was filtered through a 0.02 µm Al-Si syringe filter to remove particles 
and stop them from further dissolving. For inorganics, the filtrate was diluted by a factor of 10 with 0.1n 
HNO3 and was analyzed by ICPMS (Nexion 2000b, Perkin Elmer,) with a Meinhardt nebulizer and Argon 
gas flow of 0.92 L/min and a pump rate of 18 rpm. The external calibration used concentrations of 
0.1/1/10/100/1000/1000 ppb depending on the analyzed ion. For Si the detection limit was at 10 ppb.  
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The filtrate of organics was analyzed by UV-Vis spectroscopy (Cary 5000, Agilent Technologies, Santa 
Clara, CA, US) in 5-cm-cuvettes with calibration by the extinction coefficient as described above. For 
constituent particle analysis, we employed a SAXS, XRD and TEM with SAD. The benchmark materials 
were analyzed via TEM with SAD at an acceleration voltage of 200 keV under bright-field conditions. 
(Tecnai G2-F20ST. FEI Company, Hillsboro, USA). Therefore, the final particle dispersion was diluted by 
factor of 100.000 and centrifuged onto TEM grids at 5000 g.  
For both benchmark materials and organic pigments (which are crystalline), the sample was dried, spread on 
glass and subjected to XRD analysis of the crystalline identity (by the characteristic diffraction peaks) and 
analysis of the crystallite size (by fitting the broadening of the peaks via EVA). The instrument D8 Advance 
Serie 2 employed a Cu-Anode with 0.1° collimation; the diffracted X-rays were selected at 8 mm with Ni 0.5 
mm aperture (Soller 4°; Lynx-Eye 3°). The particle size of amorphous silica was in the detection interval of 
our local SAXS instrument. Here an analog detector was used.  
The agglomerate size analysis was employed through spICPMS. Here, spICPMS was not applicable or not 
valuable for some particles: we did not analyze materials that dissolve quickly (ZnO), very small particles 
(SiO2), organics (pigments). We did analyze TiO2, CeO2, BaSO4 with and without enzymes. We are aware, 
however, that the incubation is (by EFSA requirements) and concentrations far higher than admitted for 
spICPMS analysis. The dilution of samples invariably changes adsorbates (“soft corona”), such that only 
agglomerates induced by “hard coronas” are detectable.  
 
The initial concentration of pigments was aligned with the BfR publication. [141] We chose the “high” 
starting concentration of 6 mg/ml, which is successively diluted to 1mg/mL in intestine, because only in this 
approach the total mass is sufficient for XRD analysis. The same approach had to be taken for SAXS and 
XRD analysis of metal containing ENM.  
  
Table 2 Composition of GIT simulant media according to DIN ISO 19738 media  
Composition DIN ISO 19738 [mg/L] 
Saliva NaCl 1667 
  NaSCN 500 
  Na2SO4 1833 
  NaHCO3 500 
  KCL 1500 
  KH2PO4 2000 
  CaCl2*2H2O 500 
  Uric acid 333 





     
Stomach NaCl 4143 
  KCl 1000 





  conc. HCl 20 µl 
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Intestine KCl 300 
  CaCl2*2H2O 500 
  MgCl2*6H2O 200 
  NaHCO3 1000 







    
Bile 9000 
 
For other analytical approaches, especially with regard to the quantification of dissolved ions, and for 
substances with known daily intake, we approximated the relevant test concentration by referencing the 
maximum daily intake to the 4 to 5 L of human GIT secretions as recommended by EFSA.[153] With an 
approximate uptake of 1.1-2.2 mg/kg body-weight/day by humans, TiO2 is one of the most relevant food 
additives.[99] For SiO2, the European Food Safety Authority (EFSA) estimates an even higher daily intake 
of between 20-50 mg for a 60 kg person.[102] This estimate would translate to a maximum relevant 
concentration of 50 mg/4 L=12.5 mg/L. Considering finally the limits of analytical methods and a margin of 
uncertainty, we finally decided to compare all metal-based materials primarily at a concentration of 50 mg/L 
in the intestine compartment, which is about half of the “low” dose of Sieg et al. but still above the maximum 
relevant concentration.  
 
Results and Discussion 
Optimization of methodology on benchmark materials 
In order to optimize the methodology of cascaded GI treatment the relevance and the impact of enzymes on 
both the ion dissolution as well as the particle transformation was assessed on a selection of benchmark 
materials. Here, ZnO NM110 was used as a benchmark material for quickly dissolving ENM under acidic 
conditions within both labs. SiO2 NM200 was chosen as a partial dissolving material and tested in the lab of 




TiO2 E171  
The dissolution and transformation behavior of TiO2 E171 was assessed in both type 1 and type 3 media. 
Within the TEM comparison of TiO2 E171 (Figure XB) with and without enzymes, no significant difference 
can be observed. Furthermore, this is confirmed through SAD. TiO2 NM105 which was used as a benchmark 
material behaved similar and thus showed no significant transformation after cascaded GI treatment. The 
biopersistence in both media was also confirmed through XRD evaluation. Here the data showed no new 
peaks and no significant change in peak with. Remarkably however, the interaction of enzymes with the 
particles (DIN type 1) 
increased the ion concentration 
after filtration with 0.02 µm as 
detected via ICP-MS within the 
intestinal fluid vs. the enzyme-
free intestinal fluid (DIN type 
3). This detectable increase in 
Ti-ion concentration up to a 
very low level of <0.05% 
(Figure 6) was observed for 
both TiO2 materials, E171 and 
NM105. This is explicable 
through the complexation of 
ions with the enzymes, shifting 
the dissolution kinetics. spICP-MS showed that an agglomeration through enzymes can induce a bimodal 
size distribution of E171 but keeping within the same size range of 40-400 nm (Figure 5). NM105 only 
differed within the saliva medium. Within the other two fluids, no modulation by enzymes was detected. 
Figure 5: Particle size distribution as determined through spICP-MS for TiO2 NM105 
and TiO2 E171 with and without enzymes. 
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Figure 6: XRD Graph of pristine TiO2 E171 particles (blue), TiO2 after dissolution in cascaded GI fluids 
(black) and the media background (red). TEM images after type 1 media (A) and type 3 media (B). TiO2 
dissolution concentration in different compartments in dependence on media composition. 
SiO2 NM200  
Based on the TEM images for the comparison for SiO2 NM200 a better dispersion was observed with 
enzymes after the cascaded GI treatment (Figure 7) when compared to the results without enzymes.  
Also, for the case of SiO2 NM200, the 
filtration of the sample with enzymes 
increased the ion concentration within the 
intestinal juice vs. the enzyme-free type 3 to a 
certain extent. This observation was made in 
all three compartments. All of the resulting 
dissolved percentages remain far below the 
daily uptake of SiO2 ENM as proposed by 
EFSA cutoffs and so the enzymes are not 







Finally, we needed to check that our quickly 
dissolving benchmark is correctly detected 
without enzymes. Extensive work on the 
dissolution behavior of ZnO NM110 was done 
within the lab of IIT, here a dissolution in the range of 80-100% was detected after 30 min of incubation 
Figure 7: TEM images after type 1 media (A) and type 3 media (B). 
SiO2 NM200 dissolved percentage in different compartments in 
dependence on media composition. 
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within intestinal juice. Which resembles the time point of 150 min from start point as relevant for EFSA 
regulatory purposes. The concentration remained rather constant for initial concentrations of 25 mg/L and 
50 mg/L but showed an inferior dissolved content for the concentration of 100 mg/L over time at the end of 
the digestion process (240 min). At concentrations of 25 mg/L and 50 mg/L ZnO NM110 shows the behavior 
of an instantaneous dissolving NF. However, this test showed that the dissolution process appears to be 
concentration dependent. Though, an interaction of the ions with the media composition resulting in 
aggregation processes may occur. 
Furthermore, the data showed, that the dissolution rate is dependent on the enzyme composition with protein 
components accelerating the dissolution rate. Since no aminoacidic substrates are within the media and no 
biochemical mechanisms are present, this acceleration may be induced through improving the colloidal 
stability. The ion concentration of ZnO in juice 3 without enzymes was reduced to 50% within intestinal fluid 
at the end of the digestion process after 240 mins.  
These observations made at IIT were furthermore 
supported by results obtained within the labs at 
BASF for the gastric juice. Here the exposure of 
ZnO to two more versions of Juice 3 with 
inorganic and organic components but without 
enzymes resulted in a fast dissolution effect. ZnO 
NM110 here showed a half-time <5 min but as 
soon as the intestinal media was added, a 
reprecipitation was induced and the dissolved Zn 
content dropped close to zero with low 
dissolution. The behavior within the intestinal 
fluid as measured at BASF is in contrast to the results obtained at IIT. The significant differences between 
0% dissolution at BASF and 50% dissolution at IIT after 240 mins may be related to the initial concentration 
of the material.  
When testing three different ZnO ENM differing in particle size, surface coating, and hydrophobicity, 
NM110, NM111, NM113 with the enzyme free DIN 19738 media (type 3) similar dissolution behavior was 
observed within all three different media. With an instantaneous dissolution of nearly 100% after changing 
from saliva to gastric juice and a sudden drop as soon as the intestinal juice was added, and the pH adjusted 
to 7.4 (Figure 8) 
Figure 8: % dissvoled Zn in dependence of time in the three 
different compartments for ZnO NM110 (yellow), ZnO NM111 
(blue) and ZnO NM113 (gray). 
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Tests done within the commercially available pre-mixed FaSSIF V2 simulants were not taken into account, 
since the exact composition is not known and can therefore not help to understand potential dissolution effects 
on the media composition. 
The TEM image analysis showed that small particles were found after the exposure to the cascaded simulated 
GI conditions, however these particles could not be identified as Zn by EDX. Figure 9 shows the residues for 




Interim conclusion on optimization of methodology on benchmark materials:  
The methodology to assess the dissolution and transformation of ENMs within the gastrointestinal tract in a 
simulated cascaded system with the three relevant juices including all relevant components such as 
inorganics, enzymes, organics is regarded as gold standard. However, frequently observed a clogging of 
filters in the presence of the enzymes. This is not a mere technical issue, since ions that are complexed by 
the enzymes will then not pass the membranes and will not be detected as dissolved component. the counts 
before and after filtration were identical for Ag in saliva (SS1) and FaSSGF media with triplicate 
reproducibility of 0.48% to 0.94% (1 SD). In contrast, the counts after filtration in FaSSIF medium scattered 
by 39% (1 SD) and were 60% lower than before filtration. This is strong indication of complexation of Ag 
in the FaSSIF medium, leading to false negative conclusions on dissolution of the Ag ENM. On Cu in saliva, 
scatter increased from 0.952% to 2.59% at reduction of count rate by 15% before and after filtration. On Ti 
in FaSSIF, scatter increased from 0.14% to 9.1% at reduction of count rate by 31% before and after filtration. 
In all of the three cases (Cu@saliva, Ti@FaSSIF, Ag@FaSSIF), the effects are attributed to complexation of 
ions, leading to filtration losses and false negatives. Analogue experiments in the DIN media of Table 1 are 
ongoing and will be published elsewhere. In some cases, enzymes induce inhomogeneities that do not allow 
representative sampling of digested ENM. 
Using simplified versions of these fluids (without enzymes) resolves such practical issues separation of ions 
from particles, and on sampling and the homogeneity. By the above data, we have demonstrated that the 
morphology of remaining particles is not influenced by the enzymes. 
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We therefore propose that screening with simplified juices by removing the enzymes or organic components 
is possible, if the ion dissolution results on benchmark materials match the results obtained by full juices, 
both for quickly dissolving benchmark (ZnO NM110) and very slowly dissolving benchmark (TiO2 E171). 




Screening of dissolution and transformation  
Across all case studies, and across the three GIT compartments, the dissolved concentration spans an 
enormous range of values from 20 mg/L (fully dissolved ZnO in stomach), down to 0.02 µg/L (DPP pigment 
in stomach). These are six orders of magnitude. In the following we present and discuss case studies in order 
of decreasing dissolution 
 
ZnO comparison of NFs 
The dissolved ion concentrations of the three ZnO forms, thereof one NF (NM110), one coated NF (NM111), 
one non-nano-form (NM113) are strikingly similar in all three cascaded compartments. What’s more, also 
the kinetics with 5-minute time resolution is not significantly different: All ZnO materials remain undissolved 
in saliva, then dissolve more than 90% in less than 5 minutes in stomach. This is sufficient to fulfill the EFSA 
guidance that a nano-specific assessment is not required.  
Immediately after switching to the intestinal simulant, the free Zn ions are reduced to less than 20% of the 
total Zn content, and within 30 minutes, less than 1% remains as free Zn ions. This behavior is a 
Figure 10: Dissolved concentration in each of the three compartments, with DIN19738 type 3 juices. 
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transformation that starts from Zn ions and is linked to the limited solubility of Zn ions at the near-neutral 
pH of the intestinal fluid. We note that enzymes are not required to dissolve ZnO. They can modulate the 
complexation of ions, but this could only accelerate dissolution. However, as shown by IIT in GRACIOUS, 
the complexation of Zn ions by enzymes can interfere with the separation by ultrafiltration or 
ultracentrifugation, thus inducing false negatives of apparently limited dissolution, whereas the Zn ions have 
actually been released, but were not accessible to detection. 
 
SiO2  
The dissolution experiments on the different silicate materials, confirm the trend on solubility in dependency 
on the crystal structure. Where amorphous silicate materials dissolve whereas crystalline silicate material 
persists. Here we explored that SiO2_amorphous quicker than SiO2 NM200, which again dissolves much 
quicker than the crystalline DQ12. For the silicate materials we expect a higher dissolution within the neutral 
pH of saliva and intestinal fluid, which is in line Sohal et al. However, the observed dissolution kinetic also 
confirms the fact that NaCl favors the dissolution of SiO2. Within a GRACIOUS case study, BASF 
investigated the transformation of small silicate particles through SAXS. Here we had trouble separating the 
particles, due to their small size below 10 nm. Furthermore, for biological scenarios unrealistically high 
concentration had to be used. (See SI)  
 
CeO2 
For both CeO2, spICPMS shows similar trends: low agglomeration in saliva and intestine, higher 
agglomeration of the pristine material than as well as in the in the gastric juice. This phenomenon seems to 
be dictated by the substance primarily, and is not explicable by pH changes, especially not after the dilution 
for spICPMS measurement. The XRD evaluation did not show any significant change of crystallite size with 
11 nm before and after the digestion process. Furthermore, no new XRD diffraction peaks were found, 
confirming no transformation before and after. The TEM image (Figure 11 A and B) as well as the SAD 





Additionally, to the food-grade E171, NM105 was used as a benchmark material. Here we also did not 
observe and significant changes of crystallite size nor new XRD diffraction peaks after exposure to the three 










[5] TiO2 NM105 after GI 17 2 no 48,0 ° 
[6] TiO2 NM105 pristine 18 2 48,0 ° 
[7] TiO2 E171 after GI 46 5 no 25,4 ° 
[8] TiO2 E171 pristine 56 6 25,4 ° 
[9] CeO2 NM211 after GI 11 1 no 47,5 ° 
[10] CeO2 NM211 pristine 11 1 47,5 ° 
[11] CeO2 NM212 after GI 22 2 no 47,5 ° 
[12] CeO2 NM212 pristine 26 3 47,5 ° 
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Figure 11: TEM images of (A) CeO2 NM211 and (B) CeO2 NM212 after exposure to the cascaded GI conditions. 
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Each two forms were investigated, and showed that organic pigments were as insoluble as TiO2 or CeO2, 
with the exception of metal-lake pigments, which showed weak dissolution. Isoindolinone substance were 
stable in stomach with a comparable dissolved concentration as TiO2 or CeO2. However, within the intestine 
an about 5-fold higher concentration was found than within the stomach. The tests furthermore showed that 
in terms of biopersistence there was no significant difference between the NF and non-nano-form 
 
The NFs of metal-lake pigments (ML2A class) was unstable under GI conditions, comparable dissolved 
concentration as SiO2. The overall dissolved content was about 20-to-50-fold higher than for TiO2 and 20-
to-50-fold lower than for ZnO. The substance (classes) of laked (metal-precipitated) pigments were 
previously found to dissociate under physiological conditions.[154]  
 
The DPP pigments were insoluble, in two compartments with a 100-fold lower dissolved concentration than 
TiO2. However, in intestine the concentration was within the order of TiO2 stomach concentration. At an 
extremely low level, the highest measurable dissolved content of maximally 0.024 %, with 0.143 mg/L 
dissolved concentration is found in the intestine simulant with bile salts and nearly neutral pH6.5. There is 
no significant difference between the NF and non-nano-form 
 
The observed lack of bioavailability of purely organic pigments is in accord with in vivo findings of oral 
gavage experiments and the current REACH data,[155, 156] and sets them apart from partially dissolving 





When assessing the ion dissolution of metal-oxide ENMs, enzymes might have a relevant effect on the kinetic 
as they can act as ions scavengers. The formation of enzyme-ion complexes shifts the equilibrium to 
dissolution as observed in the case of TiO2 E171, where a 0.05% higher dissolved content was observed 
within the enzyme containing media. If the test is intended for prediction of the bio accessibility of the 
generated ions, then it is important to include enzymes and only consider the complete medium composition 
as the gold standard. However, for solubility considerations, screening and ranking NFs in simplified juices 
is possible. The EFSA guidance only provides a fixed criterion for quickly soluble materials, but no criterion 
for insoluble materials.[153, 159] For dissolution analysis, the material is considered as quickly soluble if 
more than 88% are dissolved after 30 minutes in either stomach compartment or intestine compartment. 
Based on data obtained on TiO2, we propose that the material is considered as insoluble if less than 0.1 mg/L 
are dissolved in any of the three cascaded compartments. No bioavailability of organic pigments, as compared 
to the partial degradation of some oxides (ZnO, SiO2, CuO) is predicted by the current abiotic screening and 
is in accord with in vivo findings of oral gavage experiments. [140, 155-158, 160-162] Future studies need 
to also consider alternative metrics such as a “% dissolved” cutoff or k-rate cut-off (which is not easily 
calculated in a cascaded model with re-precipitation), and limits of acceptable dissimilarity between NFs. 
On the primary particle transformation and agglomeration though, enzymes only have limited effects. The 
use of the whole juice including enzymes might be considered as a gold standard, however it can influence 
the sampling by clogging the filters and effect the homogeneity during sampling. Screening with simplified 
juices, without organics or enzymes can be applied to benchmark materials which match the results obtained 
within full juices both for quickly dissolving (ZnO NM110) and very slowly dissolving benchmark (TiO2 
E171). For particle analysis, the particles are considered as transforming if the XRD diffractogram shows the 
emergence of new peaks or the loss of peaks compared to the pristine materials. methods that do not require 
concentrations far above the expected daily intake (XRD, SAXS), and not far below (spICPMS) would be 
preferred. As a supporting criterion, a change of crystallite size that exceeds that the combined uncertainty 
of crystallite size analysis of 10% on both the pristine and GIT-aged material, is taken as indication of 
transformation. TEM is unique on morphology changes, and also widely available. We tend to not propose 
spICPMS as criterion due to dilution concerns, and limited added value from case studies. 
To the best of our knowledge this is the first contribution where cascaded GIT screening media were validated 
and then applied on different NFs per substance for grouping and read across purposes. When using the 
benchmark materials to compare the dissolution behavior to the testing materials, no difference was found 
between the NFs in terms of their dissolution and transformation behavior despite substantial differences 
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Dissolution and Transformation (after inhalation) 
In this work, the continuous flow system, which was previously developed to assess the persistence of man-
made vitreous fibres (MMVF), was adapted and used to assess the dissolution rate and transformation of a 
broad set of nanomaterials in relevant physiological media. The nanomaterials were chosen based on the 
production volume as well as industrial relevance (Figure 1). The adapted continuous flow system with an 
integrated quantification of ions by ICP-MS and detection of transformation through TEM advantages over 
a static dissolution approach was shown. This was further confirmed by exemplarily comparing BaSO4 
NM220 dissolution results with alveolar macrophage-assisted dissolution and existing in vivo clearance data 
in rats. The flow-through assessment of BaSO4 NM220 did not only predict the persistence correctly but also 
led to the same Ostwald ripening observed in in vivo studies. Control measurements on CuO demonstrated 
that this effect was not a methodological artifact.  
A high degree of consistency of the abiotic dissolution and the in vivo clearance has been achieved for CeO2 
NM211, CeO2 NM212 CuO, nano BaSO4 NM220 and ZnO NM111 (Table 3). Within this material selection, 
the measured half-times span four orders of magnitude from less than one day (ZnO, quickly dissolving) to 
about 10 days (BaSO4, partially dissolving, partially transforming) to more than 1000 (TiO2, very slowly 
dissolving). This confirmed the predictive value of our adapted CFS. We then assessed in comparative testing 
the modulation of dissolution by the particle’s structure: The dissolution is a surface-controlled process. 
Nanomaterials were measured to have the same dissolution rate as their non-nano analogues of the same 
substance. Of course, at identical dissolution rates the halftimes of the nanomaterial is shorter than that of 
larger-sized particles due to its higher specific surface area. We finally also confirmed the expectation that 
coatings can modulate dissolution, but for a quickly dissolving material as ZnO this transient retardation only 
lasts a few hours. 
 
Table 3 Comparison abiotic dynamic dissolution in PSF after 7 days vs. in vivo pulmonary clearance in % after 21 days. 
 
Abiotic dynamic dissolution PSF % dissolved per 
7 days 
In vivo pulmonary 
% cleared per 21 days 
CeO2 NM212 3 5 
CeO2 NM211 3 7 
BaSO4 NM220 58 * 52 * 
CuO 100 >85 (LoD) 
ZnO NM111 99 93 
 
We confirmed the expectation that the composition of the physiological media has a profound effect on the 
dissolution and transformation of nanomaterials: Already within the pulmonary compartment, the lung lining 
fluid with pH7.4 was compared against the lysosomal fluid with pH 4.5 and different organic acids. Materials 
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such as ZnO, BaSO4, CuO, Fe2O3, and CuPhthalocyanines exerted a higher dissolution within the more acidic 
lysosomal fluid; all SiO2 based materials dissolved significantly quicker within the neutral lung lining fluid.  
Based on the intra-lab validation of the CFS for pulmonary dissolution, we advanced the robustness of the 
method by standardisation. While the routine setup worked satisfactorily with low initial masses of ENM and 
subsequent elemental electron microscopy analysis, it was essential to further refine the setup for slowly and 
partially dissolving nanomaterials, for which we developed a model to show that dissolution is limited by 
saturation conditions dictated by the ratio of total surface area (SA) over fluid flow (V). When assessing these 
materials, a ramping of the flow rate led to an expansion of the measurable SA/V ratio by five orders of 
magnitude. It further enabled the assessment of the dissolution behaviour in more detail. By choosing a SA/V 
between 0.03 h/µm and 0.01 h/µm, the measured dissolution correctly predicted the observations made in 
vivo (Table 2). Outside of this SA/V range, false prediction invalidated the test conditions, e.g., TiO2 would 
have been predicted as partially dissolving, or, on the opposite end, ZnO would have been predicted as only 
partially dissolving. Therefore, it is mandatory to exclude all SA/V values above 0.03 h/µm and below 
0.01 h/µm. The same experimental setup for different materials ranging in chemical composition, size, shape, 
surface functionalization, and crystallinity was used to enable grouping of different nanoforms.  
The SOP describing the dissolution setup was transferred to other labs for inter-lab comparison and 
harmonization. Based on ZnO data in PSF, KRISS was able to reproduce and confirm the quick dissolution 
that we had measured. We standardised this method and drafted an SOP which is currently the basis of an 
OECD test guideline development (lead by Denmark and Germany). One of the publications was highlighted 
by ECHA in their recent guidance on “information requirements and chemical safety assessment “.[108] 
 
Dissolution and Transformation (after ingestion) 
For the biodissolution after ingestion, in the successive GIT compartments, we implemented a setup that 
allowed the cascaded incubation in complex fluids that simulate saliva, stomach, intestine. When assessing 
the ions released by dissolution of metal-oxide ENMs, enzymes (and other proteins) might have a relevant 
effect on the kinetic as they can act as ions scavengers. The formation of enzyme-ion complexes shifts the 
equilibrium to dissolution as observed in the case of TiO2 E171, where a 0.05% higher dissolved content was 
observed within the enzyme containing media. If the test is intended to predict unbound ions released from 
the ENM, then including enzymes in the simulation fluid can be useful. However, for solubility 
considerations only, more simple fluids are sufficient. Moreover, the use of simulation fluids including 
enzymes might can influence the sampling by clogging the filters and effect the homogeneity during 
sampling.  
For regulatory purposes, the EFSA provides a fixed criterion to define quickly soluble materials, but no 
criterion for less soluble materials.[153, 159] For dissolution analysis, the material is considered as quickly 
soluble if more than 88% are dissolved after 30 minutes in either stomach compartment or intestine 
compartment. Based on data obtained on TiO2, we propose that the material is considered insoluble if less 
than 0.1 mg/L are dissolved in any of the three cascaded compartments. In contrast to partially degrading of 
some inorganic oxides (ZnO, SiO2, CuO) For organic pigments no release of dissolved, bioavailable is 
 SUMMARY AND CONCLUSION 
124 
expected based on the abiotic dissolution screening. This is in accord with in vivo findings in oral gavage 
studies. [140, 155-158, 160-162] Future studies need to also consider alternative metrics such as a “% 
dissolved” or k-rate (which is not easily calculated in a cascaded model with re-precipitation) and criteria to 
define if different nanoforms are sufficiently similar dissolving after ingestion. 
To the best of our knowledge this is the first contribution where cascaded GIT screening media were validated 
and then applied to different nanoforms for grouping and read across purposes. When using the benchmark 
materials to compare the dissolution behavior to the testing materials, no difference was found between the 
nanoforms in terms of their dissolution and transformation behavior despite substantial differences (nano & 
non-nano, particle size, coating). Among three different ZnO nanoforms we found a similarity in both the 
dissolution as well as transformation behavior. The same observation was made for two different TiO2 
nanoforms. Here similar dissolution and the absence of transformation was detected for both materials. 
Eventually this setup will allow grouping of nanoforms based on their biopersistence within a cascaded GIT 
setup. 
 
Via the PATROLS and NanoHarmony projects, the results contribute to the robustness of two OECD projects 
focusing on integrated testing of oral uptake and toxicity.   
Dosimetry in in vitro toxicity studies 
The sample preparation and the dosimetry of ENM in vitro testing was explored. Through analysis of the 
mass fraction of the dose accumulating at the cells, the predictivity of results obtained in in vitro toxicity 
studies could be enhanced through relevant dose-response curves. [124, 163] By furthermore exploring the 
possibilities and limitations of a freeze-thaw protocol for sample preparation, parallel testing through flash 
freezing the samples after sonication was enabled. [164] The freeze-thaw sample preparation altered the 
fraction of agglomerates by 35% compared to freshly prepared dispersions. After one-hour incubation, 
however, the difference was below 25%. Thus, overall, it modulated the dosimetry of the particles. 
Nevertheless, characterization and in silico modelling that reflected the actual colloidal properties during in 
vitro toxicology could be obtained by freeze-thawing.  
Regarding dosimetry, the fundamental notion that the deposited dose is lower than the total administered 
dose can be easily supported by simple measurements (DLS, VCM) and DG modelling. The deposited dose 
prediction varied significantly, ranging between 9 to 73% for the different nanomaterials with reflective 
boundary conditions. Especially for well-dispersed ENMs, uncertainty was introduced by choosing an 
arbitrary value of the affinity of particles to stick to cell surfaces (“reflective” vs. “adhesive” bottom). 
Additionally, for polydisperse ENMs, minor details of the particle size distribution strongly influenced the 
modelled dosimetry, such that the choice of the measurement technique - e.g., DLS or AUC - introduced 
further uncertainties to the dosimetry modelling. For any polydisperse ENM, reducing the output 
compartment height to 0.0005 mm helped to remove dips in the particle settling traces and the generation of 
erroneous predictions, but tremendously increased the DG model computing resources. Therefore, with 
optimized computing resources, the uncertainty of the actual deposited dose was considerable. When using 
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standardized dispersion protocols (NANoREG) and polydisperse industrially relevant materials, the model's 
predictions incurred an uncertainty of the deposited dose due to uncertainty in the inputs. The dose-response 
obtained by the modelled prediction of the deposited dose can thus shift significantly: If the in vitro reactivity 
of different nanoforms differs by a factor of 2.5, one cannot conclude if the results are from a dissimilarity 
of biological interactions or the methodical uncertainty of dosimetry modelling. For very well dispersed 
nanoforms, the range of uncertainty extends to a factor of 10. 
In current grouping frameworks, the uncertainty within the dosimetry predictions is not adequately taken into 
account. Therefore, AUC data, which was previously shown to act as a reliable source for dosimetry 




















Methods developed in this thesis project provide data on extrinsic material properties which are relevant for 
the risk assessment of ENMs. A coherent ranking scheme needs to be developed to bring the data obtained 
by these methods into use for hazard and risk assessment of ENMs. Furthermore, the extrinsic reactivity of 
an ENM, needs to be included in this scheme next to the dissolution, transformation, and dosimetry of ENMs. 
Such a comprehensive grouping framework is currently developed within the GRACIOUS project. [165]  
The relevant properties describing nanomaterials' hazard potential are also playing an essential role in 
advanced materials. Some of these materials are not captured by the REACH definition of a nanomaterials 
in terms of their external dimensions. However, due to a nano-porous structure they still retain unique 
properties. As a first example, the dissolution and reactivity of a set of organic and inorganic aerogels, was 
assessed. Overall, these results showed a very low inherent toxicity of aerogels and supported a grouping 
based on similarities in physicochemical properties. The validity of the concept and methods developed for 
particles needs to be further verified for advanced materials that contain or release nanostructures. 
The current frameworks are being developed to address the risk assessment of monoconstituent 
nanomaterials. These are relatively simple in terms of their chemical composition as well as surface 
functionalization. However, with increasing applications, the complexity of nanomaterials may increase as 
well. These next-generation nanomaterials with a more complex composition, may have different and more 
difficult to understand toxicological properties. Examples include the active centers in battery electrodes, 
catalysts, or photovoltaic modules. Therefore, the validity of these frameworks must be checked. The 
HARMLESS project - which will start in 2021, aims to provide novel tools, guidance, and decision support 















Während die Anwendungsgebiete von technisch hergestellten Nanomaterialien aufgrund ihrer einzigartigen 
Eigenschaften ständig zunehmen, müssen wir auch bedenken, dass sie auch potenzielle Risiken bergen. Es 
gibt zahlreiche Wege, wie Menschen sowohl natürlich vorkommende Nanomaterialien als auch technische 
hergestellte Nanomaterialien aufnehmen können, entweder durch Einatmen, Verschlucken oder durch 
dermale Aufnahme und Injektionen für medizinische Anwendungen. Daher ist es von größtem Interesse 
deren Gefährdungspotenzial zu berücksichtigen. Alle Nanomaterialien, die auf den europäischen Markt 
kommen, müssen daher auf ihre Sicherheit für Mensch und Umwelt getestet werden. Die bisher etablierten 
Richtlinien zur Bestimmung des Gefährdungspotenzials von Bulkmaterialien müssen jedoch angepasst 
werden, um auf Nanomaterialien angewandt werden zu können. Insbesondere für Inhalationsstudien müssen 
die physikalisch-chemischen Eigenschaften von Nanomaterialien bewertet werden. Die Dispergierbarkeit, 
die Form, die Partikelgröße, die Auflösung, die Reaktivität und einige weitere intrinsische und extrinsische 
Eigenschaften haben einen direkten Einfluss auf die Ablagerung, den Transport sowie das 
Entzündungspotential in der Lunge. 
 
Im Rahmen dieser Arbeit wurde eine Auswahl an Metall-, Metalloxid- und organischen Nanomaterialien auf 
der Grundlage industrieller Relevanz und verfügbarer in-vivo Toxizitätsdaten ausgewählt, um ihre 
extrinsischen Eigenschaften hinsichtlich ihres Risikopotentials zu bewerten.  
Um den Verbleib und das Gefährdungspotenzial eines Nanomaterials im menschlichen Organismus oder in 
der Umwelt zu bestimmen, ist es zwingend notwendig zu verstehen, wie ein Nanomaterial mit 
physiologischen Medien interagiert. Wesentlich für das Verständnis des Verhaltens, ist die Bestimmung der 
Auflösung und der Transformation von ihnen in relevanten Medien. Von Mineralfasern ist bekannt, dass mit 
dem „Continuous Flow System“ (CFS) die Persistenz in der Lunge vorhergesagt werden kann.  
Das eine Ziel der hier beschriebenen Arbeit war es, Methoden zur Untersuchung der Auflösung von 
Nanomaterialien zu entwickeln und zu standardisieren, um deren Verbleib im menschlichen Körper 
vorherzusagen. Hier wurde gezeigt, dass durch Anpassung des bereits für Mineralfasern etablierten 
Durchflusssystems sowie einer Quantifizierung der Ionen durch ICP-MS und Detektion der Transformation 
durch TEM deutliche Vorteile gegenüber einem statischen Auflösungsansatz erreicht wurden. Dies wurde 
durch den Vergleich der BaSO4 NM220-Auflösungsergebnisse mit Daten aus Versuchen mit alveolaren 
Makrophagen-unterstützten Auflösung sowie bestehenden in-vivo-Daten in Ratten weiter gefestigt. Das 
angepasste Durchflusssystem war nicht nur im Stande die Persistenz des Nanomaterials im Tierversuch 
vorherzusagen, sondern zeigte auch die gleiche Ostwald-Reifung der BaSO4 Partikeln, wie zuvor in 
Tierversuchen beobachtet wurde. Kontrollmessungen an CuO zeigten, dass dieser Effekt kein methodisches 
Artefakt war.  
Ein hohes Maß an Übereinstimmung der abiotischen Auflösung und der in vivo-Clearance wurde für CeO2 
NM211, CeO2 NM212 CuO, nano BaSO4 NM220 und ZnO NM111 erreicht.  
Zusätzlich konnte mit dieser Arbeit die Erwartung bestätigt werden, dass die Zusammensetzung des 




Während der Aufbau des CFS bei dem Großteil der Messungen die erwarteten Ergebnisse darstellen konnte, 
so war es unerlässlich, das Setup für sich langsam und nur teilweise auflösende Nanomaterialien weiter zu 
verfeinern, da die Auflösung durch Sättigungsbedingungen begrenzt wird. Hier führte eine zeitabhängige 
Steigerung der Flussrate zu einer Erweiterung des messbaren Bereichs um fünf Größenordnungen. Zudem 
wurde eine detailliertere Beurteilung des Auflösungsverhaltens für ebendiese Materialien ermöglicht.  
Die Anleitung, die den Auflösungsaufbau sowie die Durchführung beschreibt, wurde an andere Labore zum 
Vergleich und zur Harmonisierung übertragen. Basierend auf ZnO-Daten in PSF konnte KRISS die in dieser 
Arbeit bestimmte, schnelle Auflösung, reproduzieren und bestätigen. Zusätzlich wurde diese Methode 
standardisiert und dient derzeit als Grundlage für die Entwicklung einer OECD-Prüfrichtlinie (unter 
Federführung von Dänemark und Deutschland). Eine der Veröffentlichungen wurde von der ECHA in ihrem 
jüngsten Leitfaden hervorgehoben. Die hieraus gewonnenen Daten können helfen, Gruppen von Nanoformen 
mit ähnlichen Gefahrenpotenzial zu identifizieren. 
 
Für die Simulation der oralen Aufnahme wurde während dieser Arbeit ein Aufbau entwickelt, der die 
aufeinanderfolgende Inkubation in komplexen Flüssigkeiten erlaubt; Speichel, Magen und Darm. Bei der 
Auflösung von Nanomaterialien könnten Enzyme (und andere Proteine) einen relevanten Einfluss auf die 
Kinetik freigesetzter Ionen haben, da sie als Ionenfänger wirken können.  
Basierend auf den für TiO2 gewonnenen Daten kann die Aussage getroffen werden, dass das Material als 
unlöslich gilt, wenn weniger als 0,1 mg/L in einem der drei simulierten physiologischen Flüssigkeiten 
aufgelöst werden. Im Gegensatz zum teilweisen Abbau einiger anorganischer Oxide (ZnO, SiO2, CuO) wird 
für organische Pigmente auf der Grundlage des abiotischen Auflösungsscreenings keine Freisetzung von 
gelöstem, bioverfügbarem Material erwartet. Dies steht im Einklang mit in-vivo-Befunden oraler Studien. 
Zukünftige Studien sollten auch alternative Metriken in Betracht ziehen, wie z. B. den prozentualen 
aufgelösten Anteil oder die Auflösungsrate k, welche durch die Auflösung in aufeinanderfolgenden Medien 
deutlich komplexer zu berechnen ist. Bei der Verwendung von Benchmark-Materialien zum Vergleich des 
Auflösungsverhaltens wurde trotz erheblicher Unterschiede (nano & nicht-nano, Partikelgröße, 
Beschichtung) kein Unterschied zwischen den Nanoformen in Bezug auf ihr Auflösungs- und 
Transformationsverhalten gefunden. Unter drei verschiedenen ZnO-Nanoformen wurden Ähnlichkeiten 
sowohl im Auflösungs- als auch im Transformationsverhalten beobachtet.  
Dieser Aufbau kann in Zukunft dazu dienen eine Gruppierung von Nanoformen basierend auf ihrer 
Biopersistenz innerhalb der verschiedenen oralen Medien zu ermöglichen. Die Daten finden Anwendung in 
den beiden Projekten, PATROLS und NanoHarmony, zwei OECD-Projekten, die sich unter anderem mit 
dem toxikologischen Potential der oralen Aufnahme beschäftigen.  
 
Das andere Ziel der arbeit war es, sowohl die Probenvorbereitung und Dosimetrie von Nanomaterialien als 
auch deren Beitrag zur Vorhersagekraft für in in-vitro-Tests zu untersuchen. Durch die Analyse des 
sedimentierten Anteils in Abhängigkeit der Zeit, konnte die Vorhersagekraft durch entsprechende Dosis-
Wirkungs-Kurven verbessert werden. Darüber hinaus wurden die Möglichkeiten und Grenzen eines Gefrier- 
und Auftau-Zykluses in der Probenvorbereitung untersucht. Wässrige Nanomaterial Dispersionen wurden 
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nach Behandlung im Ultraschallbad, schockgefrostet und erneut aufgetaut. Die Probenvorbereitung 
veränderte den Anteil der Agglomerate um 35 % im Vergleich zu frisch hergestellten Dispersionen. Nach 
einstündiger Inkubation lag der Unterschied jedoch unterhalb von 25 %. Obwohl der Gefrier-Auftau-Prozess 
die Partikel stärker agglomerieren ließ, konnten sowohl Charakterisierungen als auch Modellierungen 
durchgeführt werden, die die tatsächlichen kolloidalen Eigenschaften während in-vitro Versuche 
widerspiegelten.  
Die Vorhersage der deponierten Dosis variierte erheblich und lag zwischen 9 und 73 % für die verschiedenen 
Nanomaterialien mit reflektierenden Randbedingungen. Dies konnte die Beobachtung erklären, dass die 
deponierte Dosis meist deutlich geringer ausfiel als die Gesamtdosis des Testsystems. Diese Beobachtung 
wurde zusätzlich unterstützt durch simple gravimetrische Messungen sowie Lichtstreumethoden zur 
Bestimmung der Partikel- und Agglomeratgröße. 
Im Modelling Ansatz wurde besonders für gut dispergierte Nanomaterialien die Unsicherheit des Testsystems 
durch die Wahl eines willkürlichen Wertes für die Affinität der Partikel, an Zelloberflächen eingeführt. Die 
wahl zwischen "reflektierendem" vs. "adhäsivem" Boden, führte zur starken Beeinflussung polydisperser 
Nanomaterialien. Hier konnten bereits sehr kleine Abweichungen der Partikelgrößenverteilung die 
modellierte Dosimetrie stark beeinflussen. Durch die Verringerung des Abstands der Berechnungsabschnitte 
auf 0,0005mm von 0,015mm konnten fehlerhafte Vorhersagen beseitigt werden. Dies führte jedoch zu einem 
nahezu exponentiell gesteigerten Rechenaufwand. Bei Verwendung von standardisierten Protokollen 
(NANoREG) sowie polydispersen Materialien war die Vorhersage des Modells mit großer Unsicherheit der 
deponierten Dosis behaftet. Im Falle der Differenz in in-vitro-Reaktivität verschiedener Nanoformen um den 
Faktor 2,5 konnte bereits keine Aussage mehr getroffen werden, ob die Ergebnisse auf eine Ungleichheit der 
biologischen Wechselwirkungen oder auf die methodische Unsicherheit der Dosimetrie-Modellierung 
zurückzuführen sind. Im Falle von sehr gut dispergierten Nanoformen hat man hier Spielraum bist zu einer 
zehnfachen Unsicherheit. 
Im aktuellen Gruppierungsrahmen wird die Unsicherheit innerhalb der Dosimetrievorhersagen nicht 
angemessen berücksichtigt. Daher können die Daten - welche durch Analytische Ultrazentrifugen erzeugt 
wurden - von denen zuvor gezeigt wurde, dass sie als zuverlässige Quelle für Dosimetrievorhersagen dienen, 
als Grundlage für die Bewertung der In-vitro-Toxikologie verwendet werden. Hier müssen lediglich 
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